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Abstract 
Background 
TB is a growing public health problem. Most research focuses on secondary care. This, 
the largest study of TB in primary care to date, aims to investigate aspects of TB 
epidemiology by examining the role of primary care in case detection, management and 
outcomes.  
 
Methods 
Using data from the General Practice Research Database a case-control and a self-
controlled study were undertaken to investigate TB pre-diagnosis and a self-controlled 
and cohort study to describe and quantify TB morbidity and mortality post-diagnosis. 
 
Results 
3032 TB cases and 15,160 matched controls were analysed. The pre-TB studies showed 
that cases had higher consultation rates, consulted on multiple occasions often with 
recurrent respiratory infections and experienced a diagnostic delay of up-to-4months. 
Strengths of association between symptoms, respiratory diseases and TB were also 
noted.  
The case-control study also showed that male gender, smoking and chronic disease were 
independent risk factors for TB. 
Post-TB, patients who survived at least 18months had no increase in morbidity but TB 
led to a slight increase in all-cause mortality (adjusted HR:1.53) and a case fatality rate 
at one year of 6.5%. Mortality was highest in the first year post-diagnosis. Undiagnosed 
pulmonary TB, older age, male gender, malignancy and chronic disease were all 
  4 
associated with a worse prognosis. At 10 years, TB cases had a 70% chance of survival 
compared to 79% for patients’ without-TB.  
 
Conclusions 
Diagnosing TB in primary care remains a challenge due to its variable and non-specific 
nature but a window of opportunity exists from 4months following first presentation. 
Combining knowledge of the strength of association between TB, its symptoms and 
respiratory diagnoses, TB risk factors and raising awareness of newer investigations and 
local referral processes could help GPs make an earlier diagnosis.  
This research indicates a need for improved patient and professional awareness of TB 
and emphasises the need for earlier diagnosis.  
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Chapter 1  
 
Introduction and Background 
1.1 Introduction 
Tuberculosis (TB) is a potentially fatal infectious disease caused by the bacterium 
Mycobacterium tuberculosis. It is a worldwide public health emergency.1 Rates are 
rising once again in the UK,2 (after having fallen dramatically through most of the 20th 
century) and ways to improve TB prevention and control are being debated.2-8 
Epidemiology is “the study of the distribution and determinants of health-related states 
or events in specified populations, and the application of this study to the control of 
health problems.”9 Most published studies on TB focus on secondary care and the role 
of primary care is poorly understood.8, 10-13 To improve TB prevention and control in the 
UK a better understanding of the epidemiology of TB from a primary care perspective is 
essential. In the UK, sick patients usually consult their GP first and are likely to consult 
on a number of occasions prior to a diagnosis of TB because TB is often an insidious 
disease.14 Primary care therefore has an important role in trying to diagnose and treat 
TB early and so reduce ongoing disease transmission. To diagnose early it is important 
to understand the epidemiology of TB, the diagnostic process in primary care and the 
relationship between the onset of symptomatic disease and the start of treatment. 
Late diagnosis of active TB is thought to be responsible for increased transmission, poor 
outcomes and an increased risk of death.15-18 Research on diagnostic delay, classified as 
a delay from symptom onset to diagnosis or start of treatment,19, 20 has been conducted 
and shows large variation.19-25 
Long-term morbidity following a diagnosis of active TB has been little studied and 
mortality rates in TB patients vary considerably.16, 26-33 Analysing TB-patient deaths, 
and assessing those attributable to TB and those from other causes, as well as risk 
factors for death should increase our understanding of the epidemiology of TB. In 
Chapter 1 – Introduction and Background  19 
addition, it could help improve the care and outcomes of TB patients and thus reduce 
this potentially preventable cause of death. 
In the UK, TB remains mostly managed by secondary care. Although a diagnosis may 
be suspected in primary care, confirmatory investigations tend to occur in secondary 
care followed by prolonged treatment. An understanding of the pre-diagnostic period 
and the role of primary care is crucial to controlling TB in the UK. 
A better understanding of TB epidemiology in primary care could be used to inform 
ways to diagnose TB earlier and improve patient management and outcomes. My thesis 
therefore aims to investigate TB from a primary care perspective and to study different 
aspects of TB epidemiology, control and prevention by assessing primary care 
consultations, TB morbidity and mortality. 
1.2 Aims and Objectives 
1.2.1 Aims 
The overall aim of this research was to investigate the epidemiology of TB from a 
primary care perspective by examining the role of primary care in detection, 
management and patient outcomes. 
1.2.2 Objectives 
The objectives of this research were: 
 
1. To investigate consultation behaviour in primary care using a case-control 
study prior to a diagnosis of active TB and to assess diagnostic delay. 
2. To investigate consultation behaviour in primary care using a self 
controlled study to minimise the impact of confounders, such as ethnicity 
and social status, and compare the results of this to the case-control study 
3. To describe and quantify morbidity from TB in primary care. 
4. To describe and quantify mortality from TB. 
5. To describe risk factors for death in TB patients. 
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1.3 Overview of TB 
1.3.1 The Natural History of TB 
Tuberculosis (TB) is a potentially fatal infectious disease caused by the bacterium 
Mycobacterium tuberculosis. It is transmitted via the inhalation of infected respiratory 
droplets coughed or sneezed by a person infected with TB.34 It most commonly infects 
the lungs, but can affect any part of the body. 
Once a patient is infected with Mycobacterium tuberculosis they have ‘TB infection’ for 
life (unless treated) and their lifetime risk of developing ‘active’ or symptomatic TB is 
approximately 10%.14, 35, 36 Progression from TB infection to TB disease (a symptomatic 
state) occurs when the Mycobacterium tuberculosis bacilli overcome the patient’s 
immune response and multiply leading to symptomatic disease. A patient with TB 
infection usually remains asymptomatic and undiagnosed; however about 5% go on to 
develop primary TB disease. ‘Primary TB’ is when TB infection progresses to 
symptomatic TB disease in a relatively short period of time (a few weeks to months).14, 
37, 38 Another 5% of patients go on to develop post-primary or reactivation TB often 
many years later.14, 37 ‘Post-primary’ or reactivation TB predominantly affects the lungs 
and symptoms once started usually develop quickly and can be both respiratory and 
constitutional.6, 14 
Figure 1.1 The natural history of TB 
TB Infection
Primary TB Latent TB
Post-primary TB
5%
5% 95%
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After infection, Mycobacterium tuberculosis may remain dormant for many years 
before causing post-primary or reactivation TB. This dormant state is known as latent 
infection or latent TB. ‘Latent TB’ is defined as the absence of clinical disease 
associated with a positive tuberculin skin test (a diagnostic test for TB), a positive 
interferon-gamma blood test or a chest x-ray that shows the scars of old TB (i.e. the 
patient is well and has no symptoms or signs of TB disease).39-42 In contrast to 
individuals with active/symptomatic (primary or post-primary) TB those with latent TB 
do not transmit the infection and so pose no public health risk. The likelihood of 
progression from latent to active TB is highest in the first year after infection.40, 41, 43 
Host factors such as age, immunosuppression and other medical problems (e.g. HIV 
infection) increase the chance of developing active TB.43 
1.3.2 Transmission 
TB is not highly infectious in everyday circumstances. Prolonged close contact with an 
infectious patient is usually necessary for transmission, for example, living in the same 
household as an infectious patient.34, 44, 45 It has been estimated that an infectious patient 
(i.e. a patient whose sputum-smear is positive for Mycobacterium tuberculosis bacilli) 
will infect on average 10-15 people each year and over 20 people during the natural 
course of untreated disease.4,46 The risk of a contact becoming infected with TB depends 
on the nature and duration of their exposure; in close household contacts the risk is 
considered to be 1 in 3 and for casual social contacts 1 in 100,000.4,34,39 Transmission 
tends to occur from people with active, and infectious pulmonary or laryngeal TB, not 
latent TB or extra-pulmonary TB. 
1.3.3 Clinical Presentation 
Nearly two-thirds (62%) of patients with active TB, in England and Wales, had 
pulmonary TB in 19982 and 56% in 2007.47 Cough is the most common respiratory 
symptom and is usually present for more than 2-3 weeks;14 with haemoptysis in a small 
minority of cases.6 The classic symptoms of pulmonary TB (active TB disease affecting 
the lungs) include: chronic cough, fever, lymphadenopathy, weight loss, night sweats 
and haemoptysis.14 Not all forms of pulmonary TB are infectious. TB patients with 
“smear positive” TB are infectious and this state is defined by the fact that bacteria can 
be seen on microscopic examination of the patient’s sputum. TB can affect other parts 
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of the body, this is known as extra-pulmonary TB (for example TB of the kidney or 
spine). Symptoms depend on the organ affected and intermittent fever or weight loss are 
often also present.6 Persistent lymphadenopathy, present for longer than 4 weeks, in a 
non-white individual should be considered TB until proven otherwise.6 Extra-
pulmonary TB may present with systemic symptoms or site-specific symptoms.48 
Weight loss, fever and night sweats are particularly associated with disseminated 
(including miliary)38 and gastro-intestinal TB. However, fever and night sweats are less 
common in other extra-pulmonary TB cases (e.g. peripheral lymph nodes, skin, bone 
and joint, genitourinary TB). Nearly half of all extra-pulmonary TB occurs in peripheral 
lymph nodes.14 
1.3.4 Diagnosis 
A diagnosis of TB can be confirmed by finding Mycobacterium tuberculosis in a 
sputum49 or biopsy specimen50 (either microscopically or on culture); and is supported 
by an abnormal chest x-ray,51,52 a positive tuberculin skin test (Heaf or Mantoux)40,41,53 
or more recently, for latent infection, a positive interferon-gamma test.14,42,54,55 
1.3.5 Treatment 
TB is curable if treated early with appropriate drugs and for a minimum of six months.5, 
55-57 During treatment a patient takes 4 drugs: rifampicin, isoniazid, pyrazinamide and 
ethambutol for 2 months then rifampicin and isoniazid alone for the subsequent 4 
months. A minority of cases are resistant to at least one standard drug. For these patients 
different treatment regimes and duration are used. Patients with pulmonary TB are 
considered non-infectious after two weeks of treatment. 
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1.4 The Epidemiology of TB in the UK 
TB is a notifiable disease, i.e. it is a statutory requirement that cases of active TB are 
notified to the ‘Proper Officer’ for Health, the local Consultant in Communicable 
Disease Control. Data on notified TB cases are collected via Enhanced Tuberculosis 
Surveillance (ETS).58,1 TB nurses and respiratory consultants complete ETS forms 
which are then collated and analysed by the Health Protection Agency Centre for 
Infections. ETS data is linked to other datasets such as those from the mycobacterial 
surveillance network (MycobNet) that collates microbiological data on Mycobacterium 
tuberculosis complex isolates and their drug susceptibilities from reference laboratories 
across the UK. 
Figure 1.2 TB notifications in London, England and Wales 1982-2007 
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1  Enhanced Tuberculosis Surveillance is a surveillance system established in 1999 in England and 
Wales to collect more detailed and timely information on patients with TB. It provides an annual 
corrected analysis of TB case reports by age, sex, ethnic group, country of birth, site of disease and 
NHS region. 
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In 2007, 8417 people were newly diagnosed with active TB in the UK. This represents 
an incidence rate of 13.8 per 100,000 population.47 Since the mid-1980’s there has been 
a steady rise in the number of UK TB cases (see Figure 1.2). TB remains primarily a 
disease linked to poverty and social exclusion.59 Contributing to the rise have been 
changing patterns of immigration,60 increased homelessness3,60,61 and HIV infection60 as 
well as an ageing population. In 2007 the majority of cases were reported in England 
(92%) with London accounting for 39% (a rate of 43.2 per 100,000).47 Published 
research shows there is significant local variation in TB incidence across London62 and 
that it is especially high in new immigrants who have recently entered the UK.2,63 An 
analysis in 2003, showed that the majority (85%) of Primary Care Trusts (PCTs) had 
less than 20 cases per 100,000; 7% (24 PCTs) had a rate of ≥40 per 100,000 and most of 
these were in London.64 
Figure 1.3 Rates of TB in England by Local Authority, 2007 
 
Source: Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK 2008 47 
In 2007, 56% of UK TB cases had pulmonary TB and more than half of all TB cases 
were male (55%).47 TB occurs in all age groups but the majority (60%) of cases were 
diagnosed in people aged 15-44 years; 6% were aged 0-14 years, 19% aged 45-64 years 
and 14% aged over 65 years.47 Seventy two percent of those diagnosed with TB were 
born abroad, predominantly in South Asia and sub-Saharan Africa.47 The ethnic groups 
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with the highest rates of TB are Black Africans (309 per 100,000), followed by Indian, 
Pakistani and Bangladeshi (212 per 100,000).47 UK surveillance data shows that about 
half of all TB patients who are born abroad were diagnosed with TB within the first five 
years of first entering the UK.47 
In 2007, 7.4% of TB cases in the UK had resistance to at least one first line drug and 
1.2% were multidrug-resistant (resistant to at least isoniazid and rifampicin).47 This 
represents a small increase in resistance over a 10 year period to at least one first line 
drug and multidrug-resistance.2, 65 
Co-infection of TB patients with HIV is a small but increasing problem in the UK. In 
1993, 2.2% of TB patients were co-infected in England and Wales; by 1998 this had 
risen to 3.3%66 and by 2003 to 8.3%.67 
1.5 Public Health Issues and TB 
1.5.1 The Rising Incidence of TB 
TB is an international public health problem.68 In 1993 the World Health Organization 
(WHO) declared TB a global emergency. WHO estimated that in the year 2000 
approximately a third of the world’s population, 2 billion people, were infected with 
Mycobacterium tuberculosis, that 8.3 million new cases of TB were diagnosed and that 
1.8 million people died from the disease.69 In 2007, 9.7 million new cases of TB were 
identified.70 Much of the rising global incidence of TB is attributable to the spread of 
HIV in Africa.68 
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Figure 1.4 Estimated TB incidence by country 2007 
 
Source: WHO report 2009 – Global tuberculosis control: Epidemiology, strategy, financing.70 
The incidence of TB in the United Kingdom remains relatively low by global standards. 
Throughout most of the 20th century the incidence of TB declined in England and 
Wales;71,72 but a rise in incidence since the mid-1980’s2,58 and high rates of TB in 
certain sub-groups now make TB an increasingly important public health problem.3,47,60, 
72,73 
In the last 10 years England and Wales have seen a 25% rise in TB case numbers.4 The 
distribution of TB in England and Wales varies markedly by geographical area.73 Rates 
are highest in urban areas, particularly London,2,7 whereas a continued decline has been 
seen in most rural areas.58 Ethnic minorities contribute a substantial and increasing 
proportion of TB cases.2,47,58,73 
1.5.2 The Risk of TB Transmission 
The longer an active case of TB goes undetected, due to a delay in diagnosis, the higher 
the risk of transmission to close contacts. Research suggests that a patient with 
infectious TB will infect on average 10-15 people per year (i.e. 5-7 people if diagnosis 
is delayed by 6 months).4,46 See section 1.3.2. 
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1.6 The Organisation of TB Services in the UK 
The majority of patients who become unwell in the UK present to a GP in primary care. 
A GP’s role includes taking a thorough history, examining the patient and ordering 
baseline investigations. If a GP suspects TB they either initiate investigation themselves 
or they refer the patient to the TB Service at their local hospital. The local TB Service 
then undertakes further investigations: such as, blood tests, sputum samples and a chest 
x-ray. If TB is confirmed a respiratory consultant reviews the patient and prescribes 
treatment. Standard TB treatment lasts for 6 months, this is often prescribed and 
dispensed by the hospital and patients return to hospital once a month throughout their 
treatment for follow-up usually with a TB nurse. In some areas of the UK once a patient 
is stabilised on TB treatment they can see their GP for regular review and prescriptions. 
If the patient is extremely unwell or does not have a GP (because they are homeless or a 
newly arrived immigrant who has not yet registered with a GP) it would be usual for the 
patient to present via the Accident and Emergency department of their local hospital. If 
necessary, patients are admitted to hospital and see the TB team while an in-patient or 
alternatively are sent home with a referral to the hospital TB service, in the same way as 
a patient referred via their GP. 
As TB is an infectious disease, with the potential to infect others, part of the UK TB 
Service’s role is to investigate and screen contacts of a TB case that may be at risk of 
becoming infected. This is known as ‘contact tracing’. This role is often undertaken by 
TB nurses either at the hospital or in the community. In the UK there is no systematic 
TB screening programme. 
The majority of patients with active/symptomatic TB (as with most diseases) will first 
make contact with primary care; primary care therefore has an important role in 
diagnosing TB early. 
1.7 Control and Prevention of TB 
The most important part of TB control and prevention is the identification and treatment 
of those who already have the disease so as to shorten their infectious period and to halt 
onward transmission. 
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TB can be controlled by: 
 
• prompt diagnosis and treatment of people with active disease to achieve 
cure and so prevent transmission 
• ensuring TB patients complete their treatment 
• identifying and treating people with early infection / latent TB (i.e. through 
contact tracing or new entrant screening) 
• prevention through BCG immunisation 
 
Due to the changing epidemiology of TB in the UK, there has been increased concern 
and debate as to the effectiveness and adequacy of current TB control and prevention 
measures.2,3,7, 74 A better understanding of TB from a primary care perspective would be 
useful so that improved control and prevention measures could be taken in this setting. 
1.8 The GPRD as a Data Source for Research 
The General Practice Research Database (GPRD) is the world’s largest computerised 
primary care database.75,76 Currently it contains over 20 years of longitudinal data 
(1987-2009) on approximately 13 million patients from approximately 500 practices 
covering 5.5% of the UK population.77 Twelve percent of GPRD GP practices are based 
in London and a third in urban areas (personal communication – Mary Thompson, 
EPIC). The GPRD is considered broadly representative of the UK population in terms 
of age and sex structure76 and has been widely used for epidemiological research.78-83 
Several validation studies have shown that there is a high degree of completeness and 
reliability in the data contained within the GPRD76, 80, 84-88 and there is good agreement 
between the GPRD prescribing data and national data from the Prescription Pricing 
Authority.76,85 Data quality is high as data from practices are routinely validated by 
internal checks,85 and only data meeting a minimum preset standard are added to the 
database.75 
Anonymised patient data are collected from participating practices. Practices use 
standard software to record patient and consultation information and periodically down-
load anonymised patient information to a central computer system managed by the 
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UK’s Medicines and Healthcare Products Regulatory Agency (MHRA).77 All 
information for individual patients is handled using a unique identification number.75 
GPs record medical diagnoses and symptoms using Read and Oxford Medical 
Information System (OXMIS) codes; these codes are based on, and can be mapped to, 
the internationally recognised classification systems of Disease (ICD-10) and Surgical 
Operations and Procedures (OPCS-4). Data for each patient includes: age, sex, medical 
diagnosis and symptom records, details of each patient consultation, medication 
prescribed, a summary of specialists' clinical notes and hospital letters, results of 
laboratory tests and a free-text section.75, 77 
The GPRD is a powerful tool for epidemiological and health service research from 
which a substantial number of studies in peer-reviewed literature have been generated.75 
It has been validated for use in respiratory epidemiological studies by Hansell80 who 
used the GPRD to assess 11 respiratory diagnoses, TB being one of these. She found a 
TB rate of 1.4 patients /10,000 patient years plus good agreement between the GPRD 
and the 4th Morbidity Survey in General Practice.80,89 The GPRD has been used for 
many high quality studies including those in respiratory disease.78, 80, 83, 90-92 
The GPRD is an extremely useful tool for research purposes. Its strengths lie in its: 
1. Large size (13 million patients)77 
2. Continuous, longitudinal primary care data (now 20 years of data)77 
3. Comprehensive coverage of UK population76 
4. High-quality validated data - reliable and with a high degree of 
completeness85, 93 
5. Substantial statistical power - so it is a unique tool for rare diseases or 
events 
6. Instantly available as it is already collected and processed 
7. Ability to link prescriptions to diagnoses77 
8. Allows investigation into long-term morbidity and mortality79, 80, 83, 92 
9. Use in epidemiological studies80, 92 
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It does however have some limitations, these are: 
1. Primarily a clinical database of real-time patient notes so requires intensive 
data management and cleaning to make suitable for statistical analyses 
2. Complexity of data recording and therefore analysis93 
3. Consists of observational data 
4. No requirement to enter diagnoses for minor consultations 
5. Variation in GP recording 
6. Limited secondary care data 
7. Free-text fields not available unless requested 
8. No ethnicity data or social class data during the analysis period 
9. Many similar but different terms coded but not linked to over-arching 
diagnosis 
10. Geographic distribution of GP practices 
1.9 Overview of Thesis 
This thesis consists of a number of related studies of TB in the UK using data from the 
GPRD. The studies use classical epidemiological methods (case-control and cohort 
methodology) and a more recently developed but well established method, self-
controlled methodology, to assess TB from a primary care perspective analysing 
consultation behaviour prior to a diagnosis of TB and morbidity and mortality following 
TB. 
Chapter 1 - Introduction: This sets the scene, reviewing TB as a disease, its 
epidemiology, its public health consequences and how TB Services are run in the UK. 
In addition, it gives an overview of the GPRD dataset, which was used to undertake the 
research for this thesis. 
Chapter 2 - Literature Review: This chapter details the literature reviews on ‘TB from 
a primary care perspective’ and ‘TB and diagnostic delay’. 
Chapter 1 – Introduction and Background  31 
Chapter 3 - Methods: This chapter details the study design and methods, the dataset, 
data cleaning and the statistical analysis undertaken. 
Chapters 4 to 7 - Detail the different epidemiological studies used to assess TB from a 
primary care perspective: two describe TB epidemiology pre-TB, a third looks at 
morbidity post-TB and a fourth looks at mortality post-TB. All these studies try to 
increase our understanding of TB from a primary care perspective. The first two assess 
how TB patients present and consider how to reduce diagnostic delay and the latter two 
try to assess clinical outcomes. 
Chapter 8 - Discussion: This aims to draw the findings presented in Chapters 4 to 7 
together in a discussion, looking at what the implications of these research findings are 
for primary care and TB in the UK and then documents future steps. 
In summary, the overall aims of this thesis are to investigate TB from a primary care 
perspective, to understand the role of primary care in TB case detection and 
management, review the problem of late diagnosis and assess the long-term outcomes 
for patients in terms of morbidity and mortality. On the basis of the evidence, this thesis 
will then set out proposals for improving TB prevention and control in the primary care 
setting. 
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Chapter 2  
 
Literature Review: TB and Primary Care and TB and 
Diagnostic Delay 
2.1 Introduction 
Late diagnosis of TB is thought to be responsible for increased disease transmission,17 
poor patient outcomes and an increased risk of mortality.15,16,18,68,94 Research on 
diagnostic delay (classified as a delay from symptom onset to diagnosis or start of 
treatment)19,20 has been conducted and shows considerable variation in the length of 
such delay.15-20,23,24 Early diagnosis & treatment of TB are essential for an effective TB 
control programme. Delays need to be minimised where ever possible to reduce the risk 
of ongoing transmission and to improve clinical outcomes. Most transmission occurs 
prior to treatment when the patient is symptomatic with cough. Research has shown 
patients remain infectious for as-long as treatment is delayed.95 
2.2 Aims 
The aims of this literature review were to assess: 
1. the role of primary care in TB diagnosis 
2. the literature on diagnostic delay for TB patients: to summarise what is 
known about diagnostic delay and to quantify this delay. 
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2.3 Method 
2.3.1 Literature Retrieval 
A systematic review of computerised databases from 1980 to 2009 was carried out 
using Medline, EMBASE, CINAHL, HMIC, the Cochrane Database of Systematic 
Reviews and the Cochrane Central Register of Controlled Trials. Standard MeSH 
headings were selected using the PubMed MeSH database supplied by the US National 
Institute of Health in its digital archive of bio-med journals. The following MeSH 
headings and keywords were used; tuberculosis, primary care (primary care, general 
practice, family practice, family physician, family practitioner, general practitioner), 
diagnostic delay (diagnos*, delay*, late, patient delays, health care delays). The search 
strategies are detailed in Appendix 1. All searches were limited to studies in humans 
and English language articles. Articles from low income countries were excluded and 
those from health systems very different to that of the UK. The reference lists of articles 
identified by the systematic review were also reviewed for additional references. The 
most recent editions of relevant journals (BMJ, Thorax, Lancet, NEJM, JAMA, 
American Journal of Respiratory and Critical Care Medicine and others) were hand 
searched at the time of the literature review (2009) to identify relevant articles not yet 
entered in the electronic databases. Original papers were retrieved and critically 
appraised using the Critical Appraisal Tools developed by the Critical Appraisal Skills 
Programme (CASP) based at the Public Health Research Unit in Oxford.  
[http://www.phru.nhs.uk/casp/critical_appraisal_tools.htm] 
A summary of the search strategies is shown in Table 2.1 and 2.2. 
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Table 2.1 Search Strategy for TB and primary care literature 
Database Search terms Relevant 
Results 
Medline: 1980 – Dec 2009 Tuberculosis AND primary care, general practice, 
family practice, family practitioner, general 
practitioner, family physician 
ALL SUBHEADINGS, 
LIMITED to English language & human 
185 
EMBASE: 1980 - Dec 2009 Tuberculosis AND primary care, general practice, 
family practice, family practitioner, general 
practitioner, family physician 
ALL SUBHEADINGS, 
LIMITED to English language & human 
271 
CINAHL: 1981 – Dec 2009 
 
Tuberculosis AND primary care, general practice, 
family practice, family practitioner, general 
practitioner, family physician 
LIMITED to English language  
64 
HMIC (all years) Tuberculosis AND primary care, general practice, 
family practice, family practitioner, general 
practitioner, family physician 
8 
Cochrane Database of 
Systematic Reviews 
(all years) 
Tuberculosis AND primary care  0 
Cochrane Central Register of 
Controlled Trials 
(all years) 
Tuberculosis AND primary care  2 
Table 2.2 Search Strategy for TB and diagnostic delay in the UK 
Database Search terms Relevant 
Results 
Medline & EMBASE 
1980 – June 2009 
Tuberculosis AND diagnos*, delay*, late 
ALL SUBHEADINGS, 
LIMITED to English language & human 
596 
HMIC (all years) Tuberculosis AND diagnos*, delay*, late 4 
CINAHL 
(1981 – June 2009) 
Tuberculosis AND diagnostic delay, treatment delay 
LIMITED to English language 
1 
Cochrane Database of 
Systematic Reviews 
(all years) 
Tuberculosis AND diagnostic delay, treatment delay 
 
0 
Cochrane Central Register 
of Controlled Trials (all 
years) 
Tuberculosis AND diagnostic delay, treatment delay 
 
0 
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2.3.2 Selection of Relevant Research Papers 
To review the literature on ‘TB and primary care’ and ‘TB and diagnostic delay’ I used 
a structured approach to formulating my search questions,96 a technique recommended 
by the Evidence Based Medicine Working Group.97 This technique helped focus my 
research questions by linking a patient group with an intervention (exposure) and an 
outcome (see table 2.3) and enabled me to generate key search terms for use with 
bibliographic databases. 
The specific questions were: 
 
• What is the role of primary care / the GP in diagnosing TB? 
• What is the delay from symptoms to diagnosis experienced by TB patients? 
• What are the factors associated with, or causes of, diagnostic delay for TB 
patients? 
Table 2.3 Structured search questions on diagnostic delay 
Question Patient group / 
population 
Intervention 
 
Outcome / 
Outcome measure 
What is the delay for 
patients diagnosed with 
TB? 
TB patients ● Diagnosis (missed 
diag, delayed diag, 
late diag) 
● Primary care 
● Secondary care 
● Earlier diagnosis 
● Earlier referral 
● Less delay in diagnosis 
 
What are the causes of 
diagnostic delay for 
patients with TB? 
TB patients ● Diagnosis (missed 
diag, delayed diag, 
late diag) 
● List of causes 
 
What is the role of primary 
care / the GP in 
diagnosing TB? 
TB patients ● Primary care 
 
● Diagnosis 
● Referral 
 
What is the role of 
secondary care in 
diagnosing TB? 
TB patients ● Secondary care 
● Hospital 
● Diagnosis 
● Referral 
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2.3.3 Study Exclusion and Inclusion Criteria 
Studies were included if they: 
1. Focused on TB 
2. Included patients as individuals or groups 
3. Mentioned primary care or primary care practitioners 
4. And if they included my key search terms to answer my structured 
questions 
 
Studies were excluded if they: 
1. Did not involve humans 
2. Were not published in English 
3. Were based in countries dissimilar to the UK where TB prevalence is high 
and country income is low 
2.3.4 Assessment of the Strength of the Evidence 
I graded the evidence using a system developed by the Scottish Intercollegiate 
Guidelines Network (SIGN)98,99 and used by the National Institute for Clinical 
Excellence (NICE) (see Table 2.4). I used a standardised data collection form to extract 
data including: year, author, country, study type, sample size, factors increasing and 
decreasing delay, quantification of delay and any comments. 
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Table 2.4 Criteria for grading evidence and recommendations 99 
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2.4 Results 
2.4.1 The Role of Primary Care in the Diagnosis of Tuberculosis 
2.4.1.1 Literature Yield 
The key words used in my search strategy generated a pool of nearly 500,000 
references. Individual key words were then combined to narrow the search to references 
most likely to be relevant, so reducing the number of papers to 548. The titles and 
abstracts of these papers were then reviewed and 30 papers met my broad inclusion 
criteria (see Section 2.3.3). Ten articles8, 10-13, 20, 100-103 covered TB and primary care in a 
way relevant to my research question “what is known about the role of primary care in 
diagnosing symptomatic TB”. These were reviewed and are discussed here. Six papers 
looked at TB in primary care from a new entrant / new registrant screening perspective 
rather than that of new symptomatic disease63, 100, 104-107 these were excluded, as were a 
further twelve papers that covered TB and primary care in an international setting that 
was not directly relevant to the UK situation. 
2.4.1.2 The Research Evidence 
There is very little published on the diagnosis of TB in primary care. Of the ten articles 
that met the inclusion criteria, only one was a study specifically looking at the diagnosis 
of TB from a primary care angle,8 one assessed diagnostic delay in primary care,20 three 
were editorials,11-13 three were letters10,101,103 and the remainder just mentioned TB in a 
primary care setting. It is important to note that editorials and letters are opinions rather 
than objective evidence and as such would not normally be included in a literature 
review. However, due to the lack of published peer-reviewed research I felt it was 
appropriate to include them. 
A paper by Metcalf et al. (2007)8 was the only study in this systematic literature review 
that specifically explored TB from a primary care perspective in the UK. This small 
qualitative study assessed the process of diagnosing TB in primary care by using semi-
structured interviews with 17 patients and 16 GPs and then analysed the data 
thematically. Metcalf highlights the huge variety of TB presentations seen by GPs and 
the difficulties they face in making a timely diagnosis. She found that where diagnosis 
is clear, GPs generally test specifically and refer appropriately. She identified barriers to 
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prompt diagnosis as: atypical presentations, low level of clinical suspicion of TB by 
GPs, lack of continuity of care, workload demands that limit time with patients and sub-
optimal clinical / patient communication. Overall, this paper highlights the fact that 
early diagnosis is one of the most important contributions primary care can make to 
improved TB control and that raising awareness, through improved education among 
health professionals, is essential. In addition, as part of this study Metcalf searched the 
databases Medline, Pubmed, EMBASE from 1966 to 2005 using the terms 
“tuberculosis” and “diagnosis.” She found no study explored the process of diagnosing 
TB in primary care in high income countries. 
A study by Lewis et al. (2003),20 assessed the delay in starting TB treatment in East 
London. It showed a median delay of 18 weeks (range 0-129) from first symptoms to 
starting treatment; with a median ‘patient delay’ (from first symptom to first GP visit) of 
9 weeks and a median ‘healthcare delay’ (from first GP assessment to starting TB 
treatment) of 5 weeks. Patient delay was significantly longer than healthcare delay 
(p=0.019). This suggests there is a need to improve awareness of TB symptoms in both 
patients and GPs. 
Three references were editorials, one by Griffiths (2007),11 one by Davies (2003)13 and 
another by Singh (2002).12 “The new tuberculosis” by Griffiths11 comments that raising 
awareness of TB in general practice is vital if we are to combat the increasing incidence 
of TB in the UK. “TB in primary care” by Singh12 reflects on the responsibility of GPs 
to diagnose TB early, support and treat their patients and consider the wider community. 
Singh also states that “a low index of suspicion is emphatically required for early 
identification of TB”, and that “GPs should remain alert and vigilant”. Davies in “TB: 
current problems for primary care, a danger of complacency,”13 confirms Singh's 
statements. Basically, these three editorials discuss TB and primary care from slightly 
different angles but all reach the same conclusion that raising awareness of TB in 
primary care practitioners leads to earlier diagnosis and therefore better TB control. 
TB is traditionally seen as a disease managed in secondary care with respiratory 
consultants diagnosing and treating it. Primary care, however, could be, and should be, 
diagnosing and managing more TB. As Levin (1993)108 in the US suggests, primary 
care physicians have an important role in screening, diagnosing, treating and following 
up TB cases with the goal of controlling TB. This sentiment is supported by others8, 10, 
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101, 103 (Class D evidence). Three references that specifically looked at TB and primary 
care were letters: one from MacRorie in 200710 stating that “GPs deserved better, 
clearer guidelines on diagnosis and treatment” of TB and commented that primary care 
has a major role to play in early diagnosis and ongoing TB patient care; one from 
Singh101 reinforcing the role that GPs have to play in diagnosing and controlling TB; 
and another from MacRorie in 2002103 arguing similarly to Singh.101 
A study by White et al. (2002),102 that looked at the management of TB and the 
utilisation of resources in a British inner-city population, found that just under half of all 
TB patients admitted to hospital had not presented via primary care (42%).(Class C 
evidence) 
I have not reviewed in detail papers that my literature review found on “new entrant 
screening,” as this was not the question I sought to answer. One paper by Griffiths100 
however, is worth reviewing as although it discusses screening for TB in people 
registering in primary care it also looks at educational outreach to primary care staff to 
promote screening. Griffiths undertook a cluster randomised controlled trial for 
educational outreach and showed that an educational intervention, promoting TB 
screening in people registering with primary care, “improved identification of active and 
latent TB and increased BCG coverage”. This is supported by Margolis again with 
reference to TB,104 but has also been shown in many areas of medicine, that raising 
awareness of a disease through a specific educational intervention increases diagnosis 
and action to combat the disease. 
In summary, the role of primary care in the diagnosis of TB is little studied and 
therefore warrants greater investigation to understand how to diagnosis TB earlier and 
improve outcomes for patients. 
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2.4.2 TB and Diagnostic Delay 
2.4.2.1 Literature Yield 
Over three million references were generated by the key words in my search strategy: 
tuberculosis, diagnos*, delay*, late, ‘diagnostic delay’, ‘treatment delay’ (see Appendix 
1 for details). Individual key words were then combined to narrow the search to relevant 
references. This reduced the number of papers to 596 from Medline and EMBASE, and 
601 overall (see Table 2.2). The titles and abstracts of these papers were reviewed and 
68 papers met my broad inclusion criteria (see Section 2.3.3). I reviewed each paper and 
from these and their reference lists found 28 papers that discussed TB and diagnostic 
delay in countries and health care systems similar to the UK. 
2.4.2.2 The Research Evidence 
68 of 601 studies identified met my inclusion criteria and were subjected to detailed 
review. 28 studies were finally included in the analysis, see Table 2.5 for details.8, 19-25, 
95, 109-127 
There is a relatively large body of work looking at TB and diagnostic delay in a variety 
of international settings. These papers use a variety of definitions for diagnostic delay 
and assess different risk factors; many are not relevant to the UK setting. I therefore 
carefully selected 28 studies that met my inclusion criteria and assessed health care 
systems similar to the UK. The majority of studies were retrospective cohort studies 
(16); of the remaining studies: seven were prospective studies, two were retrospective 
analyses of national surveillance data, one was a retrospective case series, one a 
systematic review and one a qualitative interview study. See Table 2.5 for details. 
Overall, there is a small amount of research looking at diagnostic delay and TB in the 
UK and other high income countries and this I review and discuss in more detail. 
Diagnostic delay can be defined in a number of ways; the most common definitions use 
the patient pathway as the starting point. Diagnostic delay can therefore be broken down 
into a number of stages: 
• Disease Delay - is defined as delay due to the disease itself i.e. the patient is 
infected but asymptomatic (has latent TB). 
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• Patient Delay (PD) - is defined as the time interval between the onset of 
first symptom and the first consultation with a health care provider.20 It 
occurs when a patient is unaware of their likely diagnosis, when they fail to 
seek help early or are unable to access appropriate healthcare. 
• Health Service Delay (HSD) - is defined as the time interval between the 
first contact with health services and the start of treatment,20 sometimes 
known as ‘doctor’s delay’. 
• Total Diagnostic Delay (TDD) is the patient delay plus health service delay 
(PD + HSD).19
 Table 2.5 Diagnostic Delay in TB – summary details of the research evidence assessed 
 
Ref 
No. 
First 
Author 
Year Location Study type Grade of Evidence (SIGN) 
Sample 
Size 
Factors increasing 
total delay 
Factors decreasing 
total delay 
Comments 
115 Altet-Gomez 2003 Spain Prospective Study B 287 - 
- 
 
● Patients were responsible for >50% of 
delay 
● Interview based study 
110 Asch 1998 
USA 
(Los Angeles) 
Prospective study B 248 
Factors increasing PD 
● uncertainty of where to get care 
● belief in efficacy of self treatment 
● unemployment 
- 
● Only assessed PD 
● Only assessed symptomatic patients 
● Showed disease severity had little impact 
on delay 
127 
Diez 
 
2004 Spain 
Retrospective 
study 
 
B 7037 
Factors increasing PD 
● no resp. symptoms 
● age >14yrs 
● female sex if severe PD 
Factors decreasing PD 
● cough 
● extra-pulmonary TB 
● Only assessed PD 
111 Diez 2005 Spain 
Retrospective 
study 
 
B 5,184 
Factors increasing HSD 
● >44yrs 
● IVDU 
● cancer & TB 
● non-TB symptoms 
● sputum smear -ve TB 
● female sex if severe delay 
● diagnosis in primary care, but not 
statistically signific. 
Factors decreasing HSD 
● homelessness 
● immigrants 
● HCW 
● hospital admission 
● History of contact with TB 
● cough 
● LN or CNS TB (i.e. extra-
pulmonary TB 
● Only assessed culture confirmed cases 
● Only assessed HSD 
● Study covered 2/3rds of Spanish TB cases 
1996-1997 
118 Farah 2006 Norway 
Retrospective 
cohort study 
B 83 
● extra-pulmonary TB led to approx 2x 
delay 
● born in Norway HSD 2x PD 
● age>60 shorter PD (but sample 
size = 8) 
● immigrants shorter HSD 
 
● HSD > PD for those born in Norway 
● clearly defines patient & health service 
delay 
● National TB registry data combined with 
clinical case notes from hospital & primary 
care providers 
117 Franco 1996 Spain 
Retrospective 
cohort study 
 
B 109 Factors increasing PD 
● non-specific symptoms 
● sputum smear +ve TB 
● cavities on CXR 
● Small local study 
● Results mostly as % 
119 Gagliotti 2006 Italy 
Retrospective 
cohort study 
 
B 271 
Factors increasing PD 
● recent migrants 
 
Factors increasing HSD 
● 1st consult non-hospital 
● cough of recent onset or no cough 
- 
 
● Low incidence area 
● 52/48 split in Italian vs migrant cases 
 
Conclusions: 
● Need to improve migrants access to health 
services 
● Increase HCW suspicion of TB  
 Ref 
No. 
First 
Author 
Year Location Study type Grade of Evidence (SIGN) 
Sample 
Size 
Factors increasing 
total delay 
Factors decreasing 
total delay 
Comments 
114 Golub 2005 USA 
Prospective 
cohort study 
 
B 158 
TDD 
● 1st seen by private physician not A&E or 
public health 
 
Factors increasing PD 
● non-white 
● less educated 
● no resp. symptoms 
 
Factors increasing HSD 
● age >50yrs 
● non-English speaking 
● History of asthma 
● antibiotic Rx 
● 1st seen by private physician 
Factors decreasing HSD 
● cough 
● longer PD 
● sputum smear +ve TB 
● Investigation at 1st visit 
(TST/CXR/sputum) 
 
● Assessed only pulmonary TB cases with 
sputum +ve culture 
● Did not include those who died at diagnosis 
113 Golub 2005 USA 
Nested case-
control study 
within prospective 
study 
B 158 ● Alternative diagnosis and prescription of 
antibiotics 
● CXR 
 
● Study suggests need more wide spread use 
of CXR rather than immediate antibiotic for 
community acquired pneumonia - ?cost 
effective 
95 Golub 2006 USA 
Prospective 
cohort study 
B 124 - 
- 
 
● Did not assess factors leading to DD but 
risk factors for TB transmission after 
>90days delay 
122 Greenaway 2002 Canada 
Retrospective 
study 
 
B 429 
● older age 
● HIV infection 
● non-cavitatory CXR 
● no cough 
● sputum smear -ve TB 
 
● Only looked at hospitalised patients with 
active TB 
● Did not assess PD and HSD 
● Clearly showed hospitals with lower rates of 
TB had longer delays 
120 Gulbaran 1996 
France 
(Paris) 
Retrospective 
cohort study 
B 52 - 
- 
 
● Study conducted in 1 hospital over 18mths 
● Results given as mean delay not median  
125 Ho M.-J. 2004 
USA 
(New York) 
 
Retrospective 
cohort study 
B 60 ● traditional health care provider if 
unaware of national TB programme  
- 
 
● Study assessed who symptomatic Chinese 
immigrants see first 
● Concludes education of traditional Chinese 
HC providers needed 
124 Kam 2007 Canada 
Retrospective 
cohort study 
 
B 23 ● extra-pulmonary TB 
- 
 
● Very small study, 23 adolescents over a 6 
year period 
20 
Lewis 
 
2003 
UK 
(London) 
 
Retrospective 
Case series 
 
C 93 ● extra-pulmonary TB  
● Pulmonary TB 
 
● large recent immigrant population 
● TDD= symptom to treatment 
● PD > HSD 
8 Metcalf 2007 UK 
Qualitative 
inductive study 
 
C 17 - 
- 
 
● interview based study with thematic 
analysis 
● looked at barriers to prompt diagnosis from 
GP and patient viewpoint 
 Ref 
No. 
First 
Author 
Year Location Study type Grade of Evidence (SIGN) 
Sample 
Size 
Factors increasing 
total delay 
Factors decreasing 
total delay 
Comments 
126 Moudgil 1994 
UK 
(Lothian) 
 
Retrospective 
cohort study 
B 87 
● for lymph node TB - ethnic group (non-
white > white), 26 cf. 9 weeks 
● site of extra-pulmonary TB 
- 
 
● Study period 1980-89 – i.e. historic 
● lymph node TB was found to be much more 
common in NC 
● PD / HSD differentiation not possible due to 
incomplete data 
116 Ohmori 2005 Japan 
Retrospective 
analysis of 
surveillance data 
B 160,000 
● PD shown to have greater impact on 
TDD than HSD 
● Labourer 
● Low income / on benefits 
- 
 
● study used national surveillance data 
● assessed trends in delay over 15yrs 
● assessed only smear +ve cases 
109 Paynter 2004 
UK 
(London) 
 
Retrospective 
cohort study 
 
B 71 
● age >33yrs 
● born in low risk country 
● TB service capacity 
● organisational factors 
● 1st presentation to GP 
● Born in high risk country 
● First presentation to A&E 
● Younger age 
● Sputum smear +ve TB 
● Patient and HS delays contribute to delays 
in treatment 
● HSDs longer in patients who present first to 
GP 
 
21 Pirkis 1996 Australia 
Retrospective 
cohort study 
B 109 ● extra-pulmonary TB 
● 1st presentation to GP 
- 
 
● Retrospective record review at one hospital 
● assessed delay for pulmonary TB cases 
separately 
123 Rao 1998 
USA 
(St Louis) 
 
Retrospective 
cohort study 
B 
203 
over 8yrs 
● inexperience of health care 
professionals 
- 
 
● Study only looked at in-patient delays 
● Surprisingly found delays in treatment 
initiation 
● 1/3 delays > 10 days 
19 
Rodger 
 
2003 
UK (London) 
 
Retrospective 
analysis of 
surveillance data  
C 
 
853 ● sex (F>M) 
● ethnic group (white>ethnic) 
- 
● Used surveillance data 
● No HIV data 
● TDD = symptom to diagnosis or treatment 
22 Rodrigo 2001 
Spain 
(Barcelona) 
Retrospective 
study 
B 11,485 - 
- 
 
● Over 13yr period TDD little changed 
● Factors for delay not assessed 
121 Sanz 2007 
Spain 
(Madrid) 
Prospective 
cohort study 
 
B 296 
TDD 
● 1st presentation to GP 
● cough 
● extra-pulmonary TB 
 
Factors increasing HSD 
● sputum smear –ve TB 
● 1st presentation to GP 
● employment 
 
Factors decreasing PD 
● fever 
● sputum AFB +ve 
 
● Study done to assess immigrant TB 
● Found that PD & HSD of immigrants lower 
than non-immigrants  
 Ref 
No. 
First 
Author 
Year Location Study type Grade of Evidence (SIGN) 
Sample 
Size 
Factors increasing 
total delay 
Factors decreasing 
total delay 
Comments 
23 
Sherman 
 
1999 
USA 
(New York) 
Prospective study 
 
B 184 
Factors increasing PD 
● older age (55-64) 
● 2nd language English 
 
Factors increasing HSD 
● no cough 
● sputum smear -ve TB 
● Homelessness 
● no CXR at 1st visit 
 
● cough 
● sputum smear +ve TB 
Concluded – 
● patient education needed to encourage 
early seeking of care 
● High index of suspicion needed by HCWs 
112 Storla 2008 Worldwide 
Systematic review 
of observational 
studies 
B 58 studies 
● HIV 
● sputum smear-ve TB 
● Extra-pulmonary TB 
● Rural residence 
● Poor HC access 
● Older age 
● Poverty 
● Female gender 
● Alcoholism 
● Hx of immigration 
● Low educational level 
● Stigma 
 
● Reviewed 58 papers on diagnostic delay 
and TB treatment 
● Analysed together high and low income 
countries plus high and low endemic 
countries 
● Concluded risk factors exist but 
heterogeneous and vicious cycle of repeat 
visits pre-diagnosis is key problem 
25 Ward 2001 
Australia 
(Queensland) 
Retrospective 
study 
 
B 782 
Factors increasing HSD 
● >45yrs 
● female 
● failure to inv. cough 
● misdiagnosis of CXR 
PD & HSD 
● born in high risk country 
● indigenous Australians 
● complete record of all cases over 13yrs 
● very low prevalence area 
● Used surveillance data 
24 Wares 1999 UK 
Retrospective 
cohort study 
(letter) 
B 
 
43 - 
- 
 
● small study at one hospital 
● pulmonary TB only 
● retrospective 5yr record review 
● found no ethnic difference in delay 
● did not formally assess causes of delay  
Definitions 
PD = patient delay (time from 1st symptom to 1st contact with a health services) 
HSD = health service delay (time from1st contact with health services to the start of treatment) 
TDD = total delay (PD + HSD) 
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Details of the Key Studies Included in This Review 
Rodger et al. (2003)19 analysed diagnostic delay in London using national and local 
surveillance data over a 3 year period from 1998 to 2001. They showed for 853 patients 
that the median diagnostic delay (symptom onset to diagnosis or treatment) was 49 days 
(14-103) and that diagnostic delay was more common in white people (adjusted 
OR:1.67) and women (adjusted OR:1.42). This study found that nearly a third of 
patients had missing data, making it impossible to determine the relative contribution of 
patient or health service delay from the data available. Rodger’s concluded that 
although TB is more common in ethnic minority groups, campaigns to raise awareness 
of TB should not just be directed at ethnic minority groups but also white patients who 
comprise a third of TB cases in London. 
Lewis et al. (2003)20 in a retrospective analysis of diagnostic delay reviewed 93 patients 
and looked in detail at the contribution of patient and healthcare delays to total 
diagnostic delay. Their study based in East London revealed substantial delays in the 
presentation of TB patients and found a median total delay of 126 days. This total delay 
is much longer than that found in other studies. They also found that “patient delay was 
significantly longer than healthcare system delay (p=0.019)”. In addition, Lewis 
comments that many of the study patients were recent immigrants and that this group 
may have had particular difficulty accessing primary care. On multiple regression, the 
only factor associated with increased diagnostic delay was extra-pulmonary disease 
(p=0.035). Lewis concluded that there is a need to improve TB awareness both of 
patients and of health professionals in addition to improving patient access to health 
care. 
In a small retrospective cohort study, Paynter et al. (2004)109 looked at diagnostic delay 
in 2001/02 in 71 patients attending a North London hospital. Data was collected from 
hospital notes, notification forms and GP’s via a postal questionnaire. Diagnostic delay 
was shorter for those born in high prevalence countries, those presenting first to hospital 
casualty departments rather than to a GP, younger patients and those sputum smear 
positive. These factors all contributed to shorter health service delay. This study 
supports the finding of Rodger et al.19 that individuals from ethnic minority groups have 
a shorter total diagnostic delay. Paynter comments that the difference in delay between 
patients attending A&E and a GP could be explained by the fact that patients presenting 
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to A&E may be more obviously ill and may be investigated more thoroughly as a 
consequence; and that patients presenting to their GP may need to wait for the results of 
investigations and chest clinic appointments. Theoretically it should be possible to 
reduce these GP service delays. 
Golub et al. conducted a number of studies to look at diagnostic delay.95, 113, 114 Their 
primary study (2005) looked at diagnostic delay in 158 TB patients in Maryland, 
USA.114 In this study, Golub showed that median patient delay (32 days) was increased 
in patients who were non-white, less educated and those who had no respiratory 
symptoms; and that median health service delay (26 days) was increased in patients 
aged over 50, who spoke no-English, who initially presented to a private physician, had 
a negative sputum smear and had not been investigated at their first visit with a skin 
test, chest x-ray or sputum smear. Sex, race, country of origin and drug use did not 
influence health care delay. Golub also noted that patients presenting with cough or with 
long patient delays had shorter health service delays, and those with a history of asthma 
had longer health service delays. Once again the conclusion of this paper is that 
“education of the patient population about TB symptoms” and “increased physician 
awareness of the current epidemiology of TB and better use of available diagnostic 
tools” are needed to reduce diagnostic delay and in turn reduce TB transmission. 
Golub et al. (2006)95 in another study took a different approach to diagnostic delay; and 
assessed TB transmission following a diagnostic delay of over 90 days in 124 close 
contacts of patients with pulmonary TB. They showed that a longer time to diagnosis 
(>90 days) led to an increase in TB transmission and that for contacts of US-born cases 
risk factors for transmission included ethnicity (black greater than white (adjusted 
OR:3.03)), sputum smear positivity (adjusted OR:3.29) and cavitation on x-ray 
(adjusted OR:3.11). Interestingly no association was seen between foreign born patients 
and the risk of transmission among their contacts. Overall, contacts exposed for longer 
due to a delay in diagnosis experienced higher rates of TB transmission. 
Farah (2006)118 in a study conducted in Norway, found disease site to be a significant 
predictor of patient, health service and total delay. He showed extra-pulmonary TB, as 
compared to pulmonary TB, led to a relative total delay of 1.81 (95% CI:1.10-2.98) and 
that patients born abroad, as compared to patients born in Norway, had a significantly 
shorter relative health service delay of 0.32 (95% CI:0.11-0.94). Farah also showed that 
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health service delays were longer than patient delays; this is at odds with most of the 
other studies. Farah suggests that “the main reason for the long total delay was that 
healthcare providers did not initiate specific TB examination despite symptoms such as 
cough, weight loss and night sweats”, this is possibly due to the low incidence of TB in 
this population. Farah conducted a small sub-study looking at half the patients with a 
diagnostic delay greater than two months: 50% had received several courses of 
antibiotics and for 25% there had been difficulties isolating M.TB. 
Pirkis et al. (1996)21 assessed diagnostic delay in 109 patients in Australia from 1991-
1993 and found that extra-pulmonary TB and first presentation to a GP increased total 
diagnostic delay (TDD). Pirkis tried to define an acceptable standard interval between 
onset of symptoms and treatment and suggested 0-30 days. Once again this paper 
concluded that raising patient and healthcare worker awareness of TB is essential to 
reduce diagnostic delay. 
Sherman (1999)23 in his study of 184 patients in New York, showed that patient delay 
(PD) was increased in those aged 55 to 64 (adjusted OR:10.6) and in patients whose 
first language was not English (adjusted OR:2.5). He also showed that patient delay did 
not vary by ethnicity, site of disease or presence of another medical condition. 
Statistically significant health service delay (HSD) (p<0.001) was shown for patients 
with no cough (adjusted OR:2.9), sputum smear negative TB (adjusted OR:10.2) and 
the homeless (adjusted OR:7.1). 
Diez (2005)111 conducted a large retrospective study of over 5,000 culture-confirmed 
TB cases in Spain to assess health service delays. This study covered two thirds of all 
Spanish TB cases presenting during 1996 and 1997. Diez found that migration, 
homelessness and extra-pulmonary TB lead to less health service delay. The findings, 
that homelessness and extra-pulmonary TB reduce delay, are opposite to the findings of 
Sherman.23 Factors increasing health service delay included age over 44, IVDU, cancer, 
sputum smear negative diseases (a negative sputum smear increased the risk 4 times 
(OR:4.5, p<0.0001)). Diagnosis in primary care (OR 1.51) appeared to increase health 
service delay but this was statistically non-significant p=0.072. Only with extreme delay 
did gender have an impact: extreme HSD was associated with female gender. Diez 
using the same dataset assessed factors increasing patient delay and showed that age 
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greater than 14 years and non-respiratory symptoms increased patient delay and that 
cough and extra-pulmonary TB decreased patient delay.127 
Sanz et al. (2007), conducted a prospective cohort study in Spain to specifically assess 
diagnostic delay in immigrants.121 For 296 TB cases the median total diagnostic delay 
was 40 days, with a median patient delay of 15 days and health service delay of 5 days. 
Sanz found that both patient delay and health service delay in immigrants was shorter 
than that for the Spanish population. Possible explanations given for the shorter patient 
delay included: firstly, that immigrants may only receive healthcare from the hospital 
emergency services where investigations are immediately available (unlike in primary 
care) and secondly, immigrants may be more aware of the symptoms of TB and so 
present earlier. Possible explanations given for a shorter health service delay for 
immigrants included: firstly, greater suspicion of TB by healthcare professionals in this 
population; secondly, greater use of hospital emergency services leading to less delay in 
the diagnostic process; and thirdly, the younger age of the immigrant population. 
Asch (1998)110 in a prospective study of 248 patients in the US showed that disease 
severity had little impact on delay but access to care seemed to be a major problem. 
Asch concluded that “improving the availability of services for high risk groups may 
substantially reduce TB patients’ delay in obtaining care and thus limit the spread of the 
disease.” In addition Asch suggested that public education should be targeted at at-risk 
groups to raise awareness of symptoms and how to seek care. 
Storla et al. (2008)112 undertook a systematic review of 58 studies from around the 
world that looked at diagnostic delay and treatment of TB. Storla’s analysis revealed 
that defining diagnostic delay is quite complex. He showed a mean total diagnostic 
delay of 72 days +/- 28 days (SD) with no consistent pattern of delay due to patient or 
healthcare worker or between high and low income countries. He found risk factors for 
delay to be heterogeneous: “a risk factor for increased delay in some studies was a risk 
factor for decreased delay in other studies.” But this may have been due to the fact that 
he compared studies from high and low income countries with very different health care 
settings. Storla et al. concluded that the main problem leading to diagnostic delay was 
the “vicious cycle of repeat visits” to the same health care providers before a diagnosis 
was eventually reached.112 This was particularly the case in high endemic, low income 
countries with poorly trained government health personnel and private practitioners. 
Chapter 2 – Literature Review  51 
Total diagnostic delay seemed to be two-fold either due to a lack of effective diagnostic 
tools or a lack of suspicion of TB. Storla also showed, however, that once a TB 
diagnosis was reached, treatment was initiated within a reasonable time. 
The Meaning of Diagnostic Delay 
The majority of studies reviewed used the definitions for patient delay, health service 
delay, and total diagnostic delay as defined at the start of Section 2.4.2.2. However, the 
endpoint for health service delay or total diagnostic delay was defined by Wares24 and 
Sanz121 as being from first symptom to diagnosis rather than to treatment, and by 
Rodger19 as being from first symptom to diagnosis or treatment. Although not 
specifically stated, all of these studies in high income countries probably considered 
treatment to start on the day of diagnosis. 
The use of the ‘symptom onset date’ as a starting point from which to measure 
diagnostic delay is particularly problematic as the onset of TB can be insidious and so 
people find it hard to remember a specific date. This may therefore affect the calculation 
of the length of diagnostic delay. 
Quantification of Diagnostic Delay 
Most studies defined diagnostic delay as a specific number of days. Of the 28 studies 
analysed 22 quantified diagnostic delay: 12 looked at patient delay, 13 at health service 
delay and 16 at total diagnostic delay (not mutually exclusive groupings). Table 2.6 
summarises these studies. The median patient delay varied from 7 to 74 days, with most 
studies reporting patient delays of about one month (mean 33 days). The median health 
service delay varied from 6 to 39 days, with a mean of 26 days. Where studies assessed 
both patient delay and health service delay separately (nine studies)20, 23, 25, 109, 114, 115, 118, 
119, 121 seven studies showed that patient delay was longer than health service delay. For 
studies assessing total diagnostic delay (TDD), the median TDD varied from 36 to 126 
days with a mean of 65 days. Some studies did not report median total diagnostic delays 
but mean TDDs; Gulbaran120 reported a mean TDD of 14 days in just under a third of 
patients and over 28 days for 50%, Kam124 found a mean TDD of 145 days and Storla112 
a mean TDD of 72 days. 
Some studies assess delay specifically for pulmonary TB.21,24,114 The potential public 
health consequences are higher for a case of pulmonary TB as the risk of transmission is 
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greater. Total delays (TDD) of more than one month were found in 72% of smear 
positive cases in Blackburn by Wares,24 69% of pulmonary TB patients in Australia by 
Pirkis21 and 46% of pulmonary cases in Maryland USA.114 
Table 2.6 Quantification of diagnostic delay in days 
Study Location Sample Size
PD 
Median 
(range) 
HSD 
Median 
(range) 
TDD 
Median 
(range) 
Altet-
Gomez115 
2003 
Spain 
287 43 
 
38 81 
Asch110 
1998 
USA 
(Los Angeles) 
248 74 
(20% >60 days) 
- - 
Diez127 
2004 
Spain 
7037 22 
(1-160) 
- - 
Diez111 
2005 
Spain 
5,184 - 6 
(0-94) 
- 
Farah118 
2006 
Norway 
83 28 
(2-217) 
33 
(1-378) 
63 
(4-434) 
Franco117 
1996 
Spain 
109 >1mth in 30% >1mth in 71% >1mth in 90% 
Gagliotti119 
2006 
Italy 
271 7 
 
36 65 
Golub114 
2005 
USA 
158 32 
(0-539) 
26 
(0-519) 
89 
Golub113 
2005 
USA 
158 - 39 (2-519) on 
antibio. 
Vs 
15 (0-191) no 
antibio. 
- 
Gulbaran120 
1996 France 
(Paris) 
52 - - mean TDD 
14 for 27% 
21 for 19% 
>28 for 54% 
Kam124 
2007 
Canada 
23 - - mean TDD 
145 
Lewis20 
2003 
UK 
(London) 
93 56 
(0-728) 
35 
(0-1470) 
126 
(0->1000) 
Paynter109 
2004 
UK 
(London) 
71 34 29 78 
(39-159) 
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Study Location Sample Size
PD 
Median 
(range) 
HSD 
Median 
(range) 
TDD 
Median 
(range) 
Pirkis21 
1996 
Australia 
109 - 
 
- 52 
Rao123 
1998 
USA 
(St Louis) 
203 
over 8yrs 
- 6 days from 
hospital 
admission 
- 
Rodger19 
2003 
UK (London) 
 
853 - - 49 
(14-103) 
Rodrigo22 
2001 
Spain 
(Barcelona) 
11,485 - - 36 
Sanz121 
2007 
Spain 
(Madrid) 
296 15 
(IQR:6.5-30) 
5 
(IQR:0-30) 
40 
(IQR:16-90) 
Sherman23 
1999 
USA 
(New York) 
184 25 
(0-731) 
15 
(0-430) 
57 
(4-764) 
Storla112 
2008 Worldwide 
58 studies   mean TDD 
72 days 
+/- 28 days (SD) 
Ward25 
2001 
Australia 
(Queensland) 
782 29 22 - 
Wares24 
1999 
UK 
43 - - 49 
(IQR: 28-91) 
Definitions 
PD = patient delay (time from 1st symptom to 1st contact with health services) 
HSD = health service delay (time from1st contact with health services to the start of treatment) 
TDD = total delay (PD + HSD) 
Risk Factors Associated with Diagnostic Delay 
This literature review, of studies done in high income, low incidence countries, shows 
that there are a wide range of factors that lead to diagnostic delay. The main risk factors 
influencing delay are shown in Table 2.7. 
Clinical factors that clearly increase diagnostic delay include: sputum smear negative 
TB,23,109,111,112,114,117,121,122 extra-pulmonary TB,20,21,112,118,121,124,126 no respiratory 
symptoms,111,114,117,127 a history of asthma,114 no chest x-ray at first visit,23,113,114 an 
alternative diagnosis for which an antibiotic is prescribed,113,114 and HIV infection.112,122 
A few clinical factors appeared in some studies to increase delay and in others reduce 
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delay. For example a cough, Sanz121 found this to increase delay where as Sherman, 
Greenaway, Diez and Golub showed it reduced delay.23,111,114,122,127 
Other factors that were shown to reduce diagnostic delay were cavities on chest x-
ray,117,122 hospital admission111 and history of contact with TB.111 
Demographic factors increasing delay include: being white,19 older age23,25,109, 111, 112, 114, 
122,127 and being female.19,25,111,112 Immigrants from high-risk countries appeared in 
some studies to have increased diagnostic delay112,119 and in others reduced delay.25,109, 
111,118,121 
Other factors noted in some studies to increase diagnostic delay included: first 
presentation to a GP,21,109,111,119,121 inexperience of health care professionals,123 poor 
health care access,112 poverty,112,116 alcoholism,112 non-English speaking people23,114 and 
low educational attainment.112,114 
Diagnostic delay is a problem for TB patients and health services. The literature 
reviewed suggests that to lessen this delay: 
1. Patient education is needed about symptoms to encourage earlier 
presentation to health services20, 21, 23, 114 
2. Increasing awareness of TB in health professionals is needed to raise the 
index of suspicion for TB20, 21, 23, 114, 119 
3. Better access to health services is needed for recent migrants119, 121 
Table 2.7 Risk Factors for Diagnostic Delay 
Risk Factors 
Evidence supporting 
increased diagnostic delay 
Study Reference No. 
Evidence supporting 
decreased diagnostic delay
Study Reference No. 
Clinical factors 
sputum smear -ve TB 122, 112, 117, 109, 23, 121, 114, 111, 
121,  23 
 
extra-pulmonary TB 124, 20, 126, 21, 118, 121, 112 127, 111 
no respiratory symptoms  117, 114, 127, 111  
cough  121 23, 122, 127, 111, 114 
Antibiotic prescription 1st 113 ,114  
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Risk Factors 
Evidence supporting 
increased diagnostic delay 
Study Reference No. 
Evidence supporting 
decreased diagnostic delay
Study Reference No. 
History of asthma  114  
no CXR at 1st visit  23, 114, 113  
HIV infection  122, 112  
cavities on CXR  122, 117 
Demographic factors 
Immigrant  112 ,119 109, 25, 121, 111, 118 
Ethnic group 
(white>ethnic) 
19 114 
Older age 122, 112, 109, 111, 114, 25, 23, 127  
Gender (Female > Male) 19, 112, 25, 111  
Other factors 
1st seen by GP 109, 21, 121, 119, 111 1stseen in A&E 109, 114 
1st seen by private 
physician 
114  
Inexperience of health care 
professionals  
123  
Poor HC access  112  
Poverty  112, 116  
unemployed  110  
less educated 114, 112  
uncertain where to get 
care  
110  
IVDU  111  
cancer & TB  111  
non-English speaking  23, 114  
Alcoholism 112  
Homelessness 23 111 
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2.4.2.3 Discussion of Diagnostic Delay 
Understanding diagnostic delay in TB is important as diagnostic delay can lead to an 
increased risk of TB transmission,95 worsening morbidity and potentially increased 
mortality. To reduce TB incidence both theory and data suggest that shortening 
diagnostic and treatment delay would be beneficial. 
The prevalence and epidemiology of TB in high prevalence / low income countries is 
very different to the UK. I therefore analysed only the research literature on diagnostic 
delay from countries similar to the UK, i.e. countries with high income but low TB 
prevalence. Many of the studies reviewed were “retrospective studies” of the delay 
experienced by TB patients, so subject to recall bias. Patients who died without a 
diagnosis of TB or who were diagnosed at post-mortem may not be included in the 
analyses and so results could therefore be biased. 
The Meaning of Diagnostic Delay 
While assessing the meaning of diagnostic delay I found that most of the studies I 
reviewed used the same definitions for patient delay, health service delay, and total 
diagnostic delay. However, Storla et al.112 noted in their research that defining 
diagnostic delay was complex and that different studies used different definitions. This 
difference is partly explained by the fact that Storla looked at studies from around the 
world in very different populations: both low and high income countries and low and 
high prevalence areas. 
Patient delay occurs when a patient is unaware of their likely diagnosis, when they fail 
to seek help early or are unable to access appropriate healthcare. Health service delays 
occur when doctors fail to make the diagnosis, perhaps through inexperience, or failure 
to consider the diagnosis in patients perceived as being at low risk. The symptoms of 
TB are often non-specific and this makes early diagnosis difficult as symptoms such as 
cough can be explained by many different diseases. Difficulty in recognizing symptoms 
as due to TB is likely to account for much of the diagnostic delay seen in TB. 
Quantification of Diagnostic Delay 
From the studies reviewed a mean total diagnostic delay of 65 days was calculated. As 
the studies selected, were from healthcare settings similar to the UK it is interesting that 
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the mean total diagnostic delay is similar to that found by Storla et al. (72 days) in their 
systematic review of high and low income countries, and high and low prevalence 
countries.112 
Patient and health care system delays contribute to the overall delay experienced by 
patients from onset of TB symptoms to diagnosis and treatment. In this review the 
majority of studies (7 out of 9) showed that patient delay was longer than health service 
delay. It should be noted however, that patient delay can be difficult to quantify 
precisely. The date of symptom onset and first medical presentation for TB may not be 
accurately known as the symptoms and signs of TB are often nonspecific and insidious. 
Diagnostic delay leads to increased disease transmission. The public health response to 
TB in the UK tends to focus on the case once diagnosed. This response includes treating 
the case and identifying and treating close contacts. However TB transmission is likely 
to have occurred before the patient presents to health care services; therefore reducing 
patient delay should reduce the chance of transmission and therefore the burden of TB 
in the UK. Delays of more than two months have been shown to increase the risk of 
transmission to domestic contacts.95 
Risk Factors Associated with Diagnostic Delay 
Understanding the risk factors that lead to a delay in TB diagnosis is crucial to ensure 
earlier diagnosis and treatment and so minimise the risk of transmission and reduce poor 
outcomes for patients. 
This literature review suggests that there are many factors that lengthen diagnostic 
delay. Clear-cut determinants leading to increased diagnostic delay include: sputum 
smear negative TB, extra-pulmonary TB, no respiratory symptoms, a history of asthma, 
HIV infection, no chest x-ray at the first visit, being white, older and female and an 
alternative diagnosis for which an antibiotic is prescribed. From the research presented 
here, patients with extra-pulmonary TB experience longer delays prior to diagnosis. 
These patients are less likely to be infectious and are therefore considered less of a 
public health problem. However, diagnostic delay can lead to worsening disease and 
increased mortality.94, 126 Diagnostic delay increases with age and this may be due to 
diagnostic confusion in older people, where inter-current illness or co-existing disease 
may initially be diagnosed rather than TB.23, 25, 109, 111, 112, 114, 122, 127 
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For the majority of factors associated with diagnostic delay the evidence in high 
income, low prevalence countries shows the risk factors to be the same. Only in a few 
areas is the research contradictory. The main area where some studies show less delay 
and others show more is TB in immigrants. In some studies immigrants from high risk 
countries have less diagnostic delay;25, 109, 111, 118, 121 Other studies, however, show the 
opposite: that migrants experience more diagnostic delay.112, 119 Possible explanations 
for a shorter delay include: migrants may not be registered with a GP and so use 
hospital emergency services more where investigations are immediately available; 
migrants may be more aware of the symptoms of TB and so they present earlier; and in 
one UK study less delay is attributed to a greater suspicion of TB in migrants among 
healthcare workers.109 For studies that show migrants experience longer diagnostic 
delay, it is possible that access to health care and language barriers may have an 
influence. Generic research assessing immigrants access to health care has shown that 
recent immigrants are more likely to have difficulty accessing healthcare.128 Diagnostic 
delay for non-immigrants may be due to the fact that TB is less likely to be suspected.119 
In the UK, health care professionals need to be informed that ethnic minorities generally 
have a higher risk of TB regardless of how recently they arrived in the UK but also that 
a high index of suspicion for TB should be held for any person whose symptoms and 
signs suggest TB. 
Another area where the research evidence is contradictory is for cough. One study found 
cough to increase delay121 while others showed it reduced delay.23, 111, 114, 122, 127 Cough 
may increase a delay in diagnosing TB where it is attributed to other diseases such as 
chronic airways disease, asthma or pneumonia and treatment is given for these first and 
only later TB is suspected. In general however cough reduces delay, particularly when 
linked to other typical TB symptoms. 
A number of studies113,118,129,130 have documented diagnostic delay due to the 
prescription of antibiotics for a community-acquired pneumonia, which was 
subsequently diagnosed to be TB. Golub showed a doubling of diagnostic delay for 
patient's that received antibiotics prior to a TB diagnosis.113 He also showed this delay 
was regardless of the antibiotic class prescribed: fluoroquinolones are no different to 
any other antibiotic class. This is contrary to what was previously thought.129, 131, 132 In 
his conclusion Golub suggests more widespread use of chest x-rays before prescribing 
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antibiotics presumptively.113 This is not, however, a cost effective way of managing 
patients. Clearer diagnostic algorithms may help to reduce these problems. 
Although much work suggests that ethnic minorities and immigrants are at higher risk 
of TB, it is important not to forget that there is still a sizeable proportion of TB in white 
patients. In London up to a third of cases are white19 and many of these come from hard 
to reach groups such as the homeless, drug users and those with a history of 
imprisonment.133 Education of health care workers, not only to improve their knowledge 
of TB but also to raise awareness of the risk factors for TB and those groups most 
affected, is key to reducing diagnostic delay. Many of the studies reviewed here come to 
a similar conclusion: the need for improved TB education for healthcare workers. 
A number of studies comment that diagnostic delay is increased if a patient presents 
first to a GP21, 109, 111, 119, 121 and shortened if they present initially to A&E.109,114 This 
may be due to the availability of chest x-rays in A&E departments. However, increasing 
knowledge of TB in primary care professionals is also crucial if diagnostic delay is to be 
reduced. 
In low incidence countries factors leading to diagnostic delay are mostly similar and 
non-controversial. However Storla,112 in his review of high and low income countries 
and high and low prevalence countries found that risk factors for diagnostic delay exist 
but that they are heterogeneous (some studies showing one effect and others showing 
the opposite) and that a “vicious cycle of repeat visits” pre-diagnosis is a key problem. 
In summary, in low incidence countries a delay in TB diagnosis is still common and the 
risk factors for this are well documented. 
2.5 Conclusions 
This literature review assesses the literature on TB from a primary-care perspective and 
summarises current research on TB and diagnostic delay. By reviewing the literature on 
diagnostic delay, quantifying it and understanding the factors that increase it, 
conclusions can be drawn on how diagnostic delay might be reduced in a primary care 
setting. 
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This literature review shows that the role of primary care in the diagnosis of TB is little 
studied and therefore warrants greater investigation. One small study by Metcalf et al. is 
the most relevant. This paper highlights the fact that early diagnosis is one of the most 
important contributions primary care can make to improved TB control and that raising 
awareness through improved education among health professionals is essential. In 
addition this paper identifies barriers to prompt diagnosis: atypical presentations, low 
level of clinical suspicion of TB by GPs, lack of continuity of care, workload demands 
that limit time with patients, and sub-optimal clinical / patient communication. All of 
these barriers are born out in my literature review that specifically looks at diagnostic 
delay and the factors that lead to this. My literature review reveals diagnostic delay for 
TB patients in low incidence countries is still common: a median total diagnostic delay 
of 2 months is not unusual. Diagnostic delay is a problem for TB patients and the health 
service. To lessen this delay, patient and health care worker education is urgently 
needed. 
In conclusion, this literature review shows that TB patients often experience diagnostic 
delay and that the role of primary care in this and other areas of TB care is little studied. 
Further research is therefore needed to understand the role of primary care in the 
diagnosis of TB and investigate ways to reduce diagnostic delay in this setting. Early 
diagnosis & treatment of TB are essential for effective TB control. 
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Chapter 3  
 
Methods 
3.1 Introduction 
This epidemiological research was carried out using the General Practice Research 
Database (GPRD) the world’s largest computerised primary care database. At the time 
of this research it contained 15 years of anonymised longitudinal data (1987-2002), for 
8 million patients from 743 GP practices and covered 6% of the UK population with a 
median of 3.7 years of data per patient. My research to investigate the epidemiology of 
TB from a primary care perspective consisted of four studies using GPRD data: 
Study 1: Consultation Behaviour in Primary Care Prior to a Diagnosis of TB: A 
Case-Control Study 
The aims and objectives of this study were: 
• To assess the extent of missed opportunities for a diagnosis of TB in 
primary care by measuring excess GP consultations for TB cases as 
compared to controls in the 6 months prior to diagnosis 
• To describe the nature of these consultations by examining consultation 
behaviour and consultation type 
• To investigate risk factors for TB 
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Study 2: Consultation Behaviour in Primary Care Prior to a Diagnosis of TB: A 
Self-Controlled Analysis 
The aims and objectives of this study were: 
• To assess the extent of missed opportunities for a diagnosis of TB in 
primary care by measuring excess GP consultations in the 6 months prior to 
diagnosis in TB cases as compared to 12 to 18 months prior to diagnosis in 
the same individuals (i.e. a self-controlled study which eliminates the 
potential effect of relatively static unmeasured confounders such as 
ethnicity and social status) 
• To describe the nature of these consultations by examining consultations 
and consultation behaviour 
• To compare the results of this self-controlled study with the case-control 
study (Study 1) 
Study 3: Morbidity Associated with TB: A Self-Controlled Study 
The objectives of this study were: 
• To investigate the long-term outcomes (morbidity) of patients with TB 
• To describe and quantify morbidity from TB 
• To assess / examine if patients are more likely to suffer chronic respiratory 
problems following an episode of pulmonary tuberculosis 
Study 4: Mortality Associated with TB: A Cohort Study 
The objectives of this study were: 
• To describe and quantify mortality from TB 
• To calculate the mortality rate in patients with TB 
• To examine if TB indirectly increases the risk of death from non-TB causes 
• To describe risk factors for death in TB patients 
 
In this chapter I will discuss the generic methods leaving the detailed methods to be 
described in the relevant study Chapters 4-7. 
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3.2 Study Design 
To investigate TB epidemiology from a primary care perspective I needed to design a 
number of studies that would enable GPRD data to give me a window on TB pre- and 
post- diagnosis. By using GPRD data I was able to look at data not visible to 
conventional, often hospital based TB studies, i.e. data on general consultations pre-
diagnosis and also long-term outcomes. To this end I started with a conventional case-
control study to look at data pre-TB. In addition I completed another study pre-TB using 
self-controlled analysis to reduce confounding due to unmeasured confounders such as 
ethnicity and socioeconomic status. To understand TB epidemiology and outcomes 
post-diagnosis I continued using the self-controlled methodology to look at longer-term 
morbidity and undertook a cohort study to look at mortality. 
Consultation behaviour and TB disease are both influenced by age, sex, chronic disease, 
lifestyle, social class and ethnicity. Data is variably recorded / coded in the GPRD for 
these factors and so consideration needed to be given to these factors in the study design 
(see Figure 3.1). 
Figure 3.1 Study design considerations 
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Tuberculosis
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3.3 Setting 
I examined data from UK general practices that provided data to the General Practice 
Research Database (GPRD) during the time period April 1990 to April 2002. I used 
only data from practices that met a pre-set quality standard for data recording. 
3.4 Data Source - The GPRD 
The General Practice Research Database (GPRD) is the world’s largest computerised 
primary care database with over 15 years of longitudinal data at the time of this study. 
(see Chapter 1, Section 8 for more details on the GPRD)75,76 The GPRD contains 
computerised clinical information on individual patients. It is entered in a standardised 
manner by General Practitioners (GPs). At the time of this study 743 GPs, covering a 
population exceeding 8 million, systematically provided data files anonymously to the 
Office of National Statistics (ONS) and allowed their information to be used for 
research purposes.134 ONS and subsequently the MHRA organises this information and 
performs a series of regular quality checks.75,76 The information contained within the 
GPRD includes demographic details of each patient, details of all patient visits, 
medication prescribed, a summary of specialists' clinical notes and hospital letters, 
results of laboratory tests and a free-text section. The free-text section is where details 
of the consultation are recorded, such as symptoms and relevant patient history. In 
addition, the GPRD records patient deaths either entered by the GP or by ONS from 
death certification. 
The GPRD contains four types of record for each patient: 
The Patient Record 
A record of basic demographic data: date of birth, sex, family number (a number shared 
by patients living at the same address), registration data and death date. 
The Medical Record 
A record of every GP consultation a patient has had; this includes information on 
diagnoses, symptoms and signs with associated dates in addition to where the patient 
was seen or the information came from and an outcome. 
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The Therapy Record 
A record of GP prescriptions including: drug names, drug codes, doses, formulations 
and dates of prescribing. 
The Prevention Record 
A record containing additional information such as: occupation, vaccinations, smoking 
status, alcohol consumption and patient characteristics e.g. height and weight. 
In addition to the four data tables described above there are a number of lookup tables. 
These contain lists of GPRD codes and definitions, e.g. drug codes and their 
description. These lookup tables ensure that the data tables are easier to manipulate as 
they contain numeric codes rather than long text strings. 
A unique number links each patient record and is known as the “PatientId”. 
3.4.1 Clinical Data Entry 
To undertake research using the GPRD an understanding of how GPs document an 
‘event’ or diagnosis in the medical record is key. When a patient consults their GP a 
‘diagnosis’ is entered into the patient’s medical record. In the GPRD dataset this 
diagnosis appears as text and as an abbreviated code. Two types of codes are used, 
OXMIS and Read Codes. 
OXMIS (Oxford Medical Information System) codes are problem codes based on two 
widely used coding systems: the 10th version of the International Classification of 
Diseases (ICD-10) and the Office of Population Censuses and Surveys Classification of 
Surgical Operations and Procedures (4th Edition) (OPCS).135 
Read Codes are a hierarchical coded thesaurus of clinical terms whose purpose is to 
create a clinical record that can be easily manipulated by computer systems. The codes 
were developed in 1982 for use in General Practice by Dr James Read;136 in 1990 the 
NHS bought them, expanded them and now maintains and develops them. They are 
used throughout the NHS as standardised clinical codes and there usage is now 
mandatory in General Practice. Read Codes can be mapped to the 10th version of the 
International Classification of Diseases (ICD-10) and the 4th revision of the 
Classification of Surgical Operations and Procedures (OPCS-4). Read codes are not 
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based on the ICD or the OPCS codes unlike OXMIS and so contain many more 
clinically descriptive / non-mapped terms. OXMIS codes can be mapped to Read Codes. 
The codes used by GPs depend on the version of practice software used by the GP 
submitting data to the GPRD. Older versions of practice software up to VAMP 5 are 
likely to have used OXMIS codes, however ViSion software (and VAMP Millennium 
complaint software) use Read codes. There are four times as many Read codes as 
OXMIS codes, allowing GPs greater flexibility when recording patient consultations. 
3.4.2 Definition of a Consultation 
To analyse GP consultations a clear definition of a ‘consultation’ was needed. For the 
purpose of this research a ‘consultation’ or ‘visit’ refers to the date on which an ‘event’ 
or event(s) took place. An ‘event’ refers to any diagnosis or symptom recorded by the 
GP during a consultation: in any one GP consultation there may be a number of ‘events’ 
recorded. Statistical analysis of the events and consultations pre-diagnosis were similar, 
so as a ‘consultation’ seems a more understandable concept I have used this rather than 
‘events’ to support my arguments and analysis. 
3.4.3 Up-To-Standard Data 
To ensure that data entered into the GPRD database is of sufficient quality for the 
purposes of research the GPRD team at the MHRA check and validate the data against a 
set of ‘standards’ that all GP practices submitting data to the GPRD try to adhere to. 
These standards ensure that the data contained within the GPRD is as complete as 
possible to minimise missing values. When data from a GP practice meets these 
standards it is considered to be ‘up-to-standard’ (UTS), the practice is granted UTS 
status and a UTS date is generated for the practice. Any patient registering with a 
practice after this date will automatically have UTS data. If however a patient has 
registered before the practice is given UTS status, the date on which the practice 
receives UTS status is the date on which the patients UTS period begins. MHRA 
recommends that research using the GPRD should only be conducted on patients’ UTS 
data. In addition, to a practice meeting an agreed minimum standard to submit data for 
inclusion into the GPRD, ongoing quality checks occur on the data regularly extracted. 
If a practice fails to meet the quality standards they are removed from the GPRD.75 
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3.5 Study Participants 
Patients were selected from the GPRD between 1990 and 2002; they were grouped into 
cases and controls by outcome for the case-control study and TB cases and non-TB 
cases for the cohort study. In all studies cases were all patients with a diagnosis of 
active-TB. 
3.5.1 Criteria for the Selection of TB Cases 
To extract TB cases from the GPRD dataset I used the following criteria: 
Inclusion Criteria for Cases: 
• Patients with a medical code for active-TB 
• Patients with at least 18 months of up-to-standard (UTS) patient data prior 
to a diagnosis of TB 
Exclusion Criteria for Cases: 
• Patients with less than 18 months of UTS data prior to a diagnosis of TB 
To select cases with active-TB I created a search strategy to generate a TB-code list, i.e. 
medical codes, compatible with a diagnosis of active-TB (see Section 3.5.2) and then 
combined this with up-to-standard GPRD data (see Section 3.4.3). 
3.5.2 Search Strategy to Generate Medical Codes Compatible with TB 
This systematic search strategy was used to generate a list of GPRD diagnoses 
(medcodes) that were compatible with an overall diagnosis of TB. 
Step 1 - Search NHS Clinical Terminology Browser for Read Codes Compatible 
with a Diagnosis of “Tuberculosis” 
The NHS Clinical Terminology Browser (version 1.0), available from the NHS 
Information Authority, is a tool that helps to identify Read codes compatible with a 
descriptive medical diagnosis. I chose “tuberculosis” from within the infectious disease 
section of the NHS Clinical Terminology Browser and used this to search for all 
relevant Read codes and their descriptors which are associated with TB. 
[http://www.nhsia.nhs.uk/terms/pages/default.asp]. n = 164 codes 
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Step 2 - Link NHS Browser Read Codes to a “5 Digit GPRD Medcode” 
To ensure that I had a complete code list for TB diagnoses I exported the NHS clinical 
terminology codes for TB into ACCESS and then mapped these to the GPRD Read 
codes using a “5 digit medcode” common to both sets. 
Step 3 – Conduct a ‘Word’ Search for All GPRD Codes Related to Tuberculosis 
Using the GPRD “Look-up Med Code” table, that lists over 100,000 Read and OXMIS 
codes, I undertook a ‘word’ search for all Read and OXMIS codes relating to 
tuberculosis using the term “*tuberc*”. I truncated the word tuberculosis at both ends 
using *…..* to ensure all codes related to TB were found. n = 314 codes 
Step 4 - Map “5 Digit GPRD Medcode” to Equivalent PCPS Codes 
Using the complete list of TB codes generated in Step 3 I then mapped these to a PCPS 
code. A PCPS code is a unique code generated by UCL’s Department of Primary Care 
and Population Sciences (PCPS) which uniquely identifies each diagnostic code within 
the GPRD whether Read or OXMIS. 
Step 5 - Remove Medcode Duplicates Using the Statistical Package STATA  
 n = 392 codes 
Step 6 - Search for Extra Codes Specific for TB in Prevention Records 
This step was used as a cross-check to ensure that no codes for TB had been missed by 
using “*tuberc*” in the GPRD Medcode look-up table or by using “tuberculosis” in the 
NHS Clinical Terminology browser. The GPRD prevention record files were scanned 
for TB related investigations and vaccinations such as BCG. These records were then 
linked back to the medical diagnoses of individual patients - no additional information 
was found in the prevention records. 
Step 7 - Search for Codes Specific for TB in Therapy Records 
This step was used as a cross-check to ensure that no codes for TB had been missed 
using steps 1-6 above. Using the British National Formulary section 5.1.9: “TB drugs” 
as a guide [http://bnf.org/bnf/] I searched the GPRD therapy records using the main 
drugs used to treat TB: pyrazinamide, ethambutol and isoniazid with rifampicin. No 
additional information was found in the therapy records when linked back to the 
medical diagnoses of individual patients. 
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Step 8 - Remove Inappropriate Codes 
Finally the complete list of diagnostic codes for TB was reviewed by hand and 
inappropriate codes: those not diagnostic of active TB were removed. Examples of 
codes removed include: ‘TB contact’, ‘contact screening’ and ‘family history of TB’. A 
total of 88 codes were removed 
304 medical codes compatible with active-TB were found and subsequently used to 
select patients from the GPRD full dataset to generate the cases on which this research 
is based (see Appendix 2 for a full list of TB codes used in this research). 
3.5.3 Details of TB Cases Selected 
Of 5,161 cases with active-TB in the GPRD database, 3,032 had at least 18 months of 
up-to-standard data pre-diagnosis. 
3.5.4 Criteria for the Selection of Controls 
Five controls per case were randomly extracted from the GPRD dataset using the 
following criteria: 
Inclusion Criteria for Controls: 
• Age matched to age-band of linked TB case 
• Registered at the same GP practice as linked TB case (linked using practice 
id number) 
• At least 18 months UTS data preceding a control index date (a random date 
within the controls UTS period) 
 
Exclusion Criteria for Controls: 
• A medical code for active-TB 
• Taking TB drugs (see Appendix 3 for a TB drug code list) 
 
The random sample was computer generated by an independent data manager not 
involved in the study. 
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Age matching was used because the age distribution of cases differed from the age 
distribution of randomly selected ‘test’ controls. Age bands of 20 years were used to 
sub-divide the cases, and then five times the number of cases were selected for each age 
band (see following for details). 
Cases and controls were matched on practice to minimise the confounding effect of 
social class and ethnicity (for which data is not available), with the assumption that 
patients registered with the same GP are more likely to be in similar socio-economic 
and ethnic groups; although there is of course considerable heterogeneity within a 
practice. 
3.5.5 Age Matching of Cases and Controls 
To decide how to select the controls for this study I reviewed the age distribution of TB 
cases and that of a group of ‘test’ controls. Figure 3.2 shows the age distribution of TB 
cases; the mean age was 49 years and cases were not ‘normally’ distributed but slightly 
skewed to the left (a case’s age was taken to be that at diagnosis of TB). 
Figure 3.2 Distribution of age at diagnosis for 3032 TB cases 
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A randomly selected ‘test’ group of 5 controls per case was extracted from the GPRD 
and the age distribution reviewed. The ‘test’ controls were not normally distributed but 
skewed to the right therefore having a different age distribution to the cases. The mean 
age of ‘test’ controls was 12 years younger than cases at 36 years. 
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As the age distribution of cases and ‘test’ controls was different, matching by age was 
appropriate for the control group. The criteria used to select ‘controls’ from the GPRD 
dataset included the restriction ‘match by age’. To ‘match by age,’ the 3032 TB cases 
were divided into five age bands, each of 20 years, and five controls per case were 
selected from within each age band (table 3.5.3). A random date was selected on which 
each control had to be in the same age-band as its linked case. 
Table 3.1 Cases and controls by age band used  
Age Band Cases Controls 
<=20 427 2135 
>20 - <=40 651 3255 
>40 - <=60 803 4015 
>60 - <=80 929 4645 
>80 222 1110 
Total 3032 15160 
3.6 Methodological Approaches and Statistical Analysis 
The detail of individual study methods and statistical analysis can be found in the 
relevant chapter (Chapters 4 - 7). Here I discuss in generic terms the approaches I used 
and why. 
3.6.1 Study 1 - A Case-Control Study 
I used a case-control study to examine consultation behaviour prior to a diagnosis of TB 
and to explore whether differences exist between cases and controls in the six months 
prior to diagnosis. A case-control study was conducted as it offered an efficient study 
design and allowed me to take multiple controls. A six month period of analysis was 
chosen because previous research suggests that most TB patients present within 6 
months of first symptoms, within one study an average of 3 months was found.20 Five 
controls per case were randomly extracted from the GPRD to maximise statistical 
power. Research shows that taking up to 4 controls per case increases the power for 
each additional control taken; above 4 the benefits rapidly decrease.137-139 I selected 5 
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controls per case so that I would have at least 4 controls even if some controls were lost 
due to insufficient longitudinal data when analysed. 
In this study I took cases with TB and controls without-TB and looked back in time to 
see how frequently cases consulted with the symptoms of TB as compared to controls. 
For the first part of my study I was therefore not using the design of a case-control study 
in the traditional way to identify risk factors, but rather to gain an understanding of the 
natural history of TB prior to diagnosis and also to understand if opportunities exist to 
diagnose TB earlier. However, the case-control design also afforded the opportunity to 
address a secondary objective of identifying risk factors for TB. 
To assess consultation behaviour pre-TB, I analysed consultation rates for cases and 
controls, the frequency of consultations and the odds of TB for the classical symptoms 
of TB and diagnosed respiratory conditions. Odds ratios (OR) were calculated using 
conditional logistic regression and compared the odds of symptoms, or odds of 
respiratory diseases, in cases in the six months prior to a diagnosis of TB with those in 
the six months prior to an index-date in controls. Conditional logistic regression is 
appropriate for the analysis of individually matched data and for case-control studies. 
The strength of the association between classical TB symptoms and tuberculosis was 
assessed using odds ratios comparing cases to controls and similarly the association 
between TB and respiratory diagnoses (for which TB might be mistaken). Respiratory 
diagnoses were divided into 3 specific diagnostic groups: ‘all respiratory diseases’ 
which included all acute and chronic respiratory conditions other than TB, ‘respiratory 
infections other than TB’ and ‘lower respiratory infections other than TB’ (LRTI). 
To investigate potential risk factors for TB I used single and multivariable analysis to 
calculate odds ratios for TB. Multivariable conditional logistic regression models were 
constructed and all variables that showed statistical significance in the prediction of TB 
in single variable analysis (p<0.05) were retained in the final multivariable model. 
Analyses were controlled for gender, smoking and pre-existing morbidity (e.g. coronary 
heart disease, chronic renal failure, chronic respiratory disease, diabetes). Results of the 
conditional logistic regression analyses were reported as adjusted odds ratios with 95% 
confidence intervals. The multivariable analysis allowed me to control for several 
variables / confounders at the same time and to understand the dependency of certain 
variables on several other explanatory variables. 
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The results of a case-control study will be incorrect if confounding variables are not 
accounted for in the analysis. At the time of analysis the GPRD dataset did not contain 
any ethnicity data, a major confounder for TB (over two thirds of UK TB cases occur in 
people from ethnic minorities)47 So although the dataset was large, confounding may 
suggest a difference between cases and controls that does not truly exist. To try to 
minimise confounding I selected controls from the same GP practice and in a similar 
age band to TB cases: a matched design. I chose controls from the same GP practice, 
with the assumption that patients registered with the same GP were more likely to be 
from a similar social background and ethnic group; although realising that considerable 
confounding is still likely to exist. 
3.6.2 Study 2 - A Self-Controlled Study 
I used a self-controlled (case-only) study as a second method to examine consultation 
behaviour prior to a diagnosis of TB. I used this method so that self matching of cases 
would eliminate control selection bias, remove confounding by permanently fixed 
factors e.g. gender, ethnicity, genetics and minimise confounding by factors that vary 
little over the comparison period e.g. chronic illness, age, social class, lifestyle.140-142 
Due to confounding, a case-control study may not show the true association between an 
exposure and a disease or in this study between consultations pre-diagnosis and disease. 
Potentially important confounding variables, such as ethnicity and social status are not 
recorded in the GPRD or are poorly recorded e.g. smoking; and so it is important to 
control for these variables. One method to evaluate the findings of a case-control study 
and simultaneously reduce confounding is to use a ‘self-controlled’ study design. A 
self-controlled study, alternatively described as self-matching of cases or case-only 
analysis,140-143 allows a case to act as its own control during a disease-free period either 
prior to or after the event under study. A self-controlled study can be defined as 
repeated observations on an individual in two different time periods (as shown in the 
diagram below). In this study, time periods 1 and 2 are observation periods 0-6 and 12-
18 months prior to a diagnosis of TB: 
Chapter 3 – Methods  74 
Time period 2Registration
18 12 6
TB diagnosed
0
Months pre-diagnosis
Time period 1
 
Similar studies using the GPRD and this methodology have been conducted and have 
been to shown to be robust.83 
In a self-controlled study the analysis is based only on data from cases, who act as their 
own controls, “The incidence of events during one predefined time period is compared 
with the incidence of events in the same individuals in a different predefined base-line 
period”.142 
By comparing 12-18 months pre-TB with 0-6 months pre-TB I reduced the impact of 
seasonality on disease. Research shows that TB exhibits seasonal variation,144-146 in 
addition to diagnoses such as LRTI which might be confused for TB. It also ensured 
that I was comparing a TB-free period (18-12 months pre-diagnosis) with a period in 
which TB was likely to be developing (6-0 months pre-diagnosis). Since the self-
controlled analysis included only cases with at least 18 months of data prior to a TB 
diagnosis and only one control per case (that is itself) it was less powered than the case-
control study. 
This self-controlled study used the same TB cases as the case-control study presented in 
Chapter 4, i.e. TB cases with at least 18 months of data pre-diagnosis, and compared 
consultation behaviour in two time periods 12-18 months pre-TB and 0-6 months pre-
TB. 
The Generalised Estimating Equation (GEE) model was used for statistical 
analysis.22,24,25,147 The GEE model compares total counts for each individual and then 
calculates a summary measure for all individuals, the incidence rate ratio (IRR) with 
95% confidence intervals. In methodological terms the GEE model calculates an 
incidence rate ratio (IRR); in practical terms, however, in this study it calculates the 
ratio of consultations in two different time periods. I will therefore refer to it as 
calculating a rate ratio as it is not calculating a true incidence as an individual may 
consult twice with, for example, a persistent cough which would not necessarily be a 
new incidence of cough. 
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The GEE model was considered the most appropriate analytic tool for a number of 
reasons: firstly as repeated measurements were taken on the same individual,22,25,148 
secondly because the outcome measures were total number of GP consultations during 
specific time intervals, thirdly because the distribution of cases was not a ‘normal’ 
distribution, fourthly it allows for correlated observations without explicitly defining a 
model and fifthly focuses on estimating an average response over a population.  
Consideration was given to other statistical methods / models that might be used to 
analyse a self-controlled study. Conditional logistic regression would not be suitable as 
it needs independent individuals for its analysis. In this study comparisons were made in 
different time periods for the same individual, so the individuals were not independent. 
The Wilcoxon Signed Rank Test, only gives a p value and a distribution type for the 
data, it is not a decision-making tool and so gives no relative risk or comparator of cases 
to controls and a Paired T-test would not be appropriate as it compares means and we 
have a skewed distribution. A review was made of the ‘case-series’ method for 
statistical analysis but this is primarily for a time varying exposure and its association 
with an outcome event.140, 142, 149-151 A ‘case-series’ method was not appropriate for the 
analysis in this pre-TB study. 
The downside of the self-controlled analysis is the fact that only cases with at least 18 
months of data prior to TB and only one control per case can be used so reducing the 
power of the study. However, using cases as their own self-matched controls guarantees 
no difference in fixed confounders between cases and their self controls, so long as the 
matching is preserved in the analysis, and minimises differences in confounders that 
vary little over the time period in question. 
Study 1 and 2 therefore look at the same relationship between consultation behaviour 
prior to diagnosis and disease using different methodologies (case-control and self-
controlled) in an attempt to understand and minimise the impact of possible confounders 
such as ethnicity and social-status. 
3.6.3 Study 3 - A Self-Controlled Study to Assess Morbidity Post TB 
To test my null hypothesis that once TB patients have received treatment they return to 
full health I used a self-controlled study. Following a diagnosis of TB, statistical 
analysis of patient outcomes is possible with longitudinal data and the use of a cohort 
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study. But it is complex due to the loss of both cases and controls to follow-up in 
addition to the ever present problem of controlling for confounders. A self-controlled 
study using the self-controlled ‘case series’ methodology provides a good solution to 
minimise the effects of confounding variables.142,149,150,151,152,153 The use of a self-
controlled study design for the post-TB period is similar to that described for the pre-TB 
self-controlled study earlier; however, it uses data from the post-TB, 12-18 month 
period, as the control period instead of 12-18 months pre-TB. 
Time period 2Registration
18 12 12
TB diagnosed
18
Time period 1
Months pre-diagnosis Months post-diagnosis
 
In this analysis the consultation behaviour of cases in the 12-18 months prior to 
diagnosis was compared with their own consultation behaviour in the 12-18 month 
period following diagnosis. Total consultation rates, respiratory consultation rates and 
antibiotic and inhaler prescribing rates were compared in these two time periods. A 
similar approach is not possible for mortality. Standard TB treatment lasts for six 
months, occasionally patients will take treatment for over 6 months. By using data 12 
months after a TB diagnosis I can test my null hypothesis that post-treatment TB 
patients have no increase in morbidity: they consult no differently than when they 
themselves are well 12-18 months pre-diagnosis. 
To analyse this study I used the Generalised Estimating Equation (GEE) model to 
generate an incidence rate ratio (IRR) with 95% confidence interval.22,24,25,147 This 
method is the same as described for the pre-TB self-controlled study (study 2) in 
Chapter 5. 
3.6.4 Study 4 - A Cohort Study to Assess Mortality Post-TB 
I conducted a conventional cohort study to examine the survival of patients diagnosed 
with TB. To determine whether TB patients have a higher death rate not directly 
attributable to TB I compared TB cases and cases without TB using survival analysis. 
This was done using death from any cause (excluding TB coded deaths) and death from 
a respiratory cause (excluding TB coded deaths). Analyses were controlled for age, 
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gender, smoking and pre-existing disease such as coronary heart disease, chronic renal 
failure, chronic respiratory disease and diabetes. 
To identify risk factors for death in patients with TB a further survival analysis was 
performed and was restricted to cases of TB. Factors that were explored as predictors of 
death/confounders included sex, site of TB, delay in diagnosis, major chronic diseases 
and smoking status. 
Statistical analysis was first conducted using a single variable analysis. Categorical 
variables were compared using the Chi Squared test. Multivariable Cox proportional 
hazards regression analysis was used to evaluate risk factors for death. All variables 
with p<=0.05 were retained in the final multivariable model. All p values <0.05 were 
considered statistically significant. 
A Cox proportional hazards model was used to compare the survival of patients with TB 
to those without.154 This model was used to help account for patients who did not 
provide complete data throughout the follow-up period (censored observations) and was 
adjusted for sex and chronic disease. Hazard ratios and their 95% confidence intervals 
were calculated and a Cox Model survival curve plotted. 
All data in the four studies discussed above were analysed using STATA version 9.0 
(Stata Corp, College Station, TX, USA)155 and ACCESS software. Further details of the 
statistical methodology for each study are presented in the relevant chapter. 
3.7 Data Preparation 
3.7.1 Development of ‘Code’ Lists to Analyse Patient Consultations 
I assessed the NHS Clinical terminology browser codes and GPRD code groups 
developed by researchers from the Office of National Statistics, the Communicable 
Disease Surveillance Centre, now the HPA Centre for Infections, and the UCL Centre 
for Infectious Disease Epidemiology. I present here the final search strategies I 
generated using STATA to give diagnostic code lists to assess patient consultations in 
my research. 
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To compare patient consultations pre and post TB I selected the following criteria: 
• Symptoms and signs compatible with TB 
• Diagnoses similar to TB which might be diagnosed instead of TB 
• TB drugs 
• Antibiotic prescriptions 
• Inhaler prescriptions 
• Chronic diseases and smoking status 
• HIV and cancer 
 
To analyse the data in the GPRD I needed to generated code groupings compatible with 
these criteria and this is what I present here. 
3.7.2 Search Strategy to Identify Codes for the Symptoms and Signs of 
TB 
Step 1 – Determine the Classic Symptoms and Signs of TB 
Using the paper by Lewis20 as reference I selected the following symptoms and signs as 
classic for TB: 
• Cough 
• Fever 
• Sweats 
• Lymphadenopathy 
• Haemoptysis 
• Weight loss 
Step 2 – Search GPRD for All Infection Related Codes 
Using the GPRD “Look-up Med Code” table, which lists all Read and OXMIS codes 
and covers all the potential diagnoses a GP might use, I selected all codes of an 
‘infectious nature’ i.e. where infection was the likely cause. = 4292 codes 
Step 3 – Search GPRD Subset for All Respiratory Infection Codes 
From within the infectious code list I selected all the infectious respiratory codes. 
 = 242 codes 
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Step 4 – Search GPRD Respiratory Infection Subset for All Codes Related to the 
Classic Symptoms and Signs of TB 
From within the infectious respiratory codes I selected all codes relating to the classic 
symptoms and signs of TB: 
• Cough - 59 
• Fever, - 30 
• Sweats - 12 
• Lymphadenopathy - 62 
• Haemoptysis - 6 
• Weight loss - 10 = 179 codes 
Step 5 - Link Symptom and Sign OXMIS and Read Medcodes to Equivalent PCPS 
Codes 
Using the list of codes generated in step 4 I then linked each code to a PCPS code, the 
final code to be used to search the GPRD medical records database (see Section 3.5.1 
for definitions). 
3.7.3 Search Strategy to Identify Codes for Medical Conditions that 
Might Be Mistakenly Diagnosed Instead of TB 
To generate codes compatible with conditions that might be mistakenly diagnosed 
instead of TB I selected ‘all respiratory infection’ codes (excluding TB) as for step 3 in 
3.7.2 above and combined these with all GPRD codes for asthma and COPD to create a 
code group ‘all common respiratory diseases’ (378 codes). In addition I separated out 
codes specifically for lower respiratory tract infections (LRTI) (100 codes). 
3.7.4 Search Strategy to Identify Therapy Code Groups 
To search the therapy records held in the GPRD, appropriate drugs were selected from 
the British National Formulary (BNF) and converted into BNF drug codes. These BNF 
codes were then linked via the GPRD drug dictionary with GPRD recognised drug 
codes and used to search the GPRD therapy records. The BNF is a publication produced 
by the British Medical Association and Royal Pharmaceutical Society that details key 
information on the prescribing, dispensing and administration of drugs in the UK. 
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TB Drugs 
Step 1 - Search for Codes Specific for TB Drugs in the BNF 
Using the BNF, I selected chapter 5 – Respiratory Diseases and from within this chapter 
section 5.1.9 – drugs to treat TB. A BNF section number can then be converted into a 
BNF code e.g. 05.01.09.00 which can then be used to search the drugs dictionary of the 
GPRD to find all relevant drugs and their GPRD drug code, the multilex code. 
Step 2 - Search GPRD Drug Dictionary for TB Drugs Using the BNF Codes 
 
Using the BNF code for TB drugs 05.01.09.00, I searched the GPRD drugs dictionary 
for the main drugs used to treat TB: pyrazinamide, ethambutol, isoniazid and 
rifampicin. = 80 codes 
Respiratory Antibiotics 
Similar steps as those taken for TB drugs were used to search for respiratory antibiotics. 
Using chapter 5 of the BNF – Infections, I selected section 5.1 Antibacterial drugs and 
from this the subsections on – penicillins, cephalosporins, tetracyclines, macrolides, 
cotrimoxazole and quinolones (5.1.1, 5.1.2, 5.1.3, 5.1.5, 5.1.8 and 5.1.12). I then used 
the BNF codes I had generated to search the GPRD drugs dictionary for all antibacterial 
drugs used to treat chest infections. = 1721 codes 
Respiratory Inhalers 
Similar steps were taken to search for respiratory inhalers. Using chapter 3 of the BNF – 
Respiratory Systems, I selected sections 3.1 Bronchodilators, 3.2 Corticosteroids and 
3.3 chromoglycates, and used the BNF codes 03.01.00.00, 03.02.00.00 and 03.03.00.00 
to search the GPRD drugs dictionary for relevant drugs and then restricted the final code 
list to only those available as an inhaler. = 298 codes 
3.7.5 Search Strategy to Identify Chronic Disease Codes 
Code lists for coronary heart disease, chronic renal failure, diabetes and chronic 
respiratory disease (which included asthma, COPD, bronchiectasis and rarer diseases 
such as bird fanciers lung) were generated using a similar methodology to that detailed 
in Section 3.7.2. 
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3.7.6 Search Strategy to Identify HIV Codes 
Using STATA I generated a code list for HIV by searching the GPRD medcode list 
using the key words ‘HIV’, ‘human immunodeficiency virus’ and ‘AIDS’. This 
generated 57 codes for HIV. = 57 codes 
3.7.7 Search Strategy to Identify Cancer Codes 
I generated a code list for all cancers using the following method: 
1. I searched the GPRD medcode list using key words: cancer, carcinoma, 
neoplas*, sarcoma, leukaemia, lymphoma, hodgkins, malignan*, 
melanoma, mesothelioma, myeloma and tumour; 
2. I then did a ‘stem’ search query looking for all GPRD medcodes starting 
with ‘B*’ as this represents all READ codes related to cancer; 
3. I then trawled the combined list of codes generated by steps 1 and 2 to 
exclude and delete irrelevant codes such as ‘benign’, ‘FH’, ‘family history’, 
‘screen*’, ‘suspected’ and ‘non malignant’; 
4. Finally I removed all duplicate codes 
 
This method generated a list of 5,862 cancer codes. = 5,862 codes 
3.7.8 Strategy to Determine Cause of Death 
To determine a patient’s cause of death I took all deaths and grouped them into one of 
six causes; i.e. death due to TB, cardiovascular disease, respiratory disease (excluding 
TB), cancer, other diseases (including diabetes and renal failure) and unknown. I then 
cleaned the death codes per patient (varying between 1 and 6 per patient) to one code, 
the most likely cause of death, and used the following assumptions: 
1. If death occurred on the same day that TB was diagnosed I assumed TB 
was the cause of death 
2. If death occurred within 1 month of a TB diagnosis I assumed the death 
was likely to be due to TB unless another obvious cause such as CVA was 
recorded on the day of death as well as TB 
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3. All other deaths I assumed were not TB and allocated them to the most 
likely generic group listed above. 
3.8 Data Cleaning 
Medical records for 3032 TB cases were extracted from the full GPRD dataset. Over 
196,000 individual contacts with primary care were recorded for these patients. To clean 
the data of consultations in which the patient had not formally seen their GP I reviewed 
all consultations and separated the “true consultations” from the “non-GP” 
consultations. To do this I analysed how often a type of consultation occurred and 
where it occurred with the view to removing all “non-GP” consultations such as 
consultations where the patient did not see their GP, that is, “did not attend” or “had a 
test taken.” 
3.8.1 Identification of True Consultations with a GP 
To identify ‘true’ GP consultations I analysed all the patient medical records by 
frequency of contact with primary care. Over twelve thousand different contact 
descriptions and therefore analytic codes were found. The first 40 of these are tabulated 
in Table 3.2. 
Table 3.2 Top 40 reasons for TB patients to be in contact with primary care 
GPRD consultation diagnosis Frequency 
Chest infection 2884 
INFECTION CHEST 2440 
Medication requested 2435 
Tuberculosis 2336 
TUBERCULOSIS 2291 
Cough 2264 
Did not attend - no reason 2050* 
URTI (UPPER RESPIRATORY TRACT INFECTION) 1945 
Blood sample -> Lab NOS 1916* 
COUGH 1899 
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GPRD consultation diagnosis Frequency 
Upper respiratory infection NOS 1798 
Reviewed at hospital 1727* 
BLOOD TEST 1587* 
Had a chat to patient 1517 
Asthma 1405 
Injection given 1363* 
MEDICAL CERTIFICATE 1360 
REVIEWED AT HOSPITAL 1235* 
Chest pain 1228 
Influenza vaccination 1190* 
Incoming mail NOS 1183* 
MED3 - doctor's statement 1179 
ASTHMA 1178 
Respiratory tract infection 1103 
Screening - general 1068 
DNA (DID NOT ARRIVE) 1041* 
Depressive disorder NEC 1027 
Patient's condition improved 962 
Repeated prescription 926 
Urinary tract infection, site not specified NOS 922 
Pain 914 
PAIN BACK 903 
UTI (URINARY TRACT INFECTION) 887 
X-RAY CHEST 886* 
PAIN 853 
FULL BLOOD COUNT 844* 
Discharged from hospital 835* 
Chronic obstructive airways disease 831 
Backache 821 
Pulmonary tuberculosis 809 
Listed by decreasing frequency of occurrence 
* = non-consultation 
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Some of these 12,000+ descriptors of contact with primary care are not in fact 
consultations with a GP but represent codes for other things; for example; 2050 records 
were for patients who did not attend, 1916 were for blood samples and 1727 records 
referred to a hospital attendance. To meet my study objectives it was crucial to look 
only at ‘true’ contacts with a GP where a diagnosis of TB might be possible. The data 
therefore needed to be cleaned of “non-GP” consultation and the following steps were 
used: 
1. All 12,000+ descriptors of contact with primary care were ordered by 
frequency, with the commonest first. 
2. The consultation types were then reviewed manually and a preliminary 
selection of non-GP consultations was made. 
3. All consults were then re-ordered alphabetically to show up similar non-GP 
consultations which might have been missed visually the first time. 
4. A final selection was made and discussed with an epidemiologist and a GP. 
5. A consensus was reached and over 50,000 non-GP consultations were 
removed (see Appendix 4 for the top 40 “non-GP” consultations removed). 
This led to over 18% of “non-GP” consultations being removed. The top four of these 
removed were: did not attend; blood test; reviewed at hospital; and injection given. 
3.8.2 Analysis of Where the Contact with a Patient Occurred 
Within each medical record there is a descriptor called ‘locate,’ short for location. 89% 
of patient contacts within primary care had a location recorded. Of 20 possible 
locations, five were clearly not taking place in primary care and did not involve a 
consultation with the patients GP: letter from outpatients, discharge details, A&E 
attendance, mail from patient, administration (Did not attend, consultant letters…) 
I considered removing these five locations from my analysis. However, they only 
represented 2.5% of all patient contacts and most were removed by the restrictions 
applied during identification of “true” GP consultations cleaning process described 
above, and so I decided I did not need to remove these five location consultations 
specifically. 
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3.9 Approval for this Research 
A protocol summarising this research was prepared and submitted to the University 
College London (UCL) GPRD steering group. After acceptance by UCL the protocol 
was submitted to the independent Scientific and Ethical Advisory Group (SEAG) of the 
GPRD. SEAG governs the research use of the GPRD and considers the scientific and 
ethical soundness of research that will use the GPRD database. SEAG gave its approval 
for this research to be carried out and issued protocol number 608. I did not have access 
to named patient data for patients with TB and did not perform any analyses that could 
compromise patient confidentiality. 
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Chapter 4  
 
Consultation Behaviour in Primary Care Prior to a 
Diagnosis of TB: A Case-Control Study 
4.1 Introduction 
TB is on the increase but little is published on its natural history or epidemiology prior 
to diagnosis or from a primary care perspective. To understand these aspects of TB 
epidemiology, I undertook a large study to examine consultation behaviour and risk 
factors prior to a diagnosis of TB using primary care data from the General Practice 
Research Database (GPRD). 
4.2 Aims & Objectives 
4.2.1 Aims 
The aims of this study were to explore how TB patients present in primary care, to 
assess the extent of missed opportunities for a diagnosis of TB in primary care and 
assess ways to diagnose TB earlier. 
4.2.2 Objectives 
• To measure excess GP consultations for TB cases as compared to controls 
in the 6 months prior to diagnosis 
• To examine consultation behaviour and consultation type 
• To investigate risk factors for TB 
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4.3 Methods 
Study Design 
A case-control study was conducted to compare consultation rates and behaviour in the 
6 months prior to a diagnosis of TB for cases with the 6 months prior to a randomly 
selected date in age and practice matched controls (patients without TB). The same 
case/control participants were also used to assess risk factors for TB. 
Setting 
I examined data from 743 general practices in the UK who provided data to the General 
Practice Research Database (GPRD) during the time period April 1990 to April 2002. I 
used only data from practices that met a pre-set quality standard. 
Data Source 
The General Practice Research Database (GPRD) is the world’s largest computerised 
primary care database with over 20 years of longitudinal data (1987-2009). Currently it 
contains data on approx 13 million patients from approximately 500 practices covering 
5.5% of the UK population.77 It is considered broadly representative of the UK 
population,76 has been widely used for epidemiological research78-83 and data quality has 
been shown to be high in independently validated studies.76, 80, 84-86 Anonymised patient 
data is collected from participating practices and all information for individual patients 
is handled using a unique identification number.75 GPs record medical diagnoses and 
symptoms using Read and Oxford Medical Information System (OXMIS) codes; these 
codes are based on, and can be mapped to, the internationally recognised classification 
systems of Disease (ICD-10) and Surgical Operations and Procedures (OPCS-4). Data 
for each patient includes age, sex, medical diagnosis and symptom records, details of 
patient consultations, mediation prescribed, a summary of specialists' clinical notes and 
hospital letters, results of laboratory tests and a free-text section. 
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Participants 
Patients were selected from the GPRD between 1990 and 2002; they were grouped into 
cases and controls by outcome. 
Cases: were GPRD patients with a medical code for active TB (see Appendix 2) 
Controls: were a random sample of five people without TB for every person with TB; 
matched on age-band and general practice but not year of TB diagnosis. The random 
sample was computer generated by an independent data manager not involved in the 
study. For analytic purposes I chose a random index date for each control and 
considered this equivalent to the date of TB diagnosis for cases. 
‘Exclusion’ criteria: I excluded patients who had less than 18 months of pre-diagnosis 
data (see Chapter 3, Section 3.5). 
 
Measurements 
To identify all patients with a diagnosis of TB I developed Read and OXMIS code lists 
(see Appendix 2 and Chapter 3, Section 3.7 for more details). I compared consultation 
behaviour for TB cases in the six months before diagnosis with that of controls in the 
six months before a randomly selected index-date. To assess consultation behaviour, I 
analysed consultation rates for cases and controls and the frequency of consultations and 
the odds of TB for the classical symptoms of TB and diagnosed respiratory conditions. 
To investigate potential risk factors for TB I used single and multivariable analysis to 
calculate odds ratios for the association between consultations and TB. 
Bias 
I tried to reduce ethnicity and social status bias by matching patients on GP practice. 
Statistical Analysis 
All the available cases in the GPRD that met my inclusion criteria were used to 
maximise the power of the study. Five matched controls were used per case; more 
controls than this are unnecessary as research suggests they only marginally increase 
power.137-139 
Statistical analysis was performed using STATA version 9.0 (Stata Corp, College 
Station, TX, USA).155 Consultation rates for cases and controls were calculated and 
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compared. GP consultations for specific symptoms and respiratory diagnoses were 
analysed using single variable models. Odds ratios (OR) and their 95% confidence 
intervals (CI) were calculated using conditional logistic regression with TB as the 
outcome. A p value of 0.05 or less was considered statistically significant. Single 
variable and multivariable analysis was undertaken to study associations between 
several different variables: sex, smoking status, pre-existing morbidity (e.g. coronary 
heart disease, chronic renal failure, chronic respiratory disease and diabetes) and the 
odds of TB. Results of the multivariable model are reported as adjusted odds ratios with 
95% CIs. For further details of the statistical method see Chapter 3, Section 3.6. 
4.4 Results 
A total of 3,032 TB cases and 15,160 age-matched controls (5 per case) were identified 
from the GPRD. 196,518 consultations were analysed for cases and 610,539 
consultations for controls. 
4.4.1 Characteristics of Study Participants 
Table 4.1 details the baseline characteristics of cases and controls. Similar numbers of 
males and females were diagnosed during the study period. The age distribution of cases 
and controls was equivalent as controls were matched to cases on pre-selected age 
bands. The mean age of cases was 49 years and the age distribution (which is not 
‘normally’ distributed) is shown in Figure 4.1. (S.D = 23.09, range = 9 months to 98 
years). 
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Table 4.1 Characteristics of study participants 
 
At diagnosis 35% (n=1061) of cases and only 18% (n=2729) of controls had one or 
more of the four main groups of chronic disease. The largest difference was seen for 
chronic respiratory disease where 28% of cases and 12% of controls had a chronic 
respiratory disease. Only six people, 0.20% of cases, were recorded by their GP to be 
HIV positive as compared to two people, 0.01%, of controls. Fifty four percent of cases 
appeared to have been prescribed TB treatment in primary care. 
Characteristic CASES 
(n=3,032) 
No. (%) 
CONTROLS 
(n=15,160) 
No. (%) 
Sex 
Female 
Male 
1490 (49%) 
1542 (51%) 
7833 (52%) 
7327 (48%) 
Age 
<=20 
>20 - <=40 
>40 - <=60 
>60 - <=80 
>80 
427 (14%) 
651 (22%) 
803 (26%) 
929 (31%) 
222 (7%) 
2135 (14%) 
3255 (22%) 
4015 (26%) 
4645 (31%) 
1110 (7%) 
Chronic Disease 
Any 
Respiratory 
Renal 
Cardiac 
Diabetes 
1061 (35%) 
861 (28%) 
31 (1%) 
213 (7%) 
162 (5%) 
2729 (18%) 
1837 (12%) 
42 (0.3%) 
708 (5%) 
475 (3%) 
Ever smoked 
Yes 439 (15%) 1732 (11%) 
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Figure 4.1 Distribution of age at diagnosis for 3032 TB cases 
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TB can be divided in to a number of sub-types depending on its pathological site. 
Within this dataset 25% (n=759) were coded as pulmonary TB, 16% (n=483) as extra-
pulmonary TB, 58% (n=1774) as ‘unclassified TB’ and 1% ‘TB at an unknown site’. 
4.4.2 Place of TB Diagnosis 
TB was diagnosed by GPs in 40% of cases (n=1,208), by a hospital specialist in 29% 
(n=865), by another but un-named source in 16% (n=492) and the place of diagnosis 
was unknown for 15% (n=407). 
Figure 4.2 Place of TB diagnosis 
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4.4.3 Consultation Data – General 
In the 6 months prior to a diagnosis of TB, 3032 TB patients had 15,461 consultations 
recorded by their GP (as defined in Chapter 3, Section 3.4.2). In the same time period 
15,160 controls had 28,789 consultations. The median number of consultations, per TB 
case was 5 with an inter-quartile range of 3 to 8; and for controls was 2 with an inter-
quartile range of 0 to 3 (see Figure 4.3). 
Figure 4.3 Median number of consultations for cases and controls 
 
Overall, cases consulted 2.68 times more often than controls in the 6 months prior to a 
diagnosis of TB. Table 4.2 shows a comparison of consultation rates in the six months 
pre-TB for cases and prior to a fixed index-date for controls. The number of GP 
consultations for cases was 2.26 times higher than for controls at the start of the study 
period (RR 2.26), consultations then rose steadily for TB cases from 4 months pre-
diagnosis (RR 2.70 at 3 months) with the rise most marked 1 month prior to diagnosis 
when TB patients consult 3.30 times more than controls (see Table 4.2 & Figure 4.4). 
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Table 4.2 Comparison of GP consultations for TB cases and controls  
* includes only consultations occurring prior to a TB diagnosis 
Figure 4.4 Rate of GP consultations in the 6 months pre-diagnosis 
 
Consultation rates per case, per month pre-TB were reviewed from 18 months pre-
diagnosis (see figure 4.5). This showed that from about 7 months pre-TB consultation 
rates started to rise for patients who were subsequently diagnosed with TB. The 
background consultation rate for cases was therefore always higher than that of controls. 
 CASES 
0-6 months 
pre-TB 
(n=3,032) 
CONTROLS 
0-6 months 
pre-index date 
(n=15,160) 
 
CONSULTATIONS Number 
Consults 
per 
case 
Number 
Consults 
per 
control 
Consultation Rate 
Ratio 
(95% CI) 
Total consultations 
0-6 months pre-TB 15,461* 5.10 28,789 1.90 2.68 (2.63-2.74) 
Consultations per month 
0-1 months 
1-2 months pre-TB 
2-3 months pre-TB 
3-4 months pre-TB 
4-5 months pre-TB 
5-6 months pre-TB 
3560* 
3013 
2636 
2225 
2071 
1956 
1.17 
0.99 
0.87 
0.73 
0.68 
0.65 
5383 
4993 
4880 
4795 
4425 
4313 
0.36 
0.33 
0.32 
0.32 
0.29 
0.28 
3.31 (3.17-3.45) 
3.02 (2.88-3.16) 
2.70 (2.57-2.83) 
2.32 (2.20-2.44) 
2.34 (2.22-2.47) 
2.26 (2.15-2.39) 
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Figure 4.5 Rate of consultations per case per month pre-TB 
 
4.4.4 Analysis of GP Consultations per Patient 
Cases consulted more often than controls in the six months prior to a diagnosis of TB. 
The median number of consultations was 5 with a range of 0-41. In the six months prior 
to a TB diagnosis, a third of TB patients (n=1121) had 6 or more consultations 
compared to 9% (n=1419) of controls. Half (54%) of cases had more than 3 
consultations and 12% saw their GP only once. 10% of cases had no GP consultations 
compared to 43% of controls (see Figure 4.6). 
Figure 4.6 Distribution of visits for cases and controls in the 6 months pre-
TB 
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In order to explore variations in the consultation rates of TB patients, a subgroup 
analysis of the characteristics of high consulters (6 or more consults) compared to lower 
consulters was performed. TB patients with 6 or more consultations were more likely to 
be older (see Figure 4.7). Of the people who consulted 6 or more times, 26% had one or 
more chronic diseases of the four main groups assessed, compared to 35% for all TB 
cases. 
Figure 4.7 Percentage of TB cases by age band comparing those with six or 
more consults to those with less than six 
 
4.4.5 Analysis of Consultations for the Classic Symptoms of TB 
GP consultations for the classic symptoms of TB (see Chapter 3: Section 3.6.2, for 
further details) were compared for cases and controls in the 6 months pre-TB or index-
date. Nearly a third of TB patients (n=832) had symptoms suggestive of TB recorded by 
their GP prior to diagnosis as compared to 4.5% (n=682) of controls. Consultations for 
each of the classic symptoms of TB showed that in the 6 months prior to a TB 
diagnosis, cough was the most common symptom recorded by GPs (16%) (see Table 
4.3). Four percent of controls presented with cough and only very rarely with any of the 
other classic symptoms of TB. 
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Table 4.3 Consultations for TB symptoms in cases and controls in the 6 
months prior to a diagnosis of TB including odds ratios for TB 
Symptoms 
CASES 
(n=3,032) 
No. (%) 
CONTROLS 
(n=15,160) 
No. (%) 
ODDS RATIO 
for TB 
(95% CI) 
p 
value 
Cough 
Fever 
Sweating 
Lymphadenopathy 
Haemoptysis 
Weight loss 
  
Any TB symptom 
497 (16.4%) 
103 (3.4%) 
28 (0.9%) 
167 (5.5%) 
13 (0.4%) 
114 (3.8%) 
 
832 pats 
(27.4%) 
570 (3.8%) 
57 (0.4%) 
2 (0.01%) 
30 (0.2%) 
2 (0.01%) 
43 (0.3%) 
 
682 pats 
(4.5%) 
5.20 (4.56 – 5.93) 
9.66 (6.92 – 13.50) 
70.00 (16.68 – 293.82) 
32.90 (21.61 – 50.11) 
32.50 (7.33 – 144.02) 
14.05 (9.80 – 20.15) 
 
8.37 (7.43 – 9.41) 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
<0.001 
Of note: Table 4.3 shows for each TB symptom, how many cases or controls exhibit this 
symptom at least once during the 6 month study period. Any one individual may have a number 
of different symptoms recorded and so may be counted in more than one symptom group. 
The strength of association between the classic symptoms of TB and a later diagnosis of 
TB are shown by the odds ratios in Table 4.3. In the 6 months prior to diagnosis the 
odds of TB was 8.37 times greater for those with any of the classic symptoms of TB 
than those without and the odds of TB was 5.2 times greater for those with a cough than 
those without. The odds ratios for TB and its cardinal symptoms show that fever 
(OR:9.7), weight loss (OR:14.05) and lymph nodes (OR:32.9) are strongly and 
individually more predictive than cough (OR:5.2) for patients who subsequently go on 
to develop TB. Odds ratios for sweating and haemoptysis are large but are associated 
with very wide confidence intervals due to small numbers. Symptom counts for controls 
are small. 
A review of GP consultations month by month in the six months pre-TB revealed that 
TB cases have a gradual increase in consultations for ‘cough’ and lymphadenopathy 
from 4 months pre-diagnosis; with these consultations increasing most rapidly 2 months 
prior to diagnosis. Consultations for fever and weight loss showed a significant increase 
only in the last month and sweats and haemoptysis were uncommon through-out the six 
months period (see Figure 4.8). For controls, GP consultations for the classic symptoms 
of TB remained little changed throughout the 6 month period prior to a fixed index-date. 
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Figure 4.8 Classic TB symptom rates by month for cases and controls 
 
 
Further analysis of different combinations of classic TB symptoms was unhelpful. Very 
few GPs recorded more than one TB symptom at any one consultation: only 76 of 
15,461 consultations (0.5%) have two TB symptoms recorded at the same consultation. 
4.4.6 Analysis of Respiratory Consultations 
Nearly half, 42% (n=1268) of TB cases were diagnosed with a respiratory problem 
(respiratory infection or chronic respiratory disease) in the 6 months pre-TB as 
compared to 10% (n=1570) of controls. One in three TB patients (n=1177) presented 
with a respiratory infection and of these over half were lower respiratory tract infections 
(see Table 4.4). 
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On single variable analysis the odds ratio for TB for patients consulting with a 
‘respiratory disease’ was nearly seven times that of those without TB (OR:6.81) and the 
odds of TB for those with a ‘respiratory infection or cough’ was greater than seven 
times that of those without TB (OR: 7.31) (see Table 4.4). 
Table 4.4 Consultations for respiratory disease in cases and controls in the 
6 months prior to a diagnosis of TB including odds ratios for TB 
Respiratory Disease* 
 
CASES 
(n=3,032) 
No. (%) 
 
CONTROLS 
(n=15,160) 
No. (%) 
ODDS RATIO 
for TB 
(95% CI) 
p value 
 
LRTI 751 (25%) 564 (4%) 7.81 (6.92 – 8.82) <0.001 
All respiratory infections 
(incl. cough) 
1177 (39%) 1312 (9%) 7.31 (6.61 – 8.09) <0.001 
 
All respiratory diseases 
(incl. resp. infection) 
1268 (42%) 1570 (10%) 6.81 (6.19-7.51) 
 
<0.001 
Of note - each ‘respiratory disease’ group listed is a sub-group of the next 
*Excluding TB 
Analysis of the frequency with which cases presented with respiratory symptoms 
showed that 29% (n=347) of TB patients with respiratory infections had 3 or more 
respiratory infections diagnosed during the six months pre-TB. Twenty percent of all 
TB patients had two or more respiratory infections diagnosed in the six months pre-TB 
and 11%, three or more. 
For cases, a gradual increase in respiratory consultations is seen in the 6 months prior to 
a diagnosis of TB. However for controls the consultation rate is more or less constant. 
The rate of increase in respiratory consultations is significantly higher for cases one 
month before diagnosis. This is mostly explained by the diagnosis of respiratory 
infections of which about half are specifically lower respiratory tract infections (see 
Figure 4.9). 
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Figure 4.9 Respiratory diagnoses by month for cases and controls 
 
 
4.4.7 Analysis of Prescribing Data for Cases and Controls 
Prescriptions for antibiotics were analysed in the six months prior to TB for cases and 
prior to a fixed index date for controls. 8.6% of cases and 5.1% of controls received 
antibiotics during the 6 month study period (for further details of the method see 
Chapter 3; 3.6.4), this represents a significant difference between case and control 
prescribing (p<0.001). 
Analysis of antibiotic prescribing by month in the six months prior to TB showed that 
for cases there was a doubling of antibiotics prescribed over the 6 month period while 
for controls antibiotic prescriptions remained constant (see figure 4.10). 
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Figure 4.10 Percentage of cases and controls prescribed antibiotic in the 6 
months pre-TB 
 
 
4.4.8 Analysis of Risk Factors for TB 
4.4.8.1 Single Variable Analysis of Risk Factors for TB 
Variables (i.e. risk factors for TB) that might confound the findings of this case-control 
study were assessed individually using conditional logistic regression. The results are 
shown in Table 4.5. 
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Table 4.5 Results of single variable analysis of risk factors for TB 
Variable / risk factor 
CASES 
Indiv. with TB 
(n=3,032) 
No. (%) 
CONTROLS 
no TB 
(n=15,160) 
No. (%) 
Crude Odds Ratio 
(95% CI) 
p value 
Sex 
Male 
(vs female) 
1490 (49%) 
1542 (51%) 
7833 (52%) 
7327 (48%) 
1.11 (1.02 – 1.20) 
1 
0.011 
 
Ever smoked 
(vs never smoked) 
439 (15%) 1732 (11%) 1.35 (1.20 – 1.52) <0.001 
Any chronic disease 
(vs no chronic disease) 
1061 (35%) 2729 (18%) 2.72 (2.48 – 2.97) <0.001 
Chronic respiratory 
disease (vs no CRD) 
861 (28%) 1837 (12%) 2.98 (2.71 – 3.28) <0.001 
Diabetes 
(vs no diabetes) 
162 (5%) 475 (3%) 1.78 (1.48 - 2.15) <0.001 
Chronic renal disease 
(vs no CRD) 
31 (1%) 42 (0.3%) 3.69 (2.32 – 5.87) <0.001 
Chronic heart disease 
(vs no CHD) 
213 (7%) 708 (5%) 1.58 (1.34 - 1.87) <0.001 
 
The odds of TB were found to increase with male gender, smoking, any chronic disease 
and each of four chronic disease groups analysed separately. The odds of TB was nearly 
three times higher for patients with a chronic disease, or pre-existing morbidity, than 
those without (OR:2.72); and similar for patients with ‘chronic respiratory disease’ (see 
Table 4.5). 
4.4.8.2 Multivariable Analysis of Risk Factors for TB 
Following single variable analysis a multivariable analysis was conducted using a 
conditional logistic regression model. All variables assessed in single variable analysis 
were included in the multivariable model as all were statistically significant at p<0.05. 
Table 4.6 shows the adjusted odds ratios for the variables: gender, smoking and ‘any 
chronic disease’; and Table 4.7 shows the adjusted odds ratios for the variables: gender, 
smoking and each of the four chronic diseases. 
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Table 4.6 Results of first multivariable analysis of risk factors for TB 
Variable 
/ risk factor 
Crude 
Odds Ratio (95% CI) 
Adjusted 
Odds Ratio* (95% CI) 
p value 
Gender 
(male vs female) 
1.11 (1.02 – 1.20) 1.07 (1.00 – 1.17) 0.06 
Ever smoked 
(vs never smoked) 
1.35 (1.20 – 1.52) 1.29 (1.14 – 1.45) <0.001 
Any chronic disease 
(vs no chronic disease) 
2.72 (2.48 – 2.97) 2.69 (2.46 – 2.95) <0.001 
* adjusted for all other variables in the model (gender, smoking and any chronic disease) 
Multivariable analysis showed that smoking (OR:1.29) and chronic disease (OR:2.69) 
were independent risk factors for TB. The risk of TB was found to be higher in men but 
this was not statistically significant (adjusted OR:1.07). The odds of TB was nearly 
three times higher in patients with a ‘chronic disease’ than in those without (adjusted 
OR:2.69). The crude odds ratios were reduced only very slightly by the multivariable 
analysis. Further analysis of the significance of ‘any chronic disease’ was undertaken 
and each individual chronic disease (respiratory, renal, cardiac and diabetes) was 
assessed separately against other variables (see Table 4.7). 
Table 4.7. Results of second multivariable analysis of risk factors for TB 
Variables 
Crude 
Odds Ratio 
(95% CI) 
Adjusted 
Odds Ratio* 
(95% CI) 
p value 
Gender (male vs female) 1.11 (1.02 – 1.20) 1.09 (1.00 – 1.18) 0.038 
Ever smoked 1.35 (1.20 – 1.52) 1.28 (1.13 – 1.45) <0.001 
Chronic respiratory disease 2.98 (2.71 – 3.28) 2.91 (2.64 – 3.20) <0.001 
Chronic renal disease 3.69 (2.32 – 5.87) 3.20 (1.96 – 5.23) <0.001 
Chronic cardiac disease 1.58 (1.34 – 1.87) 1.30 (1.10 – 1.55) 0.002 
Diabetes Mellitus 1.78 (1.48 -2.15) 1.54 (1.27 – 1.88) <0.001 
* adjusted for all other variables in the model (gender, smoking and each of four chronic 
diseases) 
 
Chapter 4 – Consultation Care Pre-TB – Case Controlled Study 103 
The multivariable model adjusting for gender, smoking status and separate chronic 
diseases showed that chronic respiratory, renal and cardiac disease in addition to 
diabetes, male gender and smoking were all independent risk factors for TB. Adjusted 
odds ratios were very similar to the crude odds ratios for TB. The odds of TB was 
nearly three times greater for those with ‘chronic respiratory disease’ than those without 
(OR:2.91). The odds of TB was more than three times greater for those with ‘chronic 
renal disease’ however this had a wide confidence interval probably due to small 
numbers. This analysis shows that ‘chronic disease’ is strongly associated with TB and 
this is due in the main to ‘chronic respiratory disease.’ 
4.5 Discussion 
4.5.1 Key Findings 
TB cases consulted their GP three times more often than controls in the six months 
before diagnosis. Consultation rates increased from four months pre-TB suggesting a 
diagnostic delay of up to 4 months but also that opportunities exist to diagnose TB 
earlier. When comparing cases and controls, cases have higher rates of consultation for 
TB symptoms and respiratory infections and twice the amount of chronic disease 
particularly chronic respiratory disease. This study shows the strength of association 
between TB and its classic symptoms and TB and common alternative diagnoses.  
A separate analysis, using the same cases and controls, looked at risk factors for TB and 
showed that male gender, smoking and chronic disease (particularly chronic respiratory 
disease) were independent risk factors for TB. This is consistent with the research 
literature. 
4.5.2 Consultations – General 
Analysis of patient consultations showed that TB cases consulted their GP more often 
than controls. In the six months pre-diagnosis 80% of TB patients consulted their GP 
two or more times and a third consulted six or more times (four times more than 
controls). The increase in case consultation was seen from 4 months prior to diagnosis 
and was most marked 1 month pre-TB when cases consulted over 3 times more often 
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than controls. This data suggest that there was a delay in TB diagnosis of up to 4 
months; this is consistent with research on diagnostic delay conducted by others.8, 19, 20, 
24, 109, 112 
There is therefore a window of opportunity in which GPs could intervene and diagnose 
TB earlier; particularly if diagnostic criteria are clear and GPs knowledge and 
awareness of TB is high. A delay in diagnosis is an issue for public health and the 
prevention and control of TB.  
A possible explanation for repeat visits to a GP prior to a diagnosis of TB might be for 
investigation and result giving. However, this is an unlikely explanation in the context 
of this study because the rise in GP consultations is seen from about 4 months pre-TB, 
much earlier than would be explained by consultations for result giving. Furthermore, 
visits for investigations were removed during data cleaning as I considered these to be 
“non-GP consultations”. 
Further analysis of the rise in case consultation suggests that the rise occurred from 
about 7 months pre-TB (see Figure 4.5) but that it was always higher than that of 
controls. Possible explanations for the different consulting rate of cases and controls 
includes: firstly, TB cases have twice as many chronic diseases as controls; secondly, 
patients who consult more may be consulting due to a suppressed immune system 
leading to recurrent infections and may therefore be more prone to TB either through 
recrudescence or from new infection, and thirdly, it may represent the insidious onset of 
TB causing a non-specific illness that only gradually becomes increasingly 
symptomatic. This latter point is particularly evident in Figure 4.5. 
In this study 40% of TB cases were diagnosed in primary care and possibly 56% if all 
those diagnosed by an unnamed source were also in primary care. This is similar to a 
study by White et al. that found 58% of patients in an inner city population had 
presented via primary care.102 However this study finds less diagnosis occurring in 
primary care than a much smaller study by Paynter109 where 80% of TB cases were 
diagnosed by GPs. This disparity may represent a difference in the ‘recording’ of where 
the diagnosis was made rather than the ‘place’ the diagnosis was actually made. 
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4.5.3 Symptom Consultations 
Consultation rates for each of the classical symptoms of TB showed that in the 6 months 
prior to diagnosis, cough is the most commonly recorded symptom by GPs at 16%. If a 
patient is diagnosed with one or more TB symptoms, their odds of TB is eight times 
greater than those without these symptoms (i.e. those without TB). 
Diagnosing TB in primary care can be challenging; the symptoms and signs are often 
nonspecific. Cough is a common problem in primary care and for the majority of people 
it will not represent TB but rather an acute respiratory infection or chronic respiratory 
disease. It is important therefore that GPs specifically ask about, and pick-up, the other 
signs and symptoms that help diagnose TB. This study shows that particular signs and 
symptoms; fever (OR:9.7) weight loss (OR:14.05) and lymphadenopathy (OR:32.9) are 
more strongly associated with TB than cough (OR:5.2). Although these symptoms have 
higher odds ratios than cough, they are much less common. Raising GP awareness of 
TB symptoms and the strength of association between these and a diagnosis of TB could 
help GPs diagnose TB earlier. Haemoptysis and sweating are much rarer diagnoses and 
if found, are more highly associated with TB with odds ratios of 32 and 70 respectively; 
the number of consultations, however, was small and confidence intervals wide. As this 
is a case-control study it is not possible to measure the positive predictive value of 
different symptoms directly. To assess this further a clinical cohort study, using a 
network of GP practices, would be needed to show what proportion of those consulting 
with a particular symptom or symptom combination are eventually diagnosed with TB. 
Although symptom combinations are likely to increase the chance of diagnosing TB, 
this research found that very few GPs (0.5%) recorded two or more symptoms in a 
searchable form on the same day. 
Interestingly, GPs record ‘symptoms’ alone much less often than ‘diagnoses’. Only a 
minority 27% of TB cases, had a TB symptom recorded in the 6 months pre-diagnosis 
as compared to 42% who had a ‘respiratory disease’ recorded (many of these patients 
would have presented with symptoms similar to those of TB). This tendency to code 
‘diagnoses’ rather than ‘symptoms’ will have reduced the size of associations between 
classic symptoms and TB. But more importantly, the fact that only a minority of cases 
had symptoms recorded in a searchable form could mean that raising GP awareness of 
TB symptoms alone might be helpful for only a minority of cases but not the majority. 
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It is likely that further information was recorded in the free-text field, but this cannot 
easily be searched. This work suggests that raising awareness of TB symptoms and their 
strength of association is important but needs to be part of a package of measures to 
raise awareness among GPs of the local epidemiology of TB, risk factors for TB, other 
disease associations and the process of local referral for diagnostic tests. 
Although this study did not explicitly examine the positive predictive value of 
symptoms (which would have required a different design) it is clear that for the cardinal 
symptoms the positive predictive value is very low (especially for the more common 
symptoms such as cough). In the UK the annual incidence of TB is around 15 per 
100,000 population47 whereas the proportion of the population presenting with any of 
the symptoms (based on our control data) is many times higher. 
4.5.4 Respiratory Disease Consultations 
This study showed that pre-diagnosis, TB cases have a much higher consultation rate for 
respiratory disease and respiratory infections than controls. In the six months pre-TB, 1 
in 3 cases had a respiratory infection and the odds of TB in this group was seven times 
higher than in controls. As consultations for cough and respiratory infections may be 
different ways of coding the same thing, I combined these consultations into one 
variable ‘respiratory infection or cough’ for analytic purposes. 
A third of TB cases with respiratory infections, and 11% of all TB cases, had three or 
more respiratory infections in the six months pre-TB. This suggests that repeat 
respiratory infections, particularly over a short period of time, and that do not respond to 
standard treatment, could be used to increase a GPs diagnostic suspicion for TB and 
could act as an alert or a ‘red flag’ for TB. On the other hand, GPs should also be 
mindful of the fact that patients with chronic disease are at an increased risk of TB and 
should not ignore TB symptoms in those with chronic disease. 
High rates of respiratory infection are supported by the fact that cases, as compared to 
controls, are prescribed nearly twice as many antibiotics in the 6 months pre-diagnosis 
and that the receipt of these prescriptions rises gradually towards diagnosis. It is likely 
that patients are being misdiagnosed / misclassified with respiratory infections rather 
than TB and this may lead to a delay in TB diagnosis and an increase in antibiotic 
prescribing. This research supports that of others who have found that receiving 
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antibiotics prior to a diagnosis of TB delayed the start of TB treatment.113,118,129-132,156 
GPs record much more frequently that TB cases present with respiratory disease (42%) 
than with any of the classic TB symptoms such as cough (16%). This may be an 
anomaly of GP recording, in that GPs are more likely to code a ‘diagnosis’ e.g. ‘LRTI’ 
in preference to a symptom such as ‘cough’ which may just appear in the unanalyzed 
free-text field. This suggests that GPs may be misdiagnosing TB as a simple respiratory 
infection (LRTI), prescribing antibiotics and possibly delaying the diagnosis of TB. 
One third of patients prior to a diagnosis of TB consult their GP more than 6 times in 6 
months. These patients are increasingly older than those who consult less often, 
interestingly though, these patients also had less co-morbidity than all TB patients 
whatever their age. With increasing age one would expect an increase in co-morbidities 
rather than a decrease. The association between TB and chronic disease warrants further 
investigation, this I have attempted to do in the self-controlled study discussed in 
Chapter 5. 
4.5.5 Reducing Diagnostic Delay 
In my literature review, (see Chapter 2) I reviewed and discussed research that looked at 
diagnostic delay and TB in the UK and other high income countries. This case-control 
study indirectly reviews ‘health service delay’, defined as the time interval between the 
first contact with health services and the start of treatment;20 but does not assess 
‘disease’ or ‘patient delay’ as this information is not recorded in the GPRD. 
My literature review quantified ‘diagnostic delay’ using 26 studies relevant to the UK 
setting and found that the median ‘health service delay’ varied from 6 to 39 days, with a 
mean of 26 days. In this study I did not specifically quantify diagnostic delay as it is 
difficult to know when ‘health service delay’ truly started from GPRD data and whether 
increased consultations pre-TB are specifically due to TB. However, one could 
extrapolate that diagnostic delay exists because patients consulted their GP nearly 3 
times more often and with symptoms typical of TB prior to their diagnosis. The data 
suggests a delay of at least 4 months is not uncommon. Many of the studies reviewed in 
my literature review were retrospective cohort studies using data collected from cases 
specifically for TB research. This is very different to the data used in this study which 
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was data on all consultations for all diseases collected at the time of presentation in 
primary care. 
A considerable amount of research has assessed risk factors for diagnostic delay in TB 
but rarely from a primary care angle. Clear cut determinants leading to increased 
diagnostic delay include: sputum smear negative TB,111,121, 122 extra-pulmonary TB,20,121 
no respiratory symptoms,111,114 a history of asthma,114 HIV infection,122 no chest x-ray 
at the first visit,23,114 ethnic group (white>ethnic),19 older age,25,111 female gender19,25, 111 
and an alternative diagnosis for which an antibiotic is prescribed.114,129 Understanding 
the risk factors that lead to a delay in TB diagnosis is crucial to ensure earlier diagnosis 
and treatment and so minimise transmission and reduce poor outcomes. 
TB remains a diagnostic challenge in primary care because of its variable and non-
specific features. Difficulty in recognizing symptoms as due to TB is likely to account 
for much of the diagnostic delay seen in this study. Health service delays occur when 
doctors fail to make the diagnosis, perhaps through inexperience, or failure to consider 
the diagnosis in patients perceived as being at low risk. Symptoms such as cough can 
also be explained by many diseases and are only rarely attributable to TB. 
As this study and others show diagnostic delay is an issue in primary care. Ways to 
reduce diagnostic delay could include: 
1. Increase awareness of TB symptoms and risk factors in health professionals 
to raise their index of suspicion for TB.20, 21, 23, 114, 119 
2. Patient education to encourage earlier presentation to health services.20, 21, 
23, 114 
3. Improving access to health services for migrants and other at-risk 
groups.119, 121, 133 
4. Encourage earlier GP referral for screening using standard sputum and 
chest x-ray methods. 
Increasing awareness of TB in patients would help earlier presentation and therefore 
earlier diagnosis. This is not the sole responsibility of primary care, it is also that of 
public health. To this end TB Alert, a UK TB charity, has recently been asked by the 
Department of Health to produce literature on TB specifically for use in primary care. 
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4.5.6 Additional Comments 
Only 6 cases, 0.2% of the TB cases, were known by GPs to be HIV positive. This is a 
large under-representation of the known dually infected population in the UK, estimated 
in 1998 to be 3.3% by Rose,66 5.7% by Ahmed in 200367 and 26% in London TB 
patients in 2003 by Rodger.157 It is likely that, as the majority of data for this study was 
collected during the 1990s, patients may have been unaware of their HIV status as HIV 
testing was not routinely offered to subjects with active TB, that the GPRD TB subjects 
were less likely to be young non-UK born and so at lower risk perhaps of HIV co-
infection, and finally that disclosure of HIV status to general practitioners was, over the 
time of this study period, not much performed either by secondary care HIV providers 
or HIV co-infected individuals. 
The finding that 54% of cases appear to have been prescribed TB treatment in primary 
care according to GPRD data (BNF code group 05.01.09.00) is higher than expected. It 
is unlikely that TB treatment was initiated in primary care. Most drugs for TB are 
started in secondary care and continued by secondary care via the TB nurse to ensure 
compliance and free prescription. However, TB prescriptions may appear in the GPRD 
drug record not because they are prescribed by GPs but rather to remind GPs of possible 
drug interactions when they prescribe additional medication. GPs ‘flag’ prescriptions 
electronically in different ways and much of the information as to whether prescriptions 
had been truly prescribed is in the free text fields which I did not have access to. 
4.5.7 Risk Factors for TB 
This study is one of the first to examine risk factors for TB in the UK on such a large 
scale. Multivariable analysis of case and control variables showed that male gender, 
smoking and individual chronic diseases were independent risk factors for TB. These 
results are important as most health care workers think of ‘ethnicity’ alone as a risk 
factor for TB but rarely the others. 
The observed association of TB with male gender is in agreement with that reported by 
other studies where TB notification rates are higher for men than for women.47,158,159 
This research supports that of others that pre-existing morbidity and a number of 
chronic diseases increase the risk of TB. There is strong evidence of an association 
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between TB and diabetes,160,161 TB and malignancy,162-164 and TB and chronic 
respiratory disease.165,166 Although chronic renal disease has a stronger effect (OR 3.2), 
chronic respiratory disease (OR 2.91) is more common and so the population impact of 
this is greater. Multivariable analysis therefore suggests that ‘chronic disease’ is 
strongly associated with TB, and that this is mostly due to ‘chronic respiratory disease.’ 
At diagnosis a third of TB cases have at least one chronic disease; this was twice that of 
controls, with chronic respiratory disease being the most common for cases and 
controls. This association between chronic respiratory disease and TB is confounded by 
smoking but may be explained in two ways. Firstly, that patients with chronic 
respiratory disease have a higher likelihood of developing TB due to the chronically 
damaged nature of their lungs165,167,168 and secondly, by GP misdiagnosis in the six 
months prior to a TB diagnosis: the more a patient consults with a cough the greater the 
likelihood a GP will diagnose a chronic respiratory disease when in fact the case is 
presenting with the early symptoms of TB. 
This study confirms that smoking is an independent risk factor for TB and supports the 
work of others.167,169,170 Smoking status (whether smoker or non-smoker) is known to be 
a poorly recorded variable in the GPRD dataset; Osborn et al. showed this but also that 
there was no systematic difference between cases and controls.82 In this study fewer 
than 40% of individuals had a smoking status recorded; an association, however, 
between smoking and TB is still seen. Fifteen percent (n=439) of TB cases were 
recorded to have smoked as compared to eleven percent (n=1732) of controls. The 
GPRD appears to under-record smokers as exemplified by the fact that in 2007 21% of 
the UK population were considered ‘current smokers’ (ONS online 09.10.09 -
http://www.statistics.gov.uk/cci/nugget.asp?id=313-). Recording bias of TB case 
smoking status may represent a limitation in this study. I have shown that TB cases are 
likely to present to their GP with a respiratory complaint and therefore GPs are likely to 
ask about their smoking status and so may record smoking status more often for cases 
than controls. The data used in this research is pre-2002. In recent years the recording of 
smoking status by GPs has greatly improved as quality improvement initiatives have 
taken hold in primary care. 
These findings, along with those of others, that smoking is a risk factor for TB support 
the hypothesis of an increased vulnerability of smokers to TB infection and the 
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development of clinical disease.167,168 Furthermore, research by Pasipanodya shows that 
survivors of symptomatic TB have long term lung damage and are 5.4 times more likely 
to have abnormal lung function tests than those with latent TB.166 Smoking is one of the 
most modifiable of all the risk factors for TB. Primary care teams, by encouraging and 
supporting TB patients to stop smoking, could therefore have a key role in improving 
the outcome of patients that smoke. 
So in summary, this study shows that male gender, smoking and individual chronic 
diseases were independent risk factors for TB in the UK and that raising awareness of 
these risk factors (along with those found by others133) could help primary care teams 
diagnose TB earlier and reduce poor outcomes. 
4.5.8 The Role of Primary Care in the Diagnosis of TB 
I reviewed the role of primary care in TB in Chapter 2 and concluded that this area 
warranted greater investigation due to the lack of published research, the need to reduce 
diagnostic delay and the major role primary care could play in this.8,10,101,103,108 This 
study was designed to meet these needs and to investigate TB, its diagnosis and its risk 
factors, from a primary care perspective. 
A small study by Metcalf et al. specifically looked at the diagnosis of TB from a 
primary-care perspective.8 This study supports Metcalf’s finding that GPs see a huge 
variety of TB presentations and that making a timely diagnosis is difficult. Metcalf 
identified barriers to prompt diagnosis as: “atypical presentations, low level of clinical 
suspicion of TB by GPs, lack of continuity of care, workload demands that limit time 
with patients and sub-optimal clinical-patient communication.” This study confirms 
some of these barriers but also goes further and provides GPs with information on the 
strength of association between TB its classic symptoms and alternative diagnoses plus 
it elucidates risk factors for TB. Metcalf et al. suggest “a better understanding of the 
processes of diagnosis could highlight existing good practice and opportunities for 
enhanced care.”8 This study tries to do this. 
Early diagnosis is one of the most important contributions primary care can make to 
improved TB control.8,10,101,103,108 To assist GPs in making an earlier diagnosis, 
awareness of TB needs to be raised. This study suggests that awareness of the following 
could be used to raise a GPs level of suspicion for TB: 
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• Recurrent chest infections over a few months at a level higher than expected 
for this patient, or more than three chest infections in a 6 month period 
• Respiratory symptoms not responding to antibiotics 
• Recurrent cough (to trigger assessment for the other classic symptoms of 
TB, a chest x-ray and sputum specimen) 
• Any of the rarer TB symptoms i.e. weight loss, haemoptysis or 
lymphadenopathy  
• Repeat, unexplained visits to the GP for non-specific symptoms 
• Repeat, unexplained visits to the GP in which no diagnosis is made 
• Multiple visits over a few months at a level higher than expected for this 
patient 
• In GP practices, or geographic areas, with a higher proportion of ethnic 
minorities, TB should be high on any list of differentials for patients with an 
unexplained or unresolved cough or any of the classic symptoms of TB. 
 
 
Combining the knowledge of these ‘red-flags’ with the other features highlighted by this 
research such as the risk factors for TB (male gender, older age, suffering a chronic 
disease), the strength of association between clinical presentations and TB and raising 
awareness of newer investigations and the local referral process may help GPs make an 
earlier diagnosis. Practically the recurrent nature of non-specific, non-resolving 
symptoms or recurrent respiratory infections, particularly in patients with a known 
chronic disease, would be something that GP computer systems could flag and in so 
doing raise a GPs level of suspicion for TB. 
Raising awareness of TB in general practice is vital if we are to combat the increasing 
incidence of TB in the UK. This is supported by the limited existing literature on TB in 
primary care.11-13,74 There are numerous ways of raising awareness: online educational 
packages / articles in peer reviewed journals / courses / locally run TB awareness 
training etc. One example in the literature specific to TB and primary care showed that 
an educational intervention promoting information about TB and TB screening 
improved identification of active and latent TB in new GP registrants and increased 
BCG coverage.100 
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4.5.9 Strengths and Limitations of this Study 
A huge strength of this study is its very large size with 3,032 TB patients and 15,160 
controls. The findings are therefore extremely unlikely to have occurred by chance. 
Bias is a potential limitation. To limit selection bias I randomly selected five controls 
per case and these were matched on age and GP practice with the assumption that 
patients registered with the same GP were more likely to be from a similar 
socioeconomic background and ethnic group than patients selected from other practices. 
Given the fact that most practice populations are ethnically and socially diverse the 
matching at practice level will at best only partially account for these factors. The lack 
of ethnicity data in the GPRD dataset is a major issue for this study as TB in the UK is 
much more common in ethnic minority groups and particularly those born abroad in 
countries with a high incidence of TB.47, 60, 171 Not knowing the ethnicity of cases meant 
controls could not be matched on this and selection bias may have resulted. As this 
study excludes patients not registered with a GP and those registered for less than 
18months, it is likely to exclude homeless people and ethnic minority new-entrants both 
of whom are at greater risk of TB than the general population.47,59,133 The results of this 
study may therefore underestimate the true picture of TB in the community and prior to 
diagnosis in part due to selection bias. 
GP recording bias and misclassification – the recording of consultations by the GP 
may have led to recording bias with the under-recording of symptoms. This study 
analysed both symptoms and signs as recorded by GPs. GPs record these electronically 
under a specific ‘coded’ heading from a drop-down list. In the 6 months pre-TB, GPs 
may record a patient’s consultation using a ‘symptom’ such as ‘cough’ or a ‘specific 
diagnosis’ such as ‘pneumonia’. The number of symptoms coded in the GPRD is much 
fewer than the number of respiratory infections diagnosed. For example 497 patients 
were recorded to have consulted with ‘cough’ compared to 1177 with a respiratory 
infection, most of which are likely to have presented with a cough. This probably 
reflects the fact that GPs more readily record a collection of symptoms as a “coded 
diagnosis”; for example “LRTI” and then record any symptoms in the GPRD free-text 
field rather than separately. For this reason symptom analysis probably provides an 
underestimate of the true occurrence of each symptom reported to a GP due to under 
recording. Only 27% of patients had TB symptoms recorded rather than a specific 
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diagnosis. This does not mean that only 27% of TB patients had symptoms pre-
diagnosis, it reflects how GPs record their consultations. To reduce the impact of 
consultation recording bias, I conducted some additional analyses that combined all 
respiratory consultations regardless of whether they were for ‘cough’ or a specific 
‘respiratory disease’. However, a recommendation for future work would include 
further analysis of the GPRD free-text fields looking for data on specific TB symptoms 
in patients subsequently diagnosed with TB. 
Recording bias of the outcome is also a significant problem as over 50% of cases were 
not classified as ‘pulmonary’ or ‘extra-pulmonary’ TB, thereby limiting the opportunity 
to explore how consultation patterns differ for these very different clinical 
manifestations of TB. 
The GPRD with its national coverage of representative GPs has been shown to be 
broadly representative of the UK population;76 and Hansell et al.80 showed similarities 
between the rate of TB diagnosis in the GPRD and the fourth Morbidity Survey in 
General Practice (MSGP4).89 Both these studies suggest that the results of this case-
control study should be generalisable within the UK setting. However, the findings may 
not be generalisable to countries with different primary care structures. A possible 
limitation of this study is that TB cases may be under-represented in the GPRD dataset. 
Historically there have been only a few GP practices that enter data in to the GPRD in 
London.76 As London has the highest TB incidence in the UK this might lead to an 
under-representation of TB cases. However, unless the diagnostic delays and risk 
factors for disease are very different in London compared to elsewhere, this will not 
greatly affect the generalisability of these findings. 
Finally, a case-control study design allows estimates of risk to be made but not of 
absolute risk – therefore it is of limited value for assessing the positive predictive value 
of any particular symptom-set where a cohort study would be preferable. 
So in summary there are a number of limitations to this study. To reduce control 
selection bias and the effects of ethnicity and socioeconomic factors, I conducted a 
second similar study (see Chapter 5) using self-controlled methodology, where a case 
becomes its own control in a different time period. The results of the self-controlled 
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methodology can then be compared to the case-control study to assess whether the 
limitations are a serious concern. 
4.5.10 The Use of the GPRD as a Research Tool 
The General Practice Research Database is a powerful tool for epidemiological and 
primary care research. It has been validated for use in respiratory epidemiological 
studies by Hansell80 so is eminently suitable for this study. It has been used for many 
high quality studies including some respiratory studies.78, 80, 83, 90-92 To further validate 
the use of the GPRD for this study, control patient consultation rates were compared to 
the average number of GP consultations per year in a national primary care study. In the 
Fourth National Study of Morbidity Statistics from General Practice (MSGP4), 1991-
1992, 78% of patients consulted at least once during the year and each consulting 
patient had an average of 3.8 consultations per year.89 In my case-control study, control 
patients consulted a median of 2 times in the 6 months before a fixed index-date, which 
extrapolates to 4 consultations per year. So consultation rates were found to be similar 
in the Fourth National Study of ‘Morbidity Statistics from General Practice’ and in this 
study. 
The strengths of the GPRD for this study include its size, its comprehensive coverage of 
the UK population, the fact that it contains continuous, longitudinal primary care data 
which is high-quality and validated and that it has been previously used in many 
epidemiological studies, particularly respiratory studies. However, its major limitations 
for a study looking at TB are its lack of ethnicity and socioeconomic data, HIV data and 
variations in recording. 
4.6 Conclusion 
TB cases consult more often than controls, with this increasingly evident from 4 months 
pre-TB. They have higher rates of consultation for TB symptoms and respiratory 
infections and twice the amount of chronic disease. Diagnosing TB in primary care is a 
challenge due to its variable and non-specific nature but a window of opportunity exists 
from 4 months. GPs need support to make a TB diagnosis earlier. To this end, this study 
provides information on the strength of association between symptoms, respiratory 
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diseases and TB and suggests that patients who consult on multiple occasions, 
particularly with cough or recurrent respiratory infections, and without explanatory 
long-term chronic disease should be carefully assessed for the symptoms & signs of TB. 
Awareness needs to be raised among GP’s of indicators that could increase their level of 
suspicion for TB such as key symptoms, signs and diagnoses associated with TB to aid 
earlier diagnosis and so reduce diagnostic delay. But, as only a minority 27% of cases 
have TB symptoms recorded, raising GP awareness of TB symptoms alone may only be 
helpful for a minority of cases. Additional work will therefore be needed to improve 
GPs knowledge and awareness of TB, the risk factors for TB, its local epidemiology and 
management. 
People with TB tend to be older, male and have more chronic disease than those without 
TB. This is consistent with the research literature. 
To confirm the significance of the consultation rates and the other findings in this study 
and to check that chronic disease, ethnicity and socioeconomic status were not 
confounding the results I went on to conduct a self-controlled case study (see Chapter 
5). 
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Chapter 5  
 
Consultation Behaviour in Primary Care Prior to a 
Diagnosis of TB: A Self Controlled Study 
5.1 Introduction 
TB in the UK is much more common in ethnic minority groups47,60 and those on a low 
income.59 The General Practice Research Database (GPRD) can be used as a tool to 
study TB epidemiology from a primary care perspective. Certain key variables, 
however, such as ethnicity and socioeconomic status are missing. To strengthen the 
findings of my case control study and minimise confounding by known and unknown 
variables such as ethnicity, socioeconomic status, prior chronic disease and smoking I 
conducted a self controlled (case-only) study. 
5.2 Aims & Objectives 
5.2.1 Aims 
The aims of this study were to assess the extent of missed opportunities for a diagnosis 
of TB in primary care using a self-controlled study and to describe the nature of GP 
consultations. 
5.2.2 Objectives 
• To measure excess GP consultations in the 6 months prior to diagnosis in 
TB cases as compared to 12 to 18 months prior to diagnosis in the same 
individuals 
• To examine consultation behaviour and consultation type 
• To compare the results of this self controlled study with the case-control 
study of Chapter 4 
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5.3 Methods 
Study Design 
A self controlled (case-only) study based on case-crossover methodology83,140-142,143 was 
conducted to investigate consultation behaviour prior to a diagnosis of TB (see Chapter 
3, Section 3.6.2 for more detail). 
Setting 
I examined data, as previously described in Chapter 4, Section 4.3, from 743 general 
practices in the UK who provided data to the General Practice Research Database 
(GPRD) during the time period April 1990 to April 2002. 
Data Source 
I used the GPRD (see Chapter 4, Section 4.3). 
Participants 
Patients were selected from the GPRD between 1990 and 2002; 
Cases: were GPRD patients with a medical code for active TB i.e. the same TB cases as 
were used in the case-control study presented in Chapter 4 (n=3023). 
Controls: were cases acting as their own control in a time period 12-18 months prior to 
their diagnosis of TB i.e. self controls. 
‘Exclusion’ criteria: I excluded patients who had less than 18 months of pre-diagnosis 
data (see Chapter 3, Section 3.4.3). 
Measurements 
I compared the consultation behaviour of TB cases in two different time periods one 12-
18 months pre-TB and the other 0-6 months pre-TB. I analysed ‘all’ GP consultations 
and GP consultations for specific TB symptoms and respiratory diagnoses (see chapter 3 
for more details). By comparing consultations for the classic symptoms of TB and 
diagnosed respiratory conditions in two different time periods, I generated a summary 
measure the incidence rate ratio (IRR). The IRR represents statistically the comparison 
between consultations occurring 12-18 months pre-TB (when the patient is TB-free) and 
0-6 months pre-TB (when the patient may be developing TB). It gives an indication of 
which symptoms and respiratory diseases are most associated with TB. 
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Bias 
I used a self-controlled study to eliminate control selection bias, remove confounding by 
permanently fixed factors e.g. gender, ethnicity, genetics; and minimise confounding by 
factors that vary little over the comparison period e.g. chronic illness, age, social class, 
life-style. 
Statistical Analysis 
Statistical analysis was performed using STATA version 9.0 (Stata Corp, College 
Station, TX, USA).155 Consultation rates for cases in two different time periods were 
calculated and compared, generating rate ratios. GP consultations for specific symptoms 
and respiratory diagnoses were analysed using the Generalised Estimating Equation 
(GEE) Model.22,24,25,147 The GEE model compares total counts for each individual and 
then calculates a summary measure, the incidence rate ratio (IRR) for all individuals 
with a 95% confidence interval. A p value of 0.05 or less was considered statistically 
significant. In this study, in practical terms the GEE actually calculates a rate ratio: the 
ratio of consultations in two different time periods not a true incidence or IRR as 
consultations may or may not in fact be incident. For further details of the method see 
Chapter 3, Section 3.6.2. 
5.4 Results 
5.4.1 Characteristics of Study Patients 
3032 TB cases with over 196,000 consultations were analysed for the time period 1990-
2002 (see Chapter 4, Section 4.5.1). 
5.4.2 Consultation Data – General 
In the 6 months prior to a diagnosis of TB, 3032 TB patients had 18,493 consultations 
recorded by their GP. In the 12-18 months pre-TB TB patients had 9,469 visits recorded 
by their GP. The median number of consultations per patient 0-6 months pre-TB was 5 
with an inter-quartile range of 3 to 8; and for 12-18 months pre-TB the median number 
of consultations per patient was 3 with an inter-quartile range of 2 to 5 (see Figure 5.1). 
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10% of cases did not consult at all in the six months prior to diagnosis and 12% only 
once. 
Figure 5.1 Median number of consultations per patient 12-18months & 0-
6months pre-TB 
 
Table 5.1 shows a comparison of consultation rates 12-18 months and 0-6 months pre-
TB by month and the total for each six month period. The number of GP consultations 
increased pre-TB; at 6 months pre-diagnosis it was a little higher (27% higher) than 
baseline levels, but the increase was most evident from 3 months (RR 1.7) and most 
marked 1 month prior to a diagnosis of TB when patients consult more than twice as 
often (RR 2.39) (see Figure 5.2). Overall a 63% increase in consultations was seen 
between the two time periods (RR 1.63). 
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Table 5.1 Comparison of GP consultation rates for the same patient in two 
time periods pre-TB, one year apart expressed as a rate ratio  
 CASES 
12-18 months 
pre-TB 
CASES 
0-6 months 
pre-TB 
 
CONSULTATIONS Number Consults 
per case 
Number Consults 
per case 
Consultation 
Rate Ratio 
(95% CI) 
Total consultations 
12-18 and 0-6 months pre-TB 9,469* 3.1 15,461 5.10 1.63 (1.59-1.68)
Consultations per month 
13mths preTB cf. 1mth preTB 
14mths preTB cf. 2mths preTB 
15mths preTB cf. 3mths preTB 
16mths preTB cf. 4mths preTB 
17mths preTB cf. 5mths preTB 
18mths preTB cf. 6mths preTB 
1491* 
1661 
1548 
1661 
1571 
1537 
0.49 
0.55 
0.51 
0.55 
0.52 
0.51 
3560 
3013 
2636 
2225 
2071 
1956 
1.17 
0.99 
0.87 
0.73 
0.68 
0.65 
2.39 (2.25-2.54)
1.81 (1.71-1.93)
1.70 (1.60-1.81)
1.34 (1.26-1.43)
1.32 (1.23-1.41)
1.27 (1.19-1.36)
* includes only consultations occurring prior to a TB diagnosis 
Figure 5.2 Rate of GP consultations per patient per month 0-6 & 12-18 
months pre-TB 
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5.4.3 Analysis of Consultations for the Classic Symptoms of TB 
GP consultations for the classic symptoms of TB were compared 0-6 months before 
diagnosis with those during a TB-free period 12-18 months before diagnosis. Nearly a 
third (27%) of TB patients had symptoms suggestive of TB 0-6 months pre-diagnosis as 
compared to 9% in the TB-free period. Table 5.2 shows the total number of individuals 
consulting their GP with the classic symptoms of TB 12-18 months and 0-6 months pre-
diagnosis. The relative importance of the individual symptoms and a later diagnosis of 
TB are shown by the incidence rate ratio (IRR). 
Analysis using the Generalised Estimating Equation (GEE) Model shows that in the 6 
months pre-TB, patients had a 3.5 fold increase in consultation rate for ‘any’ of the 
classic symptoms of TB as compared to the TB-free period (IRR 3.48 95% CI:3.03-
4.00) and that patients had a 2.5 fold increase in consultation rate for cough (IRR 2.5). 
Consultation rates for the individual cardinal symptoms of TB were significantly higher 
in the 6 months pre-TB than the TB-free period with sweats (IRR 13.0), lymph nodes 
(IRR 7.2) and weight loss (IRR 8.9) showing a particularly strong association with a 
diagnosis of TB. These symptoms were more strongly associated with a diagnosis of TB 
than fever and cough, as shown by the incidence rate ratios in Table 5.2, but are less 
often recorded by GPs. 
Table 5.2 A comparison of TB symptom consultations for cases 12-18 and 
0-6 months prior to a diagnosis of TB expressed as an IRR 
Symptoms 
 
Individuals with 
symptoms 
12-18 mths pre-TB 
n=3032 
No. (%) 
Individuals with 
symptoms 
0-6 mths pre-TB 
n=3032 
No. (%) 
Incidence Rate 
Ratio 
(95% CI) 
p value
Cough 
Fever 
Sweating 
Lymphadenopathy 
Haemoptysis 
Weight loss 
 
Any TB symptom 
233 (7.7%) 
25 (0.8%) 
3 (0.1%) 
23 (0.8%) 
0 
15 (0.5%) 
 
284 patients* 
(9.4%) 
497 (16.4%) 
103 (3.4%) 
28 (0.9%) 
167 (5.5%) 
13 (0.4%) 
114 (3.8%) 
 
832 patients * 
(27.4%) 
2.51 (2.15 - 2.93) 
4.71 (2.99 - 7.42) 
13.00 (3.86 - 43.80) 
7.15 (4.16 - 12.29) 
- 
8.93 (5.19 - 15.38) 
 
3.48 (3.03 – 4.00) 
<0.001 
<0.001 
<0.001 
<0.001 
- 
<0.001 
 
<0.001 
* some patients had more than one symptom recorded 
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Analysis of recurrent GP consultations pre-diagnosis revealed that patients present more 
often with recurrent cough and lymphadenopathy. Patients present rarely more than 
once with fever, sweats or haemoptysis (see Chapter 4). 
In the 6 months pre-diagnosis patients were twice as likely to have a single classic 
symptom of TB and were 4.5 times more likely to have more than one TB symptom 
than in a TB-free period, see Table 5.3. 
Table 5.3 Rate Ratios for multiple TB symptoms 
 12-18 months 
pre-diagnosis 
No. (%) 
0-6 months 
pre-diagnosis 
No. (%) 
RR 
Patients with one TB symptom 212 (7%) 485 (16%) 2.29 
Patients with more than one TB symptom 72 (2%) 326 (11%) 4.53 
 
5.4.4 Analysis of Respiratory Consultations 
Nearly half (42%) of TB patients were diagnosed with a respiratory problem in the 6 
months pre-TB. One in three patients (39%) presented with a respiratory infection and 
of these over half were lower respiratory tract infections (see Table 5.4). Analysis using 
the Generalised Estimating Equation Model showed that in the 6 months pre-TB 
patients had a two fold increase in consultation rate for ‘any respiratory disease’ as 
compared to the TB-free period (IRR 2.28; 95% CI:2.1-2.5); and a nearly 3 fold 
increase in consultation rate for ‘respiratory infections & cough’ (IRR 2.73; 95% 
CI:2.5-3.0). 
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Table 5.4 A comparison of respiratory disease consultations for cases 12-
18 and 0-6 months prior to a diagnosis of TB expressed as an IRR 
(n=3032) 
* Consults by individual = Number of individuals consulting at least once with condition 
LRTI = lower respiratory tract infection 
 
Figure 5.3 A comparison of respiratory diagnoses for patients 12-18 and 0-6 
months pre-TB (showing IRRs) 
 
Respiratory disease 
(excluding TB) 
 
Individuals with 
symptoms 
12-18 mths pre-TB
No.* (%) 
Individuals with 
symptoms 
0-6 mths pre-TB 
No. (%) 
Incidence 
Rate Ratio 
(95% CI) 
 
p value
 
All respiratory diseases (incl. 
infections) 
650 (21%) 1268 (42%) 2.28 
(2.07 – 2.50) 
<0.001 
All respiratory infections 
(incl. cough) 
553 (18%) 1177 (39%) 2.73 
(2.47 – 3.01) 
<0.001 
LRTI 315 (10%) 751 (25%) 2.20 
(1.95 – 2.49) 
<0.001 
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5.4.5 Stratification of Patients by TB Type 
Data for the 3032 TB cases was re-analysed according to TB type. There are 305 
different diagnostic codes for TB in the GPRD (see Appendix 2), I reclassified these 
codes under three headings – pulmonary TB, extra-pulmonary TB and ‘unclassified’ TB 
(i.e. site not otherwise specified) to try to understand how much each type of TB 
contributed to the overall symptoms and diagnoses seen in the 6 months pre-diagnosis. 
Table 5.5 shows a summary of the characteristics of TB cases by TB type. 
Table 5.5 Characteristics of TB patients by TB type 
 All TB 
n=3032 
No. (%) 
Unclassified TB
n=1774 (58%) 
No. (%) 
Extra-pulmonary TB 
n=483 (16%) 
No. (%) 
Pulmonary TB 
n=759 (25%) 
No. (%) 
Sex 
Female 
Male 
1490 (49%) 
1542 (51%) 
820 (46%) 
954 (53%) 
301 (62%) 
182 (38%) 
359 (47%) 
400 (53%) 
Age 
<=20 
>20 - <=40 
>40 - <=60 
>60 - <=80 
>80 
427 (14%) 
651 (22%) 
803 (26%) 
929 (31%) 
222 (7%) 
316 (18%) 
397 (22%) 
447 (25%) 
515 (29%) 
100 (6%) 
57 (12%) 
132 (27%) 
141 (29%) 
114 (24%) 
39 (8%) 
48 (6%) 
121 (16%) 
211 (28%) 
297 (39%) 
82 (11%) 
Chronic Disease 
Any 
Respiratory 
Renal 
Cardiac 
Diabetes 
35% 
28% 
1% 
7% 
5% 
610 (34%) 
498 (28%) 
20 (15%) 
109 (6%) 
91 (5%) 
130 (27%) 
88 (18%) 
7 (1%) 
34 (7%) 
27 (6%) 
328 (43%) 
268 (35%) 
4 (<1%) 
69 (9%) 
44 (6%) 
Ever smoked 439 (15%) 248 (14%) 70 (14%) 118 (16%) 
* 16 patients had a tuberculoma of unknown site and are not included 
Table 5.5 shows that GPs tend to record most TB patients as having ‘unclassified TB’ 
(58%). GPs specify the site of disease as either pulmonary or extra-pulmonary in less 
than half their patients. For those patients recorded as having extra-pulmonary TB there 
is a marked difference in gender: 62% are female and 38% male as compared to 47% 
female and 53% male in pulmonary TB; and age: extra-pulmonary TB is more common 
in the younger age groups, 39% under 40 compared to 22% for pulmonary TB. In terms 
of chronic disease, patients with extra-pulmonary TB have less chronic disease than 
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patients with pulmonary TB. As the characteristics of ‘all TB’ and ‘unclassified TB’ 
were similar, I analysed in more detail only those cases sub-classified into extra-
pulmonary and pulmonary TB. 
Figure 5.4 shows how GPs recorded the specific types of TB from 1990 to 2002. Over 
the 12 years analysed there was no significant improvement in the specificity of 
diagnostic coding by GPs. 
Figure 5.4 Diagnosis by TB type, by year – 1990 to 2002 
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5.4.6 Consultation Rate by TB Type 
Table 5.6 shows the GP consultation rate for different types of TB during the two time 
periods of interest, 12-18 months and 0-6 months pre-TB. These varied from 3.12 to 
3.37 in the 12-18 months pre-TB and from 4.83 to 5.49 0-6 months pre-TB. Rate ratios 
for each TB-type show that patients consulted between 51% and 63% more in the 6 
months immediately pre-TB depending on their TB-type (see Table 5.6). Further 
analysis of consultation data showed that there was no significant difference between 
different TB-types and multiple GP consultations pre-TB (see Appendix 5) 
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Table 5.6 GP consultation rates by TB type comparing 12-18 and 0-6 
month’s pre-TB 
TB type Number of 
patients 
CASES 
12-18 mths 
pre-TB 
Consults / case 
CASES 
0-6 mths 
pre-TB 
Consults / case 
Rate Ratio 
ALL TB 3032 3.12 5.10 1.63 
Pulmonary TB 759 3.37 5.49 1.63 
Extra-pulmonary TB 483 3.19 4.83 1.51 
 
5.4.6.1 Symptom and Disease Consultations by TB Type 
For patients presenting with different types of TB, consultations were analysed by 
classic TB symptoms and respiratory diagnoses in the 6 months prior to a diagnosis (see 
Figure 5.5). Consultations for cough were much more frequent for pulmonary TB than 
for extra-pulmonary TB and consultations for lymphadenopathy were much more 
common in extra-pulmonary TB (85 per 1000) than pulmonary (5 per 1000). Weight 
loss in extra-pulmonary TB was seen in 10 per 1000 as compared to 57 per 1000 in 
pulmonary TB. Consultation rates for fever and sweats were very similar for all types of 
TB. Consultation rates for ‘all respiratory diseases’, whether infectious or non-
infectious, were more than twice as high for pulmonary TB as they were for extra-
pulmonary TB. 
So, in summary, patients with pulmonary TB had higher consultation rates for 
infectious respiratory disease, cough and weight loss. Patients with extra-pulmonary TB 
had higher consultation rates for lymphadenopathy. 
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Figure 5.5 Consultation rates for respiratory diseases & TB symptoms 0-6 
months pre-TB analysed by TB type 
 
 
GP consultations for the classic symptoms of TB and respiratory disease were then 
compared in the two time periods of interest, 0-6 months pre-TB and 12-18 months pre-
TB (a TB-free period), using a GEE model. The incidence rate ratio revealed that 
although sweats, lymph nodes and weight loss were useful indicators of TB in general 
terms, specific symptoms were more suggestive of particular types of TB. 
For extra-pulmonary TB, consultation rates for lymphadenopathy were 8 times higher 0-
6 months pre-TB than in a TB-free period (IRR 8.11; 95%CI: 2.38-27.69); and 
consultation rates for fever were 5 times higher (IRR 5.25). This suggests that lymph 
nodes are more predictive of extra-pulmonary TB than fever and weight loss (see figure 
5.6 & 5.7). 
For pulmonary TB, consultation rates for fever were 9 times higher 0-6 months pre-TB 
than in a TB-free period (IRR 8.67; 95%CI: 2.58-29.07); and consultations for weight 
loss were 16 times higher (IRR 16.25; 95%CI: 5.80-45.56). This suggests that fever and 
weight loss were more predictive of pulmonary TB than lymph nodes (see figure 5.6) 
although wide confidence intervals are noted. 
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Figure 5.6 Comparison of incidence rate ratios for consultations 0-6 months 
compared to 12-18 months for patients with different types of TB 
 
* See Appendix 6 for tabulation of IRRs that create this graph 
** Data for consultations on sweating was not subdivided as case numbers were very small 
This study shows that a diagnosis of pulmonary TB was associated with a two fold 
increase in consultation rate for ‘any respiratory disease’ in the 6 months pre-TB as 
compared to a TB-free period (IRR 2.38); and associated with a 3 fold increase in 
‘respiratory infections and cough’ (IRR 2.92) or LRTI consultations (IRR 3.04). 
5.4.6.2 Symptom and Disease Consultations by Month and TB Type 
Consultations by month in the 6 months pre-TB for respiratory diseases, respiratory 
infections and symptoms are difficult to interpret due to the small number of patients in 
each sub-group. For pulmonary TB a rise in consultations for cough and weight loss 
started about 3 months pre-TB. For extra-pulmonary TB a rise in consultations for 
lymphadenopathy was seen from 3 months but for fever from only 1 month pre-
diagnosis (see Figure 5.7). 
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Figure 5.7 Classic TB symptom rates by month pre-TB for ‘pulmonary’ and 
‘extra-pulmonary’ TB 
 
 
5.5 Discussion 
5.5.1 Main Findings 
TB cases consulted their GP nearly twice as often in the six months before diagnosis as 
compared to themselves in a TB-free period. Consultation rates for the cardinal 
symptoms of TB and respiratory infections were also significantly higher; as were 
repeat consultations. The insidious, non-specific onset of TB is confirmed and a delay in 
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diagnosis of up to four months. This self-controlled study confirms the findings of the 
case-control study discussed in Chapter 4, however, the measures of effect are smaller 
suggesting that control selection bias or confounding by chronic disease, ethnicity or 
socioeconomic status influenced the results of the case-control study. 
Multiple visits were seen equally for different pathological sites of TB but certain 
symptoms were more common: for pulmonary TB, cough and weight loss were more 
common and for extra-pulmonary TB, lymphadenopathy was more common. 
5.5.2 Self Controlled Methodology 
By using a self controlled (case only) study to examine consultation behaviour I 
overcame unmeasured confounders, such as ethnicity, social class, underlying chronic 
disease and smoking. Using a self controlled study seemed an appropriate solution when 
over two thirds of UK TB patients are from an ethnic minority 47 and the GPRD does 
not contain any ethnicity data. Unmeasured confounders may have influenced the 
results of my case control study, but by using this methodology I also eliminated control 
selection bias and allowed a case to be its own control during a disease free period. Self 
controlled analysis enables an assessment of the additional consulting behaviour 
associated with TB which cannot be analysed using a case-control study. 
The analysis was undertaken using the Generalised Estimating Equation (GEE) model 
which generates a summary measure, the incidence rate ratio (IRR). The IRR represents 
statistically the comparison between consultations occurring 12-18 months pre-TB 
(when the patient is TB-free) and 0-6 months pre-TB (when a patient may be 
developing TB). The use of 12-18 months as a TB-free time period against which to 
compare patients becoming symptomatic with TB is validated by Figure 4.6 in Chapter 
4 as the increase in case consultation rate is seen from 7 months pre-TB. 
This self-controlled study is more of a descriptive study looking at consultation rates, 
and comparisons of these in different time periods, than a study assessing the risk or 
incidence of TB. Cases act as their own controls in a TB-free period 12-18 months pre-
TB so the study cannot be used to assess the odds of TB as if it were a case-control 
study. 
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5.5.3 Consultations 
A diagnosis of TB was associated with a 63% increase in consultations, a threefold 
increase in TB symptoms and a threefold increase in respiratory infections in the six 
months pre-diagnosis as compared with a TB-free period. Consulting rates for the 
cardinal symptoms of TB were significantly higher with sweats, lymph nodes and 
weight loss being particularly elevated. Multiple GP consultations pre-diagnosis could 
provide an opportunity to diagnose TB earlier but early symptoms are often non-
specific. This study highlights ‘alert’ or ‘red-flag’ symptoms and diagnoses associated 
with TB which might help GPs make an earlier diagnosis and supports the need for 
awareness raising of these among GPs to reduce diagnostic delay. It is important to note 
that symptoms are only recorded in a minority of cases (27%), and so although useful, it 
is as essential to improve GPs knowledge of local TB epidemiology, risk factors for TB 
and the potential significance of repeat respiratory consultations to help diagnose TB 
earlier. One recommendation that might improve the symptom data would be to 
undertake an analysis of free-text data to increase our understanding of the significance 
of their association with TB. 
Clearly, an increased consultation rate would be noticed more easily by the same GP but 
research suggests that continuity of care by the same GP is decreasing.172 This 
potentially makes diagnosing a disease such as TB more difficult. 
What this self controlled study also shows is that patients are likely to be presenting 
multiple times to GPs with symptoms potentially compatible with TB but which may be 
being misdiagnosed as respiratory disease. In the 6 months pre-TB nearly a third of TB 
patients were diagnosed with a respiratory infection and 11% with three or more lower 
respiratory infections. Therefore a clearer diagnostic algorithm for GPs and when to 
‘think to investigate for TB’ may be helpful and this work may be useful to inform this. 
5.5.4 Stratification of Patients by TB Type 
Research evidence suggests that cases of pulmonary and extra-pulmonary TB present 
differently. I undertook further analysis to understand if different types of TB present to 
primary care in unique ways that might aid faster diagnosis by GPs. 
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This research confirms research by others that factors associated with extra-pulmonary 
TB include female gender173-175 and younger age.173-176 I also found that patients with 
extra-pulmonary TB had less chronic disease than pulmonary cases; this may be 
explained by their younger age. 
For pulmonary TB a 63% increase in consultation rate is seen over the two time periods 
studied. For extra-pulmonary TB a slightly lower increase in consultation rate at 51% is 
seen. This may represent the fact that pulmonary cases are more symptomatic and so 
seek medical care or may represent the fact that pulmonary TB cases have more chronic 
disease and so see their GP more often for this reason. 
Comparison, using the incidence rate ratio, of data from the two time periods 0-6 
months and 12-18 months pre-TB revealed that although sweats, lymphadenopathy and 
weight loss were useful for diagnosing TB in general terms, specific symptoms were 
more associated with particular types of TB; such as cough and weight loss for 
pulmonary TB and lymphadenopathy for extra-pulmonary TB (see Appendix 6). 
However, counts are small once TB-type is sub-divided and confidence limits wide. It is 
therefore difficult to state how conclusive this evidence is. It is also likely that other 
symptoms are hidden in the free-text fields that I could not formally examine. 
Extra-pulmonary TB is not infectious to others but is, however, more difficult to 
recognise and diagnose. In the UK the clinical presentation of tuberculosis is changing 
with an increasing proportion of patients now presenting with extra-pulmonary TB.173 
Awareness of this needs raising in primary care so that clinicians consider extra-
pulmonary tuberculosis. This research may help this as it clearly shows that patients 
with extra-pulmonary TB have more consultations for lymphadenopathy and fever and 
that there is no significant association with any respiratory disease, infection or cough. 
When the GPRD data are stratified by the pathological site of TB (pulmonary or extra-
pulmonary) it becomes evident that GPs record diagnoses differently from national 
notification data (NOIDS returns).47 This may be because GPs use electronic software 
that offers drop down diagnostic lists for fast data entry. A large proportion of TB 
patients (58%) are recorded by their GPs as having ‘Tuberculosis;’ these patients are not 
classified further into pulmonary or extra-pulmonary TB. I have termed this 
‘unclassified’ TB’ (i.e. site not otherwise specified). The high number of patients with 
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‘unclassified TB’ has probably arisen because ‘Tuberculosis’ appears at the top of the 
computer generated list of TB codes and pulmonary and extra-pulmonary or site 
specific TB are lower down. My results show that for TB cases recorded in the GPRD, 
25% had ‘pulmonary TB’ and 16% ‘extra-pulmonary TB’. National rates show that in 
2007, 56% of TB was pulmonary and 44% extra-pulmonary.47 This suggests that GPs 
are probably recording both pulmonary and extra-pulmonary TB within ‘unclassified 
TB’ but are managing to record approximately similar proportions of pulmonary and 
extra-pulmonary TB to national levels if ‘unclassified TB’ is excluded. 
Clinical data from primary care is essential for research of this type. The GPRD 
provides this in an easily searchable form. But, as data entry is occurring during every-
day, busy GP surgeries, primarily as a record of a diagnosis and actions taken, the 
specificity of recording by GPs is not necessarily a priority. It would be useful to 
encourage greater diagnostic specificity in practices supplying data to the GPRD to 
assist research. 
The recording by GPs of different types of TB changed little over the time period of this 
study. In the last few years GP coding has improved markedly,177 firstly due to practice 
computerisation and secondly due to financial incentives and the need to supply data to 
Primary Care Trusts for additional payments and the Quality and Outcomes Framework 
(QOF - a component of the new General Medical Services contract for general 
practices, introduced from 1 April 2004). One therefore would presume the recording of 
TB may have also improved, although the recording of TB is not specifically part of 
QOF. 
Overall, this analysis by TB-type is not as accurate as that available from national 
enhanced TB surveillance data where TB type is specified for each reported patient.47 
What this research adds is an angle on consultation history and an understanding of 
consultation rates and type for pulmonary and extra-pulmonary TB plus useful 
diagnostic indicators. 
5.5.5 Limitations of This Study 
The limitations of this study are similar to those encountered in the case-control study 
and are discussed in detail in Chapter 4, Section 4.6.9. These include misclassification 
by GPs and exclusion of patients who are not registered with a GP. The GPRD lacks 
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ethnicity data which is likely to confound any study on TB as over two thirds of UK TB 
patients are from an ethnic minority.47 In this self-controlled study I have overcome this, 
however, by using the case as their own control in a time period 18 months prior to 
diagnosis. Likewise the impacts of socioeconomic status are also overcome by the self 
controlled methodology. 
A further limitation of this study is the low number of symptoms recorded, particularly 
when analysis of symptoms by TB-type is undertaken. The significance therefore of the 
symptom results could be questioned. This study, however, uses statistical techniques to 
compare symptoms in different time periods to try and overcome the difference in 
absolute numbers. Additionally, when GP recording of ‘symptoms’ is compared to their 
recording of ‘diagnoses’ there is obvious disparity with many more ‘specific diagnoses’ 
being recorded than ‘symptoms.’ This could be explained by the fact that GPs may 
record a specific diagnosis while asking patients about symptoms that they then record 
in the free-text field and so analysis of symptoms alone may not be that helpful. To 
overcome this discrepancy I compared a variable ‘respiratory infections including 
cough’ in the two different time periods to bring the symptoms and diagnoses together 
more appropriately. 
5.6 Conclusion 
Overall, the results of this self-controlled study confirm those of the case-control study 
discussed in Chapter 4. They show an increase in consultation rates for symptoms, 
respiratory infections and in general during the 6-months pre-diagnosis. The measures 
of effect are smaller in the self-controlled study and this suggests that control selection 
bias or confounding by chronic disease, ethnicity or socioeconomic status may have had 
an impact on the results of the case-control study. 
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Chapter 6  
 
Morbidity Associated with TB: A Self Controlled Study 
6.1 Introduction 
Long-term morbidity following a diagnosis of TB is little studied; data is lacking 
because once patients are discharged from hospital outpatients at satisfactory 
completion of treatment further follow-up is rare. A small number of studies has looked 
at associations between TB and malignancy162-164 and TB and chronic respiratory 
disease.165,166,178,179 Research, assessing pulmonary function after pulmonary TB, 
demonstrates variable patterns and severity of pulmonary impairment. Research by 
Pasipanodya shows that survivors of symptomatic TB have long term lung damage and 
are 5 times more likely to have abnormal lung function tests than those with latent 
TB.166 To examine morbidity following TB I conducted a self controlled study using the 
GPRD, a longitudinal dataset with up to 20 years of data. 
6.2 Aims & Objectives 
• To investigate the long-term outcomes (morbidity) of patients with TB 
• To assess /examine if patients are more likely to suffer chronic respiratory 
problems following an episode of pulmonary tuberculosis 
6.3 Methods 
Study Design 
A self controlled (case-case) study140,142,149,150,151,152,153 based on the ‘case-series’ 
method was conducted to investigate consultation behaviour 12-18 months prior to a 
diagnosis of TB as compared to 12-18 months post-TB. 
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Setting 
I examined data, as previously described in Chapter 4, Section 4.3, from 743 general 
practices in the UK who provided data to the General Practice Research Database 
(GPRD) during the time period April 1990 to April 2002. 
Data Source 
I used the GPRD (see Chapter 4, Section 4.3). 
Participants 
Patients were selected from the GPRD between 1990 and 2002; 
Cases: were all GPRD patients with a medical code for active TB 
Controls: cases acted as their own control in a different time period i.e. self controls. 
‘Exclusion’ criteria: I excluded patients who had less than 18 months of pre-diagnosis 
data and patients with less than 18 months of post-diagnosis data. 
Measurements 
To investigate the long-term outcomes of TB patients I compared consultation 
behaviour in two time periods: time period 1: 12-18 months post-diagnosis and time 
period 2: 12-18 months pre-diagnosis. Time period 2 acting as the control period (see 
diagram below). I looked at total consultation rates, respiratory consultation rates and 
the prescribing of antibiotics and inhalers during the two time periods of interest. I used 
the Generalised Estimating Equation (GEE) model22,24,25,147 (see Chapter 3, Section 
3.6.3 for further details) to compare total counts for each individual, and then calculated 
a summary measure for all individuals, the incidence rate ratio (IRR) with 95% 
confidence interval. 
Figure 6.1 Diagram of comparison time periods for self-controlled morbidity 
study 
Time period 2Registration
18 12 12TB diagnosed 18
Time period 1
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Outcomes 
The outcome of interest was measures of morbidity due to TB. Morbidity being defined 
as any departure subjective or objective from a state of physical well-being.9 
Statistical Analysis 
Statistical analysis was performed using STATA version 9.0 (Stata Corp, College 
Station, TX, USA).155 I used the Generalised Estimating Equation (GEE) model to 
generate an incidence rate ratio (IRR) with 95% confidence interval (see Chapter 3 – 
section 3.6.2 for further details).22,24,25,147 This method is the same as described for the 
pre-TB self-controlled study in Chapter 5, Section 5.3. 
6.4 Results 
6.4.1 Characteristics of Study Participant 
2002 TB patients with more than 18 months of follow-up data were identified in the 
time period 1990-2002. There were similar numbers of males and females (1002 vs. 
1000); the mean age at diagnosis was 46 years (SD 22.54; Figure 6.2). 
Figure 6.2 Age distribution of TB cases with more than 18months of follow-
up 
 
At diagnosis 46% (n=915) of TB patients had one or more chronic diseases (of four 
analysed); 36% (n=724) had chronic respiratory disease (including asthma, COPD etc), 
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10% (n=198) chronic heart disease, 7% (n=140) diabetes and 2% (n=32) chronic renal 
disease. In addition, 17% (n=342) of cases had been, or were current, smokers. 
For cases with over 18 months of follow-up data (n=2002): 24% (477) were coded by 
GPs to have pulmonary TB, 17% (340) had extra-pulmonary TB, 59% (1775) had 
‘unclassified TB’ and 0.5% (10) TB at an unknown site. 
6.4.2 Consultation Behaviour 
No significant difference was seen in the overall consultation rate 12-18 months pre-TB 
and 12-18 months post-TB (p=0.328): 6558 consultations occurred 18-12 months pre-
diagnosis and 6617 consultations 12-18 months post-diagnosis (IRR 1.03; 95% 
CI:0.97–1.09). 
GP consultations for cough and specific respiratory diseases are shown in Table 6.1. No 
significant difference was seen in the consultation rates for cough, respiratory disease, 
respiratory infection and LRTI before and after diagnosis. 
Table 6.1 A comparison of GP consultations for patients’ 12-18 months pre- 
and 12-18 months post-TB expressed as an IRR 
CONSULTATIONS 18-12 
months 
pre-TB  
No. 
12-18 
months 
post-TB  
No. 
Incidence Rate Ratio* 
IRR (95% CI) 
p value 
 
Cough 
Respiratory disease 
Respiratory infections 
LRTI  
218 
882 
594 
295 
251 
946 
672 
296 
1.15 (0.93 – 1.43 ) 
1.07 (0.93 – 1.23) 
1.13 (0.98 – 1.31) 
1.00 (0.82 – 1.23) 
0.20 
0.32 
0.10 
0.97 
*Statistical analysis using GEE Model 
6.4.3 Analysis of Prescribing Data 
Similar numbers of patients were prescribed antibiotics pre- & post-TB: 622 patients 
pre-TB and 632 patients post-TB. In terms of scripts: 1070 antibiotic prescriptions were 
issued pre-TB and 1181 post-TB. Antibiotic prescription rates rose from 0.53 pre-TB to 
0.59 post-TB but this was not a statistically significant rise (IRR 1.10; 95% CI:0.99-
1.22, p=0.06). 
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Of 2002 patients, 174 patients pre-TB and 242 patients post-TB were prescribed 
inhalers. A total of 739 inhaler prescriptions were issued pre-TB and 965 post-TB. 
Inhaler prescription rates rose from 0.37 to 0.48 post-TB, a statistically significant rise 
(IRR:1.31; 95%CI:1.08-1.58, p=0.006). 
As the only significant difference between patients 12-18 months pre-TB and 12-18 
months post-TB was the prescription of inhalers, I analysed this group in more detail. 
313 people were prescribed inhalers in one or both of the time periods under 
comparison, see Figure 6.3. 
Figure 6.3 Venn Diagram of inhaler prescribing pre and post-TB 
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Figure 6.3 shows that twice as many people (n=139) were prescribed inhalers as a new 
prescription post-TB and that a third (103) remained on inhalers before and after TB. Of 
the 242 patients prescribed inhalers post-TB 102 (42%) had chronic respiratory disease 
(asthma or COPD), 63 (26%) had a cough, 82 (34%) had a LRTI and 32 (13%) had 
shortness of breath. 
The mean age of TB cases prescribed an inhaler post-TB was 56 years, i.e. 10 years 
older than all TB cases. 
Figure 6.4 charts the quantity of inhalers prescribed pre and post-TB. It shows higher 
inhaler prescribing in each of the groups analysed post-TB, apart from in those with 12 
or more inhaler prescriptions. In the 6 month time periods of analysis, twelve 
individuals were prescribed inhalers 12 or more times pre-TB and 12 individuals 12 or 
more times post-TB. Only one patient was prescribed 12 inhalers pre and post-TB. For 
patients prescribed 12 or more inhalers post-TB, 7 had no inhaler pre-TB, 3 (a quarter) 
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had received 6 or more inhalers pre-TB and 2 less than 6 inhalers pre-TB; i.e. different 
individuals were prescribed multiple inhalers pre and post-TB. I used 12 or more 
inhalers over a 6 month period as a measure of severe chronic respiratory disease. 
Figure 6.4 Inhaler prescriptions for TB patients 12-18 months pre and post-
TB 
 
Patients who were prescribed 12 or more inhalers post-TB were on average 10 years 
older than those prescribed 12 or more pre-TB. Half the patients prescribed 6 or more 
inhalers pre-TB also received them post-TB whereas only a third of those who received 
them post-TB had also received them pre-TB. 
6.4.4 Analysis of Consultations by TB Type 
No significant difference was seen in the overall consultation rate or for specific 
consultations and diagnoses when the data was re-analysed by TB type. See Appendix 7 
– for summary tables of consultation data by TB type.  
6.5 Discussion 
This study suggests that TB patients who survive at least 18 months after diagnosis have 
a good long-term prognosis. Morbidity was low and the only significant finding post-
TB was an increase in inhaler prescribing by 31% (p=0.006).  
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Following TB there was no significant increase in morbidity as measured by general 
consultation rates, consultation rates for LRTI and general respiratory infections, or for 
cough or antibiotic prescriptions. The hypothesis that, following an episode of 
pulmonary tuberculosis, patients are more likely to suffer chronic respiratory 
problems,165, 166 is not clearly supported by this research. Pasipanodya showed that over 
50% of the 107 patients he studied had significantly impaired lung function 5 months 
after starting TB treatment. However, others have shown less impairment, 18% in a 
South African study165 and in a Canadian study “minimal functional impairment” 6 
months post diangosis.178 These studies measured impairment of lung function, if 
inhaler use is assumed to correlate with worsening lung function then my study gives 
some support to this research. However, if lung function is severely impaired it would 
seem likely that consultation rates, cough and other measures of lung function would 
also increase: here they have not. Of note, is the fact that I assessed patients 12-18 
months post TB. Potentially patients with severe lung disease secondary to TB might 
have died by a year post diagnosis or perhaps the patients themselves showed further 
improvement in their lung function. In addition, in Pasipanodya’s study population, 
over 50% had been or were current smokers whereas in this study 17% were recorded as 
having been or were current smokers (although under-ascertainment of smoking status 
is a problem in the GPRD). 
The fact that 36% of TB cases surviving at least 18 months had chronic respiratory 
disease when diagnosed with TB (cf. 28% of all GPRD TB cases) but no increase in 
consultation rate post-TB suggests that the chronic respiratory disease was a long 
standing illness giving an equal number of consultations before and after TB and was 
not directly affected by TB. An alternative explanation could be that patients have been 
misclassified pre-diagnosis by GPs as having chronic respiratory disease when in fact 
they had been exhibiting the early symptoms and signs of TB. 
I used antibiotic and inhaler prescriptions as a proxy measure of respiratory disease. 
Inhalers are generally used for treatment of chronic obstructive airways disease or 
asthma. To understand the 31% increase in inhaler prescribing post-TB I undertook 
further analysis. This showed that twice as many patients were prescribed inhalers as a 
‘new’ prescription post-TB and a third remained on inhalers before and after TB. Those 
that remained on inhalers post-TB may represent patients with a true chronic respiratory 
disease at diagnosis, and this fits with the 36% of TB patients known to have chronic 
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respiratory disease at diagnosis. The rise in inhaler prescribing post-TB may therefore 
represent a true increase in respiratory morbidity post-TB, but this is not confirmed by 
the consultation data. 
There is strong evidence for an association between TB and particular conditions that 
can lead to increased morbidity, for example: TB and diabetes,160,161 TB and 
malignancy,162-164 and TB and chronic respiratory disease.165,166 This research shows 
that 18 months post-TB, however, there is no increase in morbidity due to TB or these 
conditions as reflected in the stable consultation rates. 
This study by using cases as their own controls suggests that patients who survive at 
least 18 months after a TB diagnosis have morbidity similar to patients without TB. I 
did consider conducting a cohort study to study this in more detail, but this would have 
been complicated by unmeasured confounders and the progressive loss of cases either 
through death or loss to follow-up as patients move GP. In view of the results of this 
study is seems a cohort study would have added little additional morbidity information. 
Strengths and Limitations 
To overcome the effects of unmeasured confounders such as ethnicity and 
socioeconomic status I undertook a self-controlled study. This gives strengthen to the 
study findings. 
By selecting TB patients with at least 18 months of data pre- & post-diagnosis I 
excluded patients that died in the 18 months immediately after diagnosis, that were lost 
to follow-up and those that had less than 18 months of GP registration. This latter group 
would potentially have included newly arrived immigrants. The results of this study are 
therefore likely to be an under-estimate of long-term morbidity due to these exclusions. 
6.6 Conclusion 
In TB patients surviving for at least 18 months, consultation patterns returned to levels 
seen prior to TB disease, suggesting that TB does not result in long-lasting ill health or 
disability if successfully treated. 
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Chapter 7  
 
Mortality Associated with TB: A Cohort Study 
7.1 Introduction 
Mortality following a diagnosis of tuberculosis (TB) is little studied and mortality rates 
vary considerably.16,26-33 Analysing TB-patient deaths and risk factors for death, may 
assist in gaining a better understanding of how to improve the care and the outcomes of 
patients with TB. 
In the UK TB case fatality rates are usually estimated indirectly by comparing the 
number of TB notifications, or reports to the national surveillance system, with the 
number of deaths certified as due to TB in any given year. This calculation gives a case 
fatality rate of around 9%.180 However, this indirect method of calculating case fatality 
may give an inaccurate impression and may underestimate mortality. This is because 
death certificates can be an unreliable source of the actual cause of death and result in 
misclassification.181,182 In addition, death from other causes may be increased as a result 
of having had TB but this is little studied. In the UK a number of small studies16, 18, 27, 183 
have looked at risk factors for death in TB patients but these are still poorly understood. 
By studying TB mortality it may be possible to develop more appropriate ways to 
diagnose and control TB and reduce this potentially preventable cause of death. 
7.2 Aims & Objectives 
• To describe and quantify mortality from TB 
• To calculate the mortality rate in patients with TB 
• To examine if TB indirectly increases the risk of death from non-TB causes 
• To describe risk factors for death in TB patients 
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7.3 Methods 
Study Design 
A cohort study was used to investigate patient mortality following a diagnosis of TB. 
Setting and Data Source 
I examined data, as previously described in Chapter 4, Section 4.3, from 743 general 
practices in the UK who provided data to the General Practice Research Database 
(GPRD) during the time period April 1990 to April 2002. 
Participants 
Participants in this study were the same as those in the case-control study discussed in 
Chapter 4; that is all patients diagnosed with active TB from GPRD practices between 
1990 and 2002 and a random sample of five patients without-TB for every patient with 
TB, matched on age band, GP practice and registration at the time of diagnosis of the 
matched case. Patients without TB were assigned a random index date to equate to their 
case’s date of TB diagnosis. All patients were followed up from diagnosis (or index 
date) to time of death, transfer out of GP practice or the end of the study period. 
Measurements 
All patients with a diagnosis of TB were identified using the Read and OXMIS code list 
(see Appendix 2); as described in Chapter 3, Section 3.4.1. 
Mortality was defined as death from any cause during the follow-up period - the period 
from diagnosis (or predefined index date for participants without TB) to the end of the 
study period, April 2002. Deaths were defined as TB-related if TB was listed as a 
specific cause of death (see Chapter 3, Section 3.7.8 for more detail on determining 
cause of death). Non-TB deaths were defined as those not directly due to TB but due to 
another cause: I grouped these into deaths due to cardiovascular disease, respiratory 
disease (excluding TB), cancer, other diseases (including diabetes and renal failure) and 
unknown. Over 12,000 death codes exist in the GPRD dataset and I re-allocated these to 
one of these six generic groups to aid analysis of the cause of death. 
Patient deaths were identified from the GPRD “patient records” file. All death dates and 
patient identifiers (ids) were extracted and all consultation records pre- and post- death 
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then retrieved from the associated “medical records” file. Survival after diagnosis was 
determined from GP consultations recorded post-diagnosis in the GPRD “medical 
records” file. 
Outcomes 
The primary outcomes of interest were death and the time from TB-diagnosis to death. 
This was calculated by subtracting the date of death from the date on which TB was 
diagnosed. In the survival analysis, patients were censored at death, or date of last GP 
visit if they were lost to follow-up, or at the date of transfer to another GP practice. The 
secondary outcomes of interest were cause of death, possible risk factors for death and 
frequency of death among patients with TB and those without. 
Bias 
I tried to reduce ethnicity and social status bias by matching patients on GP practice. 
Statistical Analysis 
Single variable analysis was undertaken. Categorical variables were compared using the 
Chi Squared test. A Cox proportional hazards model was used to compare the survival 
of patients with TB to those without.154 This model was used to help account for 
patients who did not provide complete data throughout the follow-up period (censored 
observations) and was adjusted for sex and chronic disease. Hazard ratios and their 95% 
confidence intervals were calculated and a Cox proportional hazards survival curve 
plotted. All p values <0.05 were considered statistically significant and statistical 
analysis was performed using STATA version 9.0 (Stata Corp, College Station, TX, 
USA). 
I compared demographic characteristics of TB patients and patients without TB that 
died during the study period, I compared demographic characteristics of TB patients 
that died and TB patients that survived and analysed GPRD consultation data to assess 
risk factors for death and cause of death. Further analysis was undertaken of the 
relationship between TB and cancer and of those patients that died prior to, or very 
shortly after, a diagnosis of TB. For the latter group, analysis was conducted to 
determine if these patients were in some way different to the TB cases that survived. 
Chapter 7 – Morbidity Associated with TB – Cohort Study 147 
7.4 Results 
7.4.1 Characteristics of Study Participants 
Over eighteen thousand individuals (3032 with TB and 15,160 without TB) met the 
inclusion criteria in the time period 1990-2002. Patient characteristics are shown in 
Table 7.1. Thirty-five percent of TB patients had one or more chronic diseases 
compared to 18% of individuals without TB and 15% of TB patients had smoked 
compared to 11% of individuals without TB. 
Table 7.1 Characteristics of study participants 
Characteristic Individuals with TB 
(n=3,032) 
No. (%) 
Individuals without TB 
(n=15,160) 
No. (%) 
Sex 
Female 
Male 
1490 (49%) 
1542 (51%) 
7833 (52%) 
7327 (48%) 
Age 
<=20 
>20 - <=40 
>40 - <=60 
>60 - <=80 
>80 
427 (14%) 
651 (22%) 
803 (26%) 
929 (31%) 
222 (7%) 
2135 (14%) 
3255 (22%) 
4015 (26%) 
4645 (31%) 
1110 (7%) 
Chronic disease 
Any 
Respiratory 
Renal 
Cardiac 
Diabetes 
1061 (35%) 
861 (28%) 
31 (1%) 
213 (7%) 
162 (5%) 
2729 (18%) 
1837 (12%) 
42 (0.3%) 
708 (5%) 
475 (3%) 
 
7.4.2 Patient Contributions to the Dataset 
The mean follow-up time for patients with TB was 38 months and the mean follow-up 
time for patients without TB was 35 months. There were 9,591 person-years of follow-
up for TB cases and 43,953 person-years of follow-up for patients without TB. Fourteen 
percent (n=437) of TB patients left their GP during the study period; the outcome of 
these patients was therefore unknown and they are censored at the last known GP visit 
for the purposes of the Cox proportional hazard calculation. 
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7.4.3 Analysis of Overall Mortality Data and Survival 
Over the follow-up period 17.3% (n=525) of TB patients died and 8.9% (n=1,352) of 
individuals without TB died (Table 7.2). The overall mortality rate in TB patients was 
54.7/1000 person-years at risk (PYAR), compared to 30.8/1000 PYAR in patients 
without TB. This gives an incidence rate ratio for death of 1.78 (95% CI 1.61-1.97). The 
TB-specific death rate was 11.5/1000 PYAR. 
For TB patients, just over half of all deaths, 54% (n=284/525) occurred within a year of 
diagnosis. Proportionally, three times as many deaths occurred in cases in the first year 
post-TB as compared to individuals without TB. Further analysis of the data showed 
that 87 patients (representing 79% of all deaths from TB-disease) died prior to, or very 
shortly after being diagnosed with TB. This group is further analysed in section 7.4.9. 
Table 7.2 Crude comparison of deaths for individuals with TB and those 
without  
 Individuals with TB 
(n=3,032) 
Individuals without TB 
(n=15,160) 
Total deaths 17.3% (525) 8.9% (1,352) 
Deaths within 1yr of diagnosis 9.4% (284) 3.6% (540) 
Deaths >1 yr from diagnosis 7.9% (241) 5.4% (812) 
 
The probability of survival after a diagnosis of TB, estimated using the Cox 
proportional hazards regression method, is shown in Figure 7.1. There is a marked 
difference in survival for patients with TB as compared to those without; a sustained 
and increasing difference is shown across the study period. Survival rates were lower at 
1, 5 and 10 years for TB patients compared to patients without TB (see Figure 7.1). The 
death rate for TB patients was highest in the year following diagnosis. The all-cause 
case fatality rate of TB patients within a year of diagnosis was 6.5%, mortality at 5 
years after diagnosis was nearly 20% and at 10 years 30%. 
Chapter 7 – Morbidity Associated with TB – Cohort Study 149 
Figure 7.1 Cox Model Survival Curve for patients with and without TB over a 
10 year follow-up period adjusted for sex and chronic disease 
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7.4.4 Analysis Using a Cox Proportional Hazards Model 
The Cox proportional hazards model showed that TB patients had a higher probability 
of death compared to patients without TB (adjusted Hazard Ratio (HR):1.53; 
95%CI:1.39-1.69) even after adjusting for other known risk factors for death; male 
gender (adjusted HR:1.18) and chronic disease (adjusted HR:2.46) (see Table 7.3). The 
risk of death was apparently unaffected by smoking (HR:1.00), although from research 
presented earlier in this thesis I know smoking is under-ascertained in the GPRD. 
    1yr      5yrs      8yrs        10yrs 
 % survival     93.5%       81.2%      74.5%        70.1%      ‐ for TB patients 
No. at risk  2268      7 6      184        23 
   
% survival     95.7%      87.2%      82.4%        79.2%      ‐ for non‐TB patients 
No. at risk  10291      3229      1038        259 
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Table 7.3 Unadjusted and adjusted hazard ratios for death in TB patients 
versus non-TB patients using a Cox Proportional Hazards Model 
Variable Unadjusted Hazard Ratio 
(95% CI) 
Adjusted Hazard Ratio 
(95% CI) 
p value 
 
Patient with TB 
(vs not TB) 
1.81 
(1.65-1.99) 
1.53* 
(1.39-1.69) 
< 0.001 
Male 
(vs female) 
1.20 
(1.10-1.31) 
1.18+ 
(1.07 – 1.30) 
0.001 
Any chronic disease 
(vs no chronic disease) 
2.64 
(2.39-2.90) 
2.46+ 
(2.23 – 2.72) 
< 0.001 
* HR adjusted for sex and chronic disease 
+ HR adjusted for other variables in the model 
In Chapter 4, Section 4.5.8, I showed that chronic respiratory disease was the most 
significant chronic disease of four common chronic diseases analysed. I therefore 
repeated the Cox proportional hazards model exchanging the variable ‘any chronic 
disease’ for ‘chronic respiratory disease’ (see Table 7.4). This led to an increase in the 
adjusted hazard ratio for death for patients with TB as compared to those without to 
adjusted HR:1.62 (95% CI:1.47–1.78). 
Table 7.4 Unadjusted and adjusted hazard ratios for death in TB patients 
versus non-TB patients using a Cox Proportional Hazards Model, 
including chronic respiratory disease 
Variable Unadjusted Hazard Ratio 
(95% CI) 
Adjusted Hazard Ratio 
(95% CI) 
p value 
 
Patient with TB 
(vs not TB) 
1.81 
(1.65-1.99) 
1.62* 
(1.47–1.78) 
< 0.001 
Male 
(vs female) 
1.20 
(1.10-1.31) 
1.19+ 
(1.09 – 1.31) 
< 0.001 
Chronic respiratory disease 
(vs no chronic resp. 
disease) 
2.07 
(1.87-2.30) 
1.89+ 
(1.70– 2.10) 
< 0.001 
* HR adjusted for sex and chronic disease 
+ HR adjusted for other variables in the model 
Chapter 7 – Morbidity Associated with TB – Cohort Study 151 
7.4.5 A Comparison of TB Patients and Patients without TB Who Died 
during the Study Period 
Table 7.5 shows a comparison of TB patients who died as compared to patients without 
TB who died during the study period. A significant difference was seen in gender, age 
and chronic disease profiles. TB cases that died were more likely to have chronic 
respiratory disease, and a significantly greater proportion of deaths occurred in TB cases 
under 60 year olds. 
Table 7.5 Single variable analysis of risk factors for death in patients with 
TB & those without 
 
Characteristic Patients 
with TB who died 
(n=525) 
No. & % of those dying 
Patients 
without TB who died 
(n=1352) 
No. & % of those dying 
p value 
 
Sex 
Male 
Female 
326 (62.1%) 
199 (37.9%) 
670 (49.6%) 
682 (50.4%) 
<0.001 
Age (years) 
<20 
>20- 40 
>40-60 
>60-80 
>80 
2 (0.4%) 
14 (2.7%) 
82 (15.6%) 
311 (59.2%) 
116 (22.1%) 
3 (0.2%) 
12 (0.9%) 
124 (9.2%) 
811 (60.0%) 
402 (29.7%) 
<0.001 
Chronic disease 
Any 
Respiratory 
Renal 
Cardiac 
Diabetes 
289 (55.0%) 
238 (45.3%) 
14 (2.7%) 
73 (13.9%) 
38 (7.2%) 
457 (33.8%) 
249 (18.4%) 
21 (1.6%) 
176 (13.0%) 
103 (7.6%) 
<0.001 
<0.001 
0.11 
0.61 
0.78 
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7.4.6 A Comparison of TB Patients that Died and TB Patients that 
Survived 
Table 7.6 shows that for TB patients that died as compared to those that survived, 
significantly more were male; they were more likely to have a chronic disease, 
particularly chronic respiratory disease and have pulmonary TB. Consultation rates in 
the 6 months pre-TB were also compared and showed that TB cases that died consulted 
nearly 40% more often than those that survived, a crude rate ratio of 1.37. 
Table 7.6 Single variable analysis of TB patients that died and those that 
survived 
 
Characteristic TB cases that died 
(n=525) 
No. & % of those dying 
TB cases that survived 
(n=2070) 
No. & % of those surviving 
p value 
 
Consultation rate in 
6mths pre-diagnosis 7.78 5.69 
<0.001 
 
Sex 
Male 
Female 
326 (62.1%) 
199 (37.9%) 
1012 (48.9%) 
1058 (51.1%) 
<0.001 
Age (years) 
<20 
>20- 40 
>40-60 
>60-80 
>80 
2 (0.4%) 
14 (2.7%) 
82 (15.6%) 
311 (59.2%) 
116 (22.1%) 
346 (16.7%) 
501 (24.2%) 
628 (30.3%) 
513 (24.8%) 
82 (4.0%) 
<0.001 
Chronic disease 
Any 
Respiratory 
Renal 
Cardiac 
Diabetes 
289 (55.0%) 
238 (45.3%) 
14 (2.7%) 
73 (13.9%) 
38 (7.2%) 
664 (32.1%) 
528 (25.5%) 
14 (0.7%) 
122 (5.9%) 
101 (4.9%) 
<0.001 
<0.001 
<0.001 
<0.001 
0.032 
TB Type 
Pulmonary 
Extra-pulmonary 
Unclassified TB 
200 (38.1%) 
57 (10.9%) 
268 (51.0%) 
451 (21.8%) 
360 (17.4%) 
1,259 (60.3%) 
<0.001 
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7.4.7 Analysis of Cause of Death in TB Patients 
The median number of diagnostic codes recorded in the GPRD on the date of death 
(death codes) was one (range 0-8) (see Figure 7.2). For the minority of cases with more 
than one code (n=230) the codes were reviewed to assess the most likely cause of death; 
see Chapter 3, Section 3.7.8 for methodology. 
Figure 7.2 Number of death codes per TB patient 
 
Of the TB patients that died: 21% were recorded as dying of TB, 21% of cancer, 16% of 
cardiovascular disease, 14% of respiratory (non-TB) disease and 5% of other causes. 
For 23% of deaths the cause was unknown. Of the 21% (110) deaths specifically 
attributable to TB the majority, 58 (53%), were in patients with pulmonary TB, 18 
(16%) were in patients with extra-pulmonary TB and 34 (31%) were in patients with 
‘unclassified’ TB. 
There was a significant difference between the cause of death for TB patients dying 
within 18 months of diagnosis and those dying after 18 months (see Table 7.7). Nearly 
all the deaths recorded as being due to TB occurred in the 18 months following 
diagnosis. A comparison of deaths before and after 18 months was chosen as, by 18 
months post-diagnosis, all patients should be well and TB-free. 
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Table 7.7 Cause of death in TB patients 
Cause of death Total 
No. (%) of TB 
patients dying 
(n=525) 
TB patients dying 
0-18 months 
post diagnosis 
No. (%) 
(n=318) 
TB patients dying 
>18 months 
post diagnosis 
No. (%) 
(n=207) 
TB 110 (21%) 109 (34%) 1 (0.5%) 
Unknown 118 (23%) 62 (20%) 56 (27%) 
Cancer 110 (21%) 70 (22%) 40 (19%) 
Cardiovascular disease 86 (16%) 33 (10%) 53 (26%) 
Respiratory disease (not TB) 74 (14%) 33 (10%) 41 (20%) 
Other 27 (5%) 11 (4%) 16 (8%) 
 
In the 18 months post diagnosis, one third of deaths (n=109; 34%) were attributed 
specifically to TB, with most of these occurring prior to or soon after diagnosis (80%; 
n=87/109). In addition, considerably fewer TB patients died of cardiovascular and 
respiratory disease during this time period. 
The majority of deaths that occurred more than 18 months after a diagnosis of TB were 
due to cardiovascular disease, respiratory disease and cancer, where the cause of death 
was known. Only one TB patient died from TB disease during this time period. 
A comparison of the mortality rates by cause of death for TB and non-TB patients 
(Table 7.8) showed that the rate of death due to cancer in patients with underlying TB 
was nearly double that of patients without TB (IRR:1.89), as was the rate of death from 
respiratory disease other than TB (IRR:1.87); but the rate of death from cardiovascular 
disease was unaffected (RR:0.94). 
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Table 7.8 Mortality rate and incidence rate ratio by cause of death for 
patients with TB and those without  
 
7.4.8 Cancer as a Cause of Death 
Cancer was the second commonest cause of death in TB patients where cause of death 
was known. In patients with underlying TB, the mortality rate from cancer was 
11.5/1000 PYAR. Of 3032 TB cases, 347 (11.4%) had a diagnosis of cancer. 173 
patients (49.9%) were diagnosed with cancer pre-TB and of these 16% died; of the 174 
patients diagnosed with cancer after their TB, 46% died. This suggests that TB patients 
who were diagnosed with cancer post-TB had a much worse prognosis than those 
diagnosed pre-TB. Nearly a third of all TB cases with cancer died from their cancer 
(n=110) during the follow-up period; two thirds within 18 months of their TB diagnosis 
and a third after 18 months. 
The commonest form of cancer seen in TB patients (Figure 7.3) was lung cancer (25%) 
followed by skin cancer (19%). Of the TB patients with lung cancer, (a cancer with 
known poor prognosis) 76% died during the period of analysis as compared to 40% of 
those with other malignancies. 
Cause of death 
TB patients 
(n=3,032) 
Non-TB patients 
(n=15,160) 
  
No. (%) 
dying 
Death rate 
/1000 
PYAR 
No. (%) 
dying 
Death 
rate /1000 
PYAR 
Incidence Rate 
Ratio 
(95% CI) 
p value
TB 110 (21%) 11.5 - -   
Unknown 118 (23%) 12.3 412 (31%) 9.4 1.31 (1.06-1.61) <0.001
Cancer 110 (21%) 11.5 267 (20%) 6.1 1.89 (1.50-2.37) <0.001
Cardiovascular disease 86 (16%) 9.0 420 (31%) 9.6 0.94 (0.74-1.19) 0.3 
Resp. disease (not TB) 74 (14%) 7.7 181 (13%) 4.1 1.87 (1.41-2.47) <0.001
Other 27 (5%) 2.8 72 (5%) 1.6 1.72 (1.06-2.71) <0.001
Total deaths 525 54.7 1352 30.8 1.78 (1.61-1.97) <0.001
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Figure 7.3 Types of cancer seen in GPRD TB patients 
 
7.4.9 Death Prior to, or Very Shortly after, a Diagnosis of TB 
Eighty seven patients were recorded in the GPRD as “dying on the day their TB was 
diagnosed” (i.e. the date of recorded patient death was the same as the date of TB 
diagnosis). These 87 patients represent 79% of all deaths from TB-disease and a third 
(31%) of all TB patient deaths occurring within a year of diagnosis. 
Demographic and other characteristics of the 87 TB cases that died prior to, or very 
shortly after, a diagnosis of TB are shown in Table 7.9. Those who died were more 
likely to have pulmonary TB, be male, be aged over 60 and have one or more chronic 
diseases with chronic respiratory disease being the most common. 
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Table 7.9 Characteristics of TB patients who died prior to, or shortly after, a 
diagnosis of TB 
Characteristics TB Cases 
No. & (%) 
(n=87) 
All other TB Cases 
No. & (%) 
(n=2,945) 
Sex 
Female 
Male 
39 (45%) 
48 (55%) 
1451 (49%) 
1494 (51%) 
Age 
<=20 
>20 - 40 
>40 - 60 
>60 - 80 
>80 
0 (0%) 
1 (1%) 
7 (8%) 
51 (59%) 
28 (32%) 
427 (14%) 
650 (22%) 
796 (27%) 
878 (30%) 
194 (7%) 
Chronic Disease 
Any 
Respiratory 
Renal 
Cardiac 
Diabetes 
48 (55%) 
39 (45%) 
4 (5%) 
15 (17%) 
7 (8%) 
1013 (34%) 
822 (28%) 
27 (1%) 
198 (7%) 
155 (5%) 
Ever smoked 13 (15%) 426 (14%) 
TB Type 
Pulmonary 
Extra-pulmonary 
Unclassified TB 
44 (51%) 
16 (18%) 
27 (31%) 
715 (24%) 
467 (16%) 
1747 (59%) 
 
Figure 7.4 shows that the proportion of cases with any chronic disease is highest in 
patients that died prior to, or shortly after, a diagnosis of TB and lowest in those without 
TB. 
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Figure 7.4 Chronic diseases in different TB patient populations 
 
In the 6 months pre-diagnosis, the median number of consultations for cases diagnosed 
with TB at or near death was six (IQR=4 to 11; range 0-33); this was very similar to that 
for all-TB cases (n=3032) at five. Only 8% of these 87 cases were not seen pre-
diagnosis. Symptoms compatible with TB were reported by 18 of 87 patients, these 
patients were evenly distributed between pulmonary, extra-pulmonary and 
‘unclassified’ TB; the majority had cough, followed by fever and weight loss. Of the 87 
TB patients that died at, or near diagnosis, 35% had a chest infection in the 6 months 
prior to death and 14% had consultations for chronic respiratory disease. 
Over half of the patients diagnosed with TB at or near death, had pulmonary TB, as 
compared to only 25% of all TB cases. Analysis of the number of consultations per case 
in the 6 months prior to a diagnosis of TB showed that patients with pulmonary TB had 
a median of 7 consultations and those with extra-pulmonary had a median of 9 
consultations. 
7.5 Discussion 
7.5.1 Main Findings 
This is the most detailed review of TB patient deaths in the UK to date. The all-cause 
case fatality rate of TB patients within a year of diagnosis was 6.5%, mortality 5 years 
after diagnosis was nearly 20% and at 10 years 30%. The majority of TB patient deaths 
occurred in the first year after diagnosis, nearly a third of these occurred prior to or 
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shortly after diagnosis. Death from TB-disease specifically, occurred almost exclusively 
within the first 18 months, with 80% occurring prior to, or very shortly after, a 
diagnosis of TB suggesting a missed diagnosis, serious delay in diagnosis and/or 
advanced disease. Excess mortality in TB patients was greatest in the first year after 
diagnosis, thereafter there was an excess but it was less marked. Patients with TB had a 
greatly increased risk of death if they had pulmonary TB, were male, aged over 60 and 
had a chronic disease or cancer. TB was associated with a higher probability of death 
(adjusted HR:1.53) and the TB-specific death rate in this study was 11.5/1000 PYAR. 
7.5.2 Case Fatality Rates and Survival Rates 
There was a marked difference in survival of patients with TB as compared to patients 
without TB. A TB patients chance of survival was 81% at 5 years and 70% at 10 years, 
survival for those without TB was 87% and 79% respectively; TB patients had an 
elevated mortality following diagnosis and this risk remained even after treatment 
completion. This finding is supported by that of Tocque et al.27 
In this study the 12-month all-cause case fatality rate was 6.5%. Strikingly different TB 
case fatality rates have been found in various studies in different countries. Many of 
these studies assess mortality by looking at deaths within a year of diagnosis or during 
treatment.16,26, 28, 30, 32, 184 These studies show case fatality rates that vary between 3.6%16 
and 24%.32 In 2006 the global TB case fatality rate for smear-positive pulmonary TB 
patients was 4.6%.185 One of the strengths of my study is that in addition to calculating 
the case fatality rate at one year I have been able to assess the long-term outcomes of 
TB patients by using up to 12 years of longitudinal data contained within the GPRD. 
This study adds to the existing UK literature and particularly the studies of Crofts et 
al.180 Ditah186 and Martineau187 who each reviewed national UK TB surveillance and 
mortality data. It adds both in terms of its size, its length of longitudinal follow-up data 
and the fact that it uses quality controlled primary care data from the GPRD, rather than 
national surveillance data, and links this to national mortality data. This study differs 
from previous studies in that it is the first to use a proper primary method. Previous 
estimates of case-fatality have been based on triangulation of data; here I have used a 
cohort study with robust methods. The 12 month case fatality rate in this study (6.5%) is 
between that found by Crofts180 and Martineau;187 Martineau describes a decrease in 
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case fatality rate from 9.26% in 1998, to 5.59% in 2001; Crofts describes a case fatality 
rate of 8.9% in 2001/2. A lower case fatality rate may represent better TB diagnosis and 
control, may represent younger patients with less co-morbidity or may represent 
incomplete ascertainment. In Crofts conclusion he comments that mortality among TB 
cases is underestimated in national TB surveillance data (in fact by 25%) but by 
triangulating three different data sources a higher estimate of 8.9% was found. Overall 
therefore, it seems that the case fatality rate of 6.5% found in my study is similar to the 
case fatality rate calculated from other single national UK data sources. 
This study supports the findings of others16, 26, 27 and shows that TB increases the risk of 
all-cause mortality compared to the general population. Tocque et al. found 24% all-
cause mortality in 8 years, with 31% of cases dying from TB;27 Bakhshi found 3.6% all-
cause mortality in 6 years.16 My study, which is considerably larger than these, showed 
a 20% all-cause mortality at 5 years and 30% at 10 years with 1 in 5 deaths attributable 
to TB disease. Most TB patients die of something other than TB and have a higher death 
rate even after successful treatment. 
In this study half of all TB patient deaths occurred in the first year after diagnosis. This 
research shows that TB patients who died, consulted more often in the 6 months pre-TB 
than those that survived (RR:1.37). If excess consultations are taken to be a proxy 
measure of delay in diagnosis, then diagnostic delay appears to have contributed to 
death. 
It is important for national TB programmes to understand TB patient deaths so that they 
can assess how effective their TB management and control has been. This is particularly 
true in high income countries where death is often the most commonly reported reason 
for TB treatment failure. In the UK, death whilst on treatment is the main reason that we 
fail to meet the WHO’s global target of 85% treatment success.1, 186, 188 
7.5.3 Risk Factors for Death 
This study confirms, and adds to what other smaller studies have found, that specific 
risk factors are associated with increased mortality in TB patients. These risk factors 
include: male gender,16,27,30,31,33,94, 184 older age,16, 26, 30-32, 183, 184, 189 pulmonary disease,30, 
184,190 presence of malignancy or HIV27,30,31,94 and having an underlying medical 
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condition32 (particularly chronic respiratory disease.16) Sterling also showed that the 
more independent risk factors a patient has, the greater their risk of death.31 
A few studies have looked at social determinants of ill health and found associations 
between alcohol or drugs and TB.26,30,31 This was not possible in my study, nor was 
analysis of the impact of ethnicity on death. Results differ in studies that assess the 
impact of ethnicity on death; Pablos-Mendez found an association between TB death 
and ethnic minority group,94 where as Bakhshi and Sterling did not.16,31 
Another risk factor for death is treatment delay. Very few studies have looked at 
treatment delay and its impact on death. Pablos-Mendez in New York, however, found 
higher death rates in those who were delayed in starting treatment.94 Although I cannot 
directly show that repeat consultations prior to diagnosis constitute treatment delay, it is 
likely that this is the case, as TB patients consulted their GP nearly three times more 
often (OR:2.68), and with symptoms and respiratory conditions compatible with TB in 
the 6 months pre-diagnosis (see Chapter 4, Section 4.5.3). Moreover, a comparison of 
TB cases that died, with TB cases that survived, revealed that those that died consulted 
nearly 40% more often in the 6 months pre-TB than those that survived. This suggests a 
delay in diagnosis that impacted on survival. Repeat consultation behaviour pre-
diagnosis has been little studied and this information is one of the strengths of using the 
GPRD dataset which contains such data. Diagnostic delay is likely to be one of the main 
contributors leading to death from TB, particularly for those who die prior to, or soon 
after, diagnosis. Diagnostic delay, whether patient or health care worker delay, is a 
factor that can be changed and reduced by the provision of TB information and 
education to patients and health care workers. 
This study gives a unique insight into the risk factors for death from TB in a large 
sample population. Single variable and multivariable analysis of TB patients that died 
and those who survived helps us to understand the possible risk factors that are 
associated with death in TB patients. Knowledge of these factors in conjunction with an 
increase in consultation rates and repeat chest infections could help health care 
professionals diagnose TB earlier, and lead to quicker treatment and decreased 
mortality. Specifically in the UK, consideration of a diagnosis of TB in older, male 
patients with a known chronic disease (particularly chronic respiratory disease) and 
cancer may help to reduce TB related deaths. 
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7.5.4 Co-Morbidity and TB Deaths 
The analyses presented in this thesis show that chronic disease is associated with an 
increased risk of developing TB, diagnostic delay and an increased likelihood of death. 
This supports the work of others.32,123 The importance of co-morbidity is shown here by 
a 2.5 times greater risk of death in TB patients with a chronic disease (adjusted 
HR:2.46). One third of TB cases analysed had a chronic disease at diagnosis compared 
to 18% of patients without TB and 55% of those dying prior to, or very shortly after 
diagnosis. This suggests that TB cases are generally sicker (as measured by rates of 
chronic disease) than cases without TB. This may be one explanation as to why patients 
are more susceptible to contracting TB and why TB cases have a higher death rate than 
cases without TB. Another explanation might be that TB symptoms have been wrongly 
assigned to a chronic respiratory disease and so delayed the diagnosis of TB which can 
present in a similar way. 
Of all the chronic diseases analysed, chronic respiratory disease had the greatest impact 
on the risk of death for TB patients’. Survival was 62% worse for these patients; a fact 
that needs to be considered and acted upon by GPs when treating patients with TB. 
7.5.5 Cause of Death 
A detailed analysis of cause of death was not possible, as the GPRD provides secondary 
data and there is no direct access to the actual records or patient letters. Over a fifth of 
deaths were directly attributable to TB, the majority occurred early and were due to 
pulmonary TB. The latter finding is interesting as theoretically these patients would 
have been more likely to have symptoms compatible with an early diagnosis. Cause of 
death differed significantly (p<0.001) depending on how soon it occurred after 
diagnosis; for those dying early (within 18 months of diagnosis), most died from TB 
disease or cancer, for those dying later most died of cardiovascular disease, respiratory 
disease or cancer. In addition, this study showed that the increased risk of death for TB 
patients continued long-term. 
This study suggests that the single most important factor causing death from ‘TB 
disease’ was the failure to diagnose (and therefore treat) patients with TB earlier. 
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7.5.6 Cancer and TB 
Death from cancer is associated with TB. This is confirmed by this and other 
studies.27,30,31 Here, cancer doubled the rate of death in TB patients as compared to 
patients without TB. In this study 10% of TB cases had a diagnosis of cancer; half were 
diagnosed with cancer prior to their TB and half after. This research suggests that TB 
patients diagnosed with cancer post-TB have a much worse prognosis; nearly three 
times as many TB patients died if their cancer was diagnosed after their TB than before. 
Tocque et al. found that malignancy was the cause of death in 28% of TB patients that 
died, and that lung cancer was particularly common.27 Similarly my study shows the 
importance of malignancy as a cause of death (seen in 21%) and that lung cancer was 
the most common form of cancer (seen in 25%). Research suggests that cancer and its 
treatment lead to immune-suppression and this in turn can lead to reactivation of TB in 
those already infected or increase susceptibility to new infection. For those cases 
diagnosed with TB prior to their cancer, TB might be acting as a marker of underlying 
immune-suppression associated with cancer. 
7.5.7 Death Prior to, or Shortly after Diagnosis 
Seventeen percent of TB cases that died are recorded to have died prior to, or shortly 
after, diagnosis. From GPRD data it is not possible to distinguish whether the diagnosis 
of TB was made clinically or at post-mortem. The description “death prior to, or very 
shortly after a diagnosis of TB” is probably an artefact of how GPs record patient death 
and diagnosis in their records. It could represent those patients who died prior to a 
formal diagnosis of TB and then were subsequently diagnosed at post-mortem or 
following a positive microbiological culture; or it could represent patients who were 
diagnosed late and died while in hospital shortly after diagnosis. In the latter group GPs 
are likely to be informed of the patient’s diagnosis and death at the same time and so 
record these in the patient’s notes as having occurred on the same date. 
Croft et al.180 made a similar finding that 25% of TB patients were diagnosed post-death 
or on the day they died. Any factors that differentiate this group from TB cases that 
survive could be used to help healthcare workers investigate and diagnose TB earlier 
and so reduce this mortality. Those who died at diagnosis were more likely to have 
pulmonary TB, be male, aged over 60 and have one or more chronic diseases; chronic 
respiratory disease being the most common. Risk factors to help diagnose TB prior to 
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death appear to be no different to those associated with increased mortality in all TB 
patients, whether diagnosed pre or post death. 
80% of all deaths directly attributable to TB-disease occur prior to, or shortly after, 
diagnosis and the majority of these patients are seen multiple times with a median of 6 
consults in the 6 months pre-diagnosis. These patients are therefore likely to have had 
advanced undiagnosed TB suggesting a serious delay in diagnosis. 
Diagnosis at death suggests an unacceptable and potentially avoidable delay in 
diagnosis and treatment to such a degree that it has resulted in death. Ways to reduce 
this delay need to be further investigated but would probably need to take a two-
pronged approach: firstly to educate patients of the signs and symptoms of TB so that 
they present earlier to a health care professional, and secondly to educate health care 
professionals in primary care and accident and emergency departments to “THINK TB”. 
7.5.8 Study Limitations 
This study has several limitations: 
1. Determining the cause of death by reviewing GP data records is subject to 
possible misclassification. Some patients had multiple entries on the day of 
death. I estimated a single cause of death by reviewing all multiple entries 
on the day of death and allocating one using a pre-determined method (see 
Chapter 3, Section 3.7.8). By following a strict protocol I tried to reduce 
misclassification. 
2. The mean patient follow-up period was 38 months, although up to 10 years 
of follow-up time was available for some. I analysed deaths within the time 
period available for each patient; survival data is therefore not based on a 
life-time but rather the time available in the dataset. The Cox proportional 
hazards model allows for this. 
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3. The data available in the GPRD did not allow me to assess some important 
known risk factors for TB such as ethnicity and social class. To lessen the 
effect of these possible confounders I randomly selected patients without 
TB from the same GP practice as the case, making the assumption that 
patients registered with the same GP are likely to be from similar ethnic and 
social groups. 
4. Fourteen percent (n=437) of TB patients were ‘transferred out,’ i.e. left the 
GP practice in which they were first diagnosed during the study period; the 
outcome of these patients is therefore unknown. Their exclusion from the 
final analysis may add a degree of bias to the results. 
5. Smoking was poorly recorded in the GPRD dataset used (only 15% of 
patients were recorded to have ever-smoked, where as the current 
percentage of active smokers in UK society is more like 25%). This under-
ascertainment has been noted in other studies and is equally poor in both 
the exposed and the unexposed groups. Smoking may therefore be 
inadequately controlled for in the multivariable analysis. The risk of death 
in the Cox proportional hazards model was unaffected by smoking (hazard 
ratio of 1.00); it is important however for smoking to remain in the model 
as it is a risk factor for chronic disease and TB169, 170 and therefore a 
potential confounder. 
7.6 Conclusion 
TB leads to increased mortality and a case fatality rate at one year of 6.5%. Mortality is 
particularly high in the first year following diagnosis. Undiagnosed TB, pulmonary TB, 
older age, male gender, malignancy and chronic disease are all associated with a worse 
prognosis. A TB patients chance of survival was 81% at 5 years and 70% at 10 years. 
Death from TB-disease occurred almost exclusively within the first 18 months 
following diagnosis, with 80% occurring prior to, or very shortly after a diagnosis of 
TB. This suggests a missed diagnosis or serious delay in diagnosis and advanced 
disease. Strikingly, the excess mortality of TB patients persists well beyond 5 years 
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even after successful treatment. In patients with TB the rate of death due to cancer was 
nearly double as was the rate of death from respiratory disease other than TB. 
Interventions to improve early diagnosis and treatment of TB may help reduce mortality 
as well as interventions to increase patient awareness of symptoms and when to seek 
health care advice. Awareness needs to be raised in health care professionals, not only 
of the risk factors for TB disease and death, but also that TB patients with a diagnosis of 
chronic respiratory disease and cancer have a higher risk of death. 
By having a greater understanding of TB deaths it should be possible to develop more 
appropriate ways to diagnose and control TB and reduce this potentially preventable 
cause of death. 
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Chapter 8  
 
Discussion 
8.1 Introduction 
This thesis describes the epidemiology of TB from a primary care perspective using 
data from the General Practice Research Database. It is the largest study of TB in 
primary care to date and uses classical epidemiological methods in a case-control and a 
cohort study, and a more recently developed but well established method in two self-
controlled studies. It investigates the epidemiology of TB by assessing primary care 
consultations prior to a diagnosis of TB and morbidity and mortality following TB. In 
so doing it examines the role of primary care in detection, management and patient 
outcomes. 
This research is important because TB is a growing public health problem;2,68,70 and 
most TB research focuses on secondary care. This leads to the role of primary care 
being poorly understood.8,10-13 Primary care has a vital role in identifying TB early to 
reduce patient morbidity, mortality and ongoing disease transmission. To diagnose TB 
early it is essential to understand its epidemiology from a primary care perspective, the 
diagnostic process in primary care, the relationship between the onset of disease and the 
start of treatment and the outcomes for TB patients. The results of this thesis increase 
our understanding of these aspects of TB and could be used to inform ways to diagnose 
TB earlier and improve our prevention and control of TB in the UK. 
8.2 The Epidemiology of TB from a Primary Care Perspective 
Epidemiology as defined in chapter 1 is “the study of the distribution and determinants 
of health-related states or events in specified populations, and the application of this 
study to the control of health problems.”9 This thesis analyses the epidemiology of TB 
from a primary care perspective: pre-TB, via a case-control and a self-controlled study, 
and morbidity and mortality post-TB, via a self-controlled and a cohort study. By using 
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the GPRD as the data source, a longitudinal picture of the course of TB disease and its 
impact on patients can be obtained: this is unique. 
8.2.1 The Epidemiology of TB Pre-Diagnosis 
In the 6 months prior to a diagnosis of TB the research presented in this thesis shows 
that there are clear differences between cases and controls. The case-control study 
reveals that TB cases consult three times more often than controls, with this increasingly 
evident from 4 months pre-TB; cases have higher rates of consultation for TB 
symptoms and respiratory infections, and twice the amount of chronic disease with a 
particularly strong association between TB and chronic respiratory disease. 
The self-controlled study reveals similar findings but of a smaller magnitude: cases 
consult twice as often as controls and show a 3.5 fold increase in consultations for the 
classic symptoms of TB and a nearly 3 fold increase in consultations for ‘respiratory 
infections’ (see Table 8.1). 
The case-control and the self-controlled studies use different methodologies but both 
assess consultation behaviour in the 6 months pre-TB. Consultation behaviour was 
assessed in cases and controls (whether randomly selected controls for the case-control 
study or self controls for the self-controlled study) by comparing consultation rates, the 
frequency of consultations for TB symptoms and respiratory diagnoses and the relative 
importance of these symptoms and respiratory diagnoses and a later diagnosis of TB. 
The relative importance of symptoms and respiratory diagnoses are documented in the 
case-control study by the ‘odds of TB’ and in the self-controlled study by the ‘incidence 
rate ratio’ (IRR). 
The odds ratios for TB in the case-control study and the IRRs for TB in the self-
controlled study were different (see Table 8.1). For example, for cases with ‘any’ of the 
symptoms of TB the odds of TB was 8.37 times higher, whereas the IRR was 3.48 times 
higher. Although not directly comparable these differences may have occurred by 
chance, may represent a true difference between the samples compared (such as more 
chronic disease in cases), may represent an error in the results due to bias (for example 
in the different selection of cases and controls or the impact of the lack of ethnicity / life 
style information) or could be due to confounding (see Section 8.4 for a critique of the 
methods used). 
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Table 8.1 Comparison of case-control and self-controlled study results 
Symptoms  
/ Respiratory diseases 
Case-control study 
OR (95% CI) 
Self-controlled study 
IRR (95% CI) 
Cough 
Fever 
Sweating 
Lymphadenopathy 
Haemoptysis 
Weight loss 
 
Any TB symptom 
5.20 (4.56 – 5.93)* 
9.66 (6.92 – 13.50)* 
70.00 (16.68 – 293.82)* 
32.90 (21.61 – 50.11)* 
32.50 (7.33 – 144.02)* 
14.05 (9.80 – 20.15)* 
 
8.37 (7.43 – 9.41)* 
2.51 (2.15 - 2.93)* 
4.71 (2.99 - 7.42)* 
13.00 (3.86 - 43.80)* 
7.15 (4.16 - 12.29)* 
- 
8.93 (5.19 - 15.38)* 
 
3.48 (3.03 – 4.00)* 
 
*p<0.001 
The important result of these studies pre-TB, is the fact that both studies show that in 
the 6 months before diagnosis, cases consult differently and more often than controls. 
This suggests that there is a delay in the diagnosis of TB in primary care but also that 
opportunities exist to diagnose TB earlier. Chapters 4 and 5 show that from 4 months 
pre-diagnosis there is a clear window of opportunity in which GPs could intervene and 
diagnose TB earlier. Dissemination of the findings of these studies to GPs may raise 
awareness of the different presentations of TB and the strength of their association 
which in turn may assist GPs to make an earlier diagnosis. 
The case-control and self-controlled studies suggest that patients who consult on 
multiple occasions over a 6 month period, particularly with cough or recurrent 
respiratory infections, and without explanatory long-term chronic disease have a greater 
likelihood of TB and should be carefully assessed by GPs for TB. 
Of note, there was a clear difference in case and control consultations even at 6 months 
pre-TB (a time when cases are generally considered to be TB-free). There was a two-
fold difference in case and control consultation rates and a 27% difference between case 
and self-control consultation rates (see Figure 8.1). This difference in consultation rate 
between cases, controls and self-controls may reflect the higher rates of chronic disease 
All respiratory diseases 
(incl. resp. infection) 
6.81 (6.19-7.51)* 
 
2.28 (2.07 – 2.50)* 
All Respiratory infections 7.31 (6.61 – 8.09)* 2.73 (2.47 – 3.01)* 
LRTI 7.81 (6.92 – 8.82)* 2.20 (1.95 – 2.49)* 
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in cases (adjusted OR:2.69) and the therefore higher rates of consultation through 
routine chronic disease follow-up. Further research is needed to understand the 
association between chronic respiratory disease and TB. 
Figure 8.1 Consultation rates in the months pre-TB or index-date for cases, 
controls and self-controls superimposed for comparison 
 
This thesis presents analysis of pulmonary and extra-pulmonary TB and shows that 
these subtypes of TB present differently. The research literature suggests that patients 
with extra-pulmonary TB experience longer delays prior to diagnosis.118 Understanding 
this and how cases present is important to assist faster diagnosis by GPs. My research 
showed that patients with extra-pulmonary TB were younger, had less chronic disease 
and were more likely to be female than those with pulmonary TB. This confirms work 
by others.173-176 As extra-pulmonary TB is on the rise in the UK47 a higher index of 
suspicion by health care workers is needed. My research clearly showed that patients 
with pulmonary and extra-pulmonary TB consulted differently with consultations for 
lymphadenopathy and fever being more common in extra-pulmonary TB, and cough 
and weight loss in pulmonary TB. Interestingly multiple visits are seen equally in 
pulmonary and extra-pulmonary TB. 
Male gender, smoking and individual chronic diseases (particularly chronic respiratory 
disease) were shown by this research to be independent risk factors for TB; this 
confirms and extends the research of others.47,158-160,165-167,169 Raising awareness of these 
risk factors along with those found by Story et al.,133 which included born abroad, 
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homelessness and problem drug use, could help primary care practitioners diagnose TB 
earlier and reduce poor outcomes. 
8.2.2 The Epidemiology of TB Post-Diagnosis 
Morbidity following TB was examined in a self-controlled study. This showed that 
patients who survive at least 18 months post-TB have a good long-term prognosis; 
morbidity was low and the only significant finding was an increase in inhaler 
prescribing (p=0.006). Overall, it appears that TB patients once successfully treated 
return to pre-TB consultation rates and morbidity levels. 
Mortality was examined in a cohort study which showed that TB leads to increased 
mortality (adjusted HR:1.53) and a case fatality rate at one year of 6.5%. Mortality was 
particularly high in the first year following diagnosis and in large part this was due to 
death from undiagnosed and untreated TB. Undiagnosed TB, pulmonary TB, age over 
60, male gender, malignancy and chronic disease were all found to be associated with a 
worse prognosis. This research adds substantially and uniquely to the existing UK 
literature on risk factors for death in TB patients.16,18,27,183 A TB patients chance of 
survival was 81% at 5 years and 70% at 10 years, survival for those without TB was 
87% and 79% respectively. Death from TB disease occurred almost exclusively within 
the first 18 months following diagnosis, with 80% occurring prior to, or very shortly 
after, a diagnosis of TB. This suggests a missed diagnosis or serious delay in diagnosis 
and advanced disease. Strikingly, the excess mortality of TB patients persists well 
beyond 5 years, even after successful treatment. Few other studies have looked at this 
length of follow-up.16,27 Excess mortality beyond 18 months is mostly due to underlying 
chronic disease or cancer. Further research is needed to understand these associations in 
greater depth.  
This thesis shows that chronic disease appears to increase the risk of developing TB, 
delay diagnosis and increase the likelihood of death. The latter association confirms 
work by Fielder that underlying medical conditions are independent risk factors for 
death.32 It is important that GPs are made aware of the association between chronic 
disease and TB mortality as some of the symptoms of TB and chronic respiratory 
disease are obviously similar.  
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For those patients that die at or near diagnosis it was not possible from GPRD data to 
distinguish whether the TB diagnosis was made clinically or at post-mortem. It is a sad 
reflection of UK health care at the start of the 21st century, when TB diagnostics have 
been available for over 100 years and good treatment for at least 50,191 that 17% of TB 
cases that died were diagnosed with TB only at or near death this represents 80% of 
those dying of TB-disease. Diagnosis at death suggests an unacceptable and potentially 
avoidable delay in diagnosis and treatment to such a degree that it has resulted in death. 
Ways to reduce this delay need to be further investigated but would probably need to 
take a two-pronged approach: firstly to educate patients of the signs and symptoms of 
TB and where to seek help so that they present earlier to health care professionals, and 
secondly to educate health care professionals in primary care and accident and 
emergency departments to “THINK TB”. Clinicians should be encouraged to have a 
high index of suspicion for TB and consider TB in any differential diagnosis for a 
variety of conditions especially in older patients with recent chest infections, recurrent 
non-specific consultations or chronic respiratory disease that is not responding to the 
usual forms of treatment. Increasing awareness among health care workers of ‘red flag’ 
symptoms as discussed in Chapters 4 and 5 plus linking these to risk factors for death 
identified by this research – male gender, older age, chronic disease, multiple 
consultations and chest infections could help increase investigation, diagnosis and 
treatment of TB and in turn lead to reduced mortality. Khan et al.189 showed that 
physician experience and knowledge of TB led to a decrease in deaths. This is evidence 
to support the idea that TB education for health care workers improves patient survival. 
8.3 Diagnostic Delay 
Diagnosing TB in low prevalence settings, and in primary care, is challenging as the 
research presented in this thesis shows and is consistent with research conducted by 
others.8, 19, 20, 24, 109, 112 By extrapolation, a diagnostic delay of up to 4 months is seen 
here. There are several possible reasons why TB is diagnosed late in the UK: firstly, 
patients may be unaware of the significance of their symptoms; secondly, doctors are 
less experienced at recognising and managing TB;74 and thirdly, the geographic 
distribution varies with high and increasing rates seen in London and other large cities 
but much lower rates elsewhere.73 The diagnostic challenge that TB poses in primary 
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care is in part due to its variable and non-specific presentation. The difficulty in 
recognising that early symptoms are due to TB is likely to account for much of the 
diagnostic delay seen in this research. Cough is a common problem in primary care and 
for the majority it will not represent TB. This argument is well discussed by Nardell in 
his editorial: “Needles in haystacks: diagnosing tuberculosis under low prevalence 
conditions.”192 Ultimately, the non-specific nature of the symptoms and signs of TB 
makes a degree of diagnostic delay inevitable no matter what interventions are used. 
Understanding the risk factors that lead to a delay in TB diagnosis are crucial to 
reducing delay. I discussed these in depth in Chapter 2. Known risk factors for 
diagnostic delay include: sputum smear negative TB,111,121, 122 extra-pulmonary TB,20,121 
no respiratory symptoms,111,114 a history of asthma,114 HIV infection,122 no chest x-ray 
at the first visit,23,114 ethnic group (white>ethnic),19 older age,25,111 female gender19,25, 111 
and an alternative diagnosis for which an antibiotic is prescribed.114,129 
Diagnostic delay is preventable or at least reducible and ways in which it might be 
reduced in a primary care setting include: 
• Educate the public on TB disease and transmission 
• Initiate targeted population interventions to improve TB knowledge 
• Re-educate healthcare workers (particularly those in primary care) on the 
signs and symptoms of TB and risk factors associated with TB 
• Raise the level of suspicion for TB in health care professionals. 
• Search out active cases via contact tracing investigations 
• Provide UK primary care physicians with clear diagnostic tips / an 
algorithm for diagnosing TB (see Section 8.6 for more details) 
 
This research shows that TB remains a diagnostic challenge and that diagnostic delay 
exists in the UK. A delay in diagnosis is an issue for public health and the prevention 
and control of TB. This research suggests that more needs to be done to raise awareness 
among GPs of TB, its risk factors and other key diagnostic features in the hope that this 
will lead to earlier diagnosis and treatment; and in turn reduce the likelihood of TB 
transmission (see Section 8.6). 
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8.4 A Critique of the Methods Used 
The General Practice Research Database is a powerful tool for epidemiological and 
primary care research. The strengths of the GPRD for this thesis include its size, its 
comprehensive coverage of the UK population (so findings are generalisable within the 
UK setting),76 the fact that it contains continuous, longitudinal primary care data which 
is high-quality and validated80 and that it has been previously used in epidemiological 
studies, particularly respiratory studies.78,80,83,90-92 Its major limitations for a study 
looking at TB, however, are its lack of ethnicity data, HIV data and variations in 
recording. To overcome the lack of ethnicity and socioeconomic data, I used a self-
controlled methodology in addition to a case-control methodology. Additional 
limitations include the fact that the GPRD consists of observational data, there is no 
requirement to enter diagnoses for minor consultations, data recording and analysis is 
complex, it has poor smoking data (a potential confounder) and the details of 
consultations may be hidden in the unsearchable free-text field. Finally, the geographic 
distribution of GP practices submitting data to the GPRD may have meant that the 
patients analysed in this research were a slightly different group to ‘all’ UK TB patients. 
This is because, the GPRD only contains 12% of London GP practices and yet 40% of 
the UKs TB cases are resident in London. However, as the GPRD dataset does not 
provide the actual geographic locality of each patient I may well have analysed more 
patients resident in London and urban settings due to the fact that TB is more prevalent 
in these areas. On balance, the GPRD provided a unique resource for assessing TB 
epidemiology and TB patients pre-diagnosis and long-term. 
An initial weakness of the overall study design was the fact that it excluded patients 
who were not registered with a GP, such as new-entrants and homeless patients who are 
at higher risk of TB. However a recent study in London has identified that the vast 
majority of TB patients are registered with a GP.105 
To understand the diagnosis and management of TB in primary care and to identify risk 
factors for TB I conducted a case-control study as it offered an efficient study design 
and allowed me to take multiple controls. Due to confounding, however, a case-control 
study may not show the true association between an exposure and a disease or in this 
study between consultations pre-diagnosis and disease. At the time of analysis the 
GPRD dataset did not contain any ethnicity data (a major confounder for TB when over 
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two thirds of UK TB occurs in people from ethnic minorities) so although the dataset 
was large, confounding may have affected the results. To try to minimise confounding I 
selected controls from the same GP practice and in a similar age band to TB cases. I 
chose controls from the same GP practice, with the assumption that patients registered 
with the same GP were more likely to be from a similar social background and ethnic 
group; although realising that considerable confounding was likely to still exist.  
To confirm the significance of the results of my case-control study I conducted a self-
controlled (case-only) study as a second method to examine consultation behaviour pre-
TB. Self matching of cases eliminated control selection bias and removed confounding 
by subject characteristics such as gender, ethnicity, chronic illness, social class and life-
style.83,140-142,143 Since the self-controlled analysis included only cases with at least 18 
months of data prior to a TB diagnosis and only one control per case (that is itself) it 
was less powered than the case-control study. I used the self-controlled methodology 
mostly in a descriptive way, rather than analytically, to further understand the 
presentation of TB cases in primary care.  
By using two different methods to essentially measure the same thing, the relationship 
between consultation behaviour prior to diagnosis and disease, I attempted to 
understand and minimise the impact of control selection bias and possible confounders. 
In general, the results of the self-controlled study did not differ greatly from those of the 
case-control study. The self-controlled study confirmed the significance of increased 
consultation rates, a diagnostic delay of up to 4 months and other findings of the case-
control study and showed confounding and control selection bias could be usefully 
minimised by this method. The most striking difference between the two studies was the 
magnitude of the findings in the case-control study.  
Published research clearly shows that TB is more common in ethnic minorities and 
lower socioeconomic groups. I favour the results of the self-controlled study as the truer 
representation of the impact of TB disease on patients. This is because the self-
controlled study, removes the effect of ethnicity and socioeconomic status, in addition, 
to removing the impact of chronic disease and smoking. 
I have discussed most of the strengths and limitations of each study within the 
discussion section of the relevant chapters and so will not do so again here. 
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8.5 Implications for Patients 
This research shows a delay in diagnosis of up to four months was not unusual but that 
patients in the main presented to their GP multiple times before diagnosis. There is 
therefore a window of opportunity for diagnosis. Increasing patient's knowledge through 
education campaigns of TB, its symptoms, signs and risk factors might help patients 
raise the possibility of TB as a diagnosis with their GP. 
This thesis provides new information on the impact of TB on patient’s lives. It shows 
that TB does not influence long-term morbidity and that mortality, if it occurs from TB-
disease is most likely early, where as long-term mortality although slightly elevated is 
similar in cause to the general population. This information if disseminated could 
provide patients with a more realistic picture of the implications of their disease.  
This research suggests that TB screening should be actively encouraged in patients with 
unexplained, recurrent, nonspecific symptoms or chest infections and any patient with 
symptoms suggestive of TB. 
8.6 Implications for Primary Care 
There is little research on TB in primary care. A common finding it that GPs have a 
major role to play in the early diagnosis and treatment of TB.8,10,101,103,108 This thesis 
strongly supports the need for earlier diagnosis in primary care. To help GPs make an 
earlier diagnosis, awareness of TB needs to be raised. This research suggests that 
awareness of the following could be used as ‘red flags’ to raise a GP’s level of suspicion 
for TB: 
• Recurrent chest infections over a few months at a level higher than expected 
for this patient, or more than three chest infections in a 6 month period 
• Respiratory symptoms not responding to antibiotics 
• Recurrent cough (to trigger assessment for the other classic symptoms of 
TB, a chest x-ray and sputum specimen) 
• Any of the rarer TB symptoms i.e. weight loss, haemoptysis or 
lymphadenopathy  
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• Repeat, unexplained visits to the GP for non-specific symptoms 
• Repeat, unexplained visits to the GP in which no diagnosis is made 
• Multiple visits over a few months at a level higher than expected for this 
patient 
• In GP practices, or geographic areas, with a higher proportion of ethnic 
minorities, TB should be high on any list of differentials for patients with an 
unexplained or unresolved cough or any of the classic symptoms of TB. 
 
Combining the knowledge of these ‘red-flags’ with the other features highlighted in this 
thesis such as the risk factors for TB (male gender, older age, suffering a chronic 
disease), the strength of association between clinical presentations and TB and raising 
awareness of newer investigations and the local referral process may help GPs make an 
earlier diagnosis. Practically the recurrent nature of non-specific, non-resolving 
symptoms or recurrent respiratory infections, particularly in patients with a known 
chronic disease, would be something that GP computer systems could flag and in so 
doing raise a GPs level of suspicion for TB. Earlier investigation could be encouraged 
by the use of an electronic prompt based on an algorithm that draws together the 
electronic back-data held on a patient such as consultation rates, symptoms, signs and 
risk factors for TB. 
Informing primary care professionals of the above, of the current epidemiology, risk 
factors and clinical presentations of TB and the process of local referral may lead to 
improved knowledge of the disease as well as earlier diagnosis. This should be a high 
priority in the UK, or at least in areas of higher incidence, and is supported by the work 
contained within this thesis and the limited existing literature on TB in primary care.11-
13,74 There are numerous ways of raising awareness in primary care professionals: online 
educational packages, articles in peer reviewed journals, courses, and locally run TB 
awareness training. 
This thesis shows that patients consult their GP multiple times pre-TB. These visits 
therefore provide an opportunity to potentially diagnose TB earlier. The non-specific 
nature of the early symptoms of TB can, however, make diagnosis harder for GPs. This 
research highlights the strength of association between TB and its symptoms and TB 
and respiratory infections which might help GPs make an earlier diagnosis. In terms of 
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strength of association, symptoms other than cough are more suggestive of TB, and 
‘alert’ symptoms include fever, weight loss and lymphadenopathy plus recurrent 
(greater than three), lower respiratory infections over a 6 month period. Consultations 
for fever and weight loss rise only in the last 1 month pre-diagnosis; it therefore seems 
unlikely that presentation with these will reduce existing diagnostic delay. 
Raising awareness of TB symptoms alone may only help GPs diagnose a minority of 
cases as only 27% of cases in this study had symptoms recorded in a searchable form. It 
is likely however, that the coded symptoms are not a true reflection of the symptoms 
complained of, due to the fact, that GPs tend to record ‘diagnoses’ rather than 
‘symptoms’ (as discussed in Chapter 4). Further symptom information is likely to be 
recorded in the free-text field of the GPRD, but this is not easily searchable. This work 
suggests that raising awareness of TB symptoms and their strength of association is 
important but needs to be part of a package of measures to raise awareness among GPs 
of the local epidemiology of TB, risk factors for TB, other disease associations and the 
process of local referral for diagnostic tests. Further research is needed to assess the 
free-text fields of the GPRD for further information on symptoms and the strength of 
their association to TB. 
This study confirms smoking as a risk factor for TB. The risk of smoking in TB cases is 
one of the most modifiable of all the risk factors. Smoking not only increases the risk of 
developing TB167,168 but also of suffering long-term lung damage.166 Primary care 
practitioners by encouraging and supporting TB patients who smoke to stop could 
therefore have a key role in improving the outcomes of these patients. 
Raising awareness through improved education among health professionals is 
essential,11-13 and particularly for general practitioners, to help them diagnose TB 
earlier. Continuing professional development online modules may be useful for this. 
Davies in a personal paper “The challenge of tuberculosis”74 stated that “the most 
important challenge for TB care in the UK today is the re-education of the medical and 
allied professions in diagnosis and management of the disease.” This statement is very 
much supported by my research. TB awareness-raising among health care professionals 
was highlighted as an area of need in the Chief Medical Officer’s TB Action Plan. As 
primary care is often the first place a symptomatic patient is seen it is important to raise 
awareness of TB in primary care. Using the findings of my research I have written an 
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online educational package about TB for GPs available on doctors.net and for nurses 
available on nursing.net. These online educational packages aim to improve knowledge, 
diagnosis and treatment of TB cases. In addition, in my position as a Consultant in 
Communicable Disease Control I lecture to NW London GPs, practice nurses and health 
visitors on TB, its symptoms, signs and control to try and raise awareness locally. 
Education of health care workers should not only be to improve their knowledge of TB 
but also to raise awareness of the risk factors for TB disease and death and those groups 
most affected. 
8.7 Implications for TB Prevention and Control 
This thesis examines the epidemiology of TB and provides a better understanding of the 
diagnosis, management and outcomes of TB. By understanding the role of primary care 
in TB diagnosis, reviewing the problem of late diagnosis and assessing the long-term 
outcomes of patients in terms of morbidity and mortality, recommendations can be 
made to improve TB control and prevention in the UK. 
It is important for national TB programmes to understand TB patient deaths so that they 
can assess how effective their TB management and control programmes have been. This 
is particularly true in high income countries where death is often the most commonly 
reported reason for TB treatment failure.47 
My cohort study looking at mortality gives a unique insight into the risk factors for 
death from TB in a large sample population. Knowledge of these risk factors in 
conjunction with an increase in consultation rates and repeat chest infections could help 
health care professionals diagnose TB earlier, and lead to quicker treatment and 
decreased mortality. Specifically in the UK, consideration of a diagnosis of TB in older, 
male patients with a known chronic disease (particularly chronic respiratory disease) 
may help to reduce TB mortality. 
This research shows that there is a high burden of potentially preventable mortality as 
shown by the 80% of deaths from TB-disease that occur shortly before, or after 
diagnosis. The information on mortality and its risk factors discussed in this thesis could 
be used to inform the development of strategies to minimise mortality. 
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For clinicians based in both primary and secondary care, this research highlights the 
relative importance of specific symptoms and signs as diagnostic markers for TB. For 
patients, this work could mean faster diagnosis, quicker treatment and reduced 
transmission. 
Serious consideration needs to be given to how to prevent the high early mortality in TB 
patients. The research presented here suggests that diagnosing TB earlier (to reduce 
morbidity and mortality) is not just about educating GPs and patients about the 
symptoms and signs of disease but also what appears to be needed are other ways to 
improve case detection. Examples of this could include increased screening of patient's 
for TB on registration with a new GP, particularly if patients are from an ethnic 
minority, newly arrived immigrants, have existing chronic disease or are smokers; or 
encouraging earlier investigation of patient's who present with symptoms and signs 
compatible with TB, or unexplained respiratory disease; possibly via an electronic 
prompt within a GPs computer system that encourages consideration of TB.  
With the increasing use and availability in hospitals of new blood tests for TB (the 
interferon gamma release assays - IGRAs)193 it may be appropriate to review their use 
and availability in primary care. IGRA tests indicate mycobacterial infection but cannot 
distinguish between latent from active TB. This is an area where further research is 
needed by national bodies to determine the best use of IGRAs and their cost 
effectiveness. 
8.8 Unanswered Questions and Future Research 
As with any research, constraints of time place limits on what can be achieved. Further 
research that could usefully follow from this thesis includes: 
1. An analysis of the GPRD free-text fields to assess what specific TB 
symptoms GPs recorded during the six months pre-TB; or to assess if TB 
was mentioned in the differential diagnosis prior to it appearing as the 
‘actual’ diagnosis. This would help determine if diagnostic delay is in fact 
shorter than this research suggests. 
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2. A cohort study using GP practices to measure the positive predictive value 
of different symptoms and the incidence of TB; two things unobtainable 
from the studies discussed in this thesis. 
3. A critical case review of patients dying from TB disease, looking at patient 
pathways and avoidable causes. 
4. The development and trialling of an electronic decision tool for TB, for use 
in primary care, and based on these research findings. 
8.9 Conclusion 
This thesis presents the largest study of TB in primary care to date. By using the 
General Practice Research Database and up to 12 years of longitudinal data I have 
gained new insight into TB in the UK. As a consequence this research provides a wealth 
of information on TB from a primary care perspective. It increases our understanding of 
the early progression of TB, the risk factors for TB, the strength of association between 
TB, its symptoms and respiratory diagnoses plus quantification of the long-term 
outcomes of TB both in terms of morbidity and mortality. This research offers a unique 
view of the epidemiology of TB and the role of primary care in its diagnosis and 
control. It fills a gap in the research literature on the role of primary care in TB and the 
long-term outcomes of TB patients. Overall, this research indicates a need for improved 
patient and professional awareness of TB and emphasises the need for earlier diagnosis. 
The dissemination of the findings of this work could shorten diagnostic delay and 
improve patient outcomes. 
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Appendix 1  
 
Detailed Search Strategies for Literature Review 
TB and Primary Care 
No. Database Search term 
1 EMBASE, MEDLINE, CINAHL exp TUBERCULOSIS/ 
2 EMBASE, MEDLINE, CINAHL "primary care".ti,ab 
3 EMBASE, MEDLINE, CINAHL "general practice".ti,ab 
4 EMBASE, MEDLINE, CINAHL "family practice".ti,ab 
5 EMBASE, MEDLINE, CINAHL "family practitioner".ti,ab 
6 EMBASE, MEDLINE, CINAHL "general practitioner".ti,ab 
7 EMBASE, MEDLINE, CINAHL "family physician".ti,ab 
8 EMBASE, MEDLINE, CINAHL exp FAMILY PRACTICE/ 
9 EMBASE, MEDLINE, CINAHL exp PHYSICIANS, FAMILY/ 
10 EMBASE, MEDLINE, CINAHL 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 
11 EMBASE, MEDLINE, CINAHL 1 AND 10 
12 EMBASE, MEDLINE, CINAHL 11 [Limit to: Publication Year 1980-2009] 
13  EMBASE, MEDLINE, CINAHL 
12 [Limit to: Humans and English Language] for 
EMBASE, MEDLINE 
 
TB and Diagnostic Delay 
No. Database Search term 
1 EMBASE, MEDLINE exp TUBERCULOSIS/ 
2 EMBASE, MEDLINE diagnos*.ti,ab 
3 EMBASE, MEDLINE delay*.ti,ab 
4 EMBASE, MEDLINE late*.ti,ab 
5 EMBASE, MEDLINE 3 or 4  
6 EMBASE, MEDLINE 2 and 5 
7 EMBASE, MEDLINE 1 and 6 
8 EMBASE, MEDLINE 
7 [Limit to: Publication Year 1980-2009 and 
Humans and English Language] 
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TB Medical Codes Used in GPRD Search 
medcode pcpsmedcode flag description 
010 A 100123 O TUBERCULOSIS WITH ASBESTOSIS 
010 C 100124 O SILICOTUBERCULOSIS 
010 M 100125 O TUBERCULOSIS WITH MINERS' LUNG 
011 100126 O TUBERCULOSIS PULMONARY 
011 A 100127 O TUBERCULOSIS 
011 B 100128 O TUBERCULOUS ABSCESS LUNG 
011 C 100129 O TUBERCULOSIS MILIARY LUNG 
011 D 100130 O TUBERCULOUS BRONCHIECTASIS 
011 P 100132 O TUBERCULOSIS PRIMARY PULMONARY 
0120P 100133 O T B PRIMARY RESPIRATORY (TUBERCULOSIS) 
0121 100134 O TUBERCULOSIS WITH PLEURISY 
0121A 100135 O TUBERCULOUS ADHESIONS PLEURA 
0121B 100136 O TUBERCULOUS EMPYEMA 
0121C 100137 O TUBERCULOUS PLEURAL EFFUSION 
0123 100140 O TUBERCULOUS LARYNGITIS 
0124A 100141 O TUBERCULOMA 
0129 100142 O TUBERCULOUS LYMPHADENOPATHY 
0129A 100143 O TUBERCULOUS NASAL SINUS 
0129B 100144 O TUBERCULOUS LYMPH NODES HILAR 
0129BM 100145 O TUBERCULOUS LYMPH NODES MEDIASTINAL 
0130 100146 O TUBERCULOUS MENINGITIS 
0130M 100147 O TUBERCULOUS MENINGOMYELITIS 
014 100148 O TUBERCULOSIS ABDOMINAL 
014 A 100149 O TUBERCULOUS ABSCESS ISCHIORECTAL 
014 B 100150 O TUBERCULOUS LYMPH NODES MESENTERIC 
014 C 100151 O TUBERCULOUS PERITONITIS 
014 D 100152 O TUBERCULOSIS INTESTINAL 
014 DC 100153 O TUBERCULOSIS ILEOCAECAL 
014 H 100154 O TUBERCULOUS HEPATITIS 
014 RP 100155 O TUBERCULOUS ABSCESS RETROPERITONEAL 
0150A 100156 O TUBERCULOSIS SPINE 
0150AA 100157 O TUBERCULOUS ABSCESS JOINT VERTEBRAL 
0150AB 100158 O TUBERCULOUS ABSCESS VERTEBRA 
0150B 100159 O TUBERCULOUS ABSCESS LUMBAR 
0150C 100160 O TUBERCULOUS ABSCESS ILIOPSOAS 
0150D 100161 O TUBERCULOUS ABSCESS SACRUM 
0150G 100164 O TUBERCULOUS SPONDYLITIS 
0151 100165 O TUBERCULOUS JOINT HIP 
0152 100166 O TUBERCULOUS JOINT KNEE 
0158A 100167 O TUBERCULOUS JOINT 
0158B 100168 O TUBERCULOUS BONE 
0158C 100169 O TUBERCULOUS MASTOIDITIS 
0158D 100170 O TUBERCULOUS DACTYLITIS 
0159 100171 O TUBERCULOSIS SKELETAL 
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0159A 100172 O TUBERCULOUS OSTEOMYELITIS 
0159B 100173 O TUBERCULOUS ARTHRITIS 
0159C 100174 O TUBERCULOUS TENOSYNOVITIS 
0159CW 100175 O T B ABSCESS CHEST WALL (TUBERCULOSIS) 
016 100176 O TUBERCULOSIS GENITO-URINARY SYSTEM 
016 A 100177 O TUBERCULOUS ORCHITIS 
016 BL 100178 O TUBERCULOSIS URINARY BLADDER 
016 EP 100179 O TUBERCULOSIS EPIDIDYMIS 
016 F 100180 O TUBERCULOSIS FALLOPIAN TUBE 
016 K 100181 O TUBERCULOSIS KIDNEY 
016 P 100182 O TUBERCULOSIS PROSTATE 
016 PA 100183 O TUBERCULOSIS SEMINAL VESICLES 
016 PB 100184 O TUBERCULOSIS PROSTATE & SEMINAL VESICLES 
016 PN 100185 O TUBERCULOSIS PENIS 
016 TE 100186 O TUBERCULOSIS URETER 
016 TH 100187 O TUBERCULOSIS URETHRAL 
0170A 100188 O TUBERCULOUS ERYTHEMA NODOSUM 
0170B 100189 O TUBERCULOSIS LUPUS VULGARIS 
0171 100196 O TUBERCULOUS ADENITIS 
0171A 100197 O TUBERCULOSIS AXILLA GLAN 
0171NG 100198 O TUBERCULOUS GLANDS NECK 
0172A 100199 O TUBERCULOUS CHOROIDITIS 
0172L 100200 O TUBERCULOSIS ACHROACYTOSIS LACHRYMAL GLA 
0179 100201 O TUBERCULOUS PERICARDITIS 
0179AR 100202 O T B RELAPSE (TUBERCULOSIS) 
0179B 100203 O TUBERCULOSIS BREAST 
0179C 100204 O TUBERCULOSIS STOMACH 
0179D 100205 O TUBERCULOSIS ADRENAL GLANDS 
0179DA 100206 O TUBERCULOUS ADDISON'S DISEASE 
0181 100207 O TUBERCULOSIS MILIARY 
0189C 100208 O CHRONIC MILIARY TUBERCULOSIS 
5202CT 105094 O OCCLUSAL TUBERCULUM 
4E38.00 124561 R Sputum: tubercle on Z-N stain 
65V9.00 127765 R Notification of tuberculosis 
65V9.11 127766 R TB - tuberculosis notification 
A1...00 147742 R Tuberculosis 
A10..00 147743 R Primary tuberculous infection 
A100.00 147744 R Primary tuberculous complex 
A101.00 147745 R Tuberculous pleurisy in primary progressive tuberculosis 
A10y.00 147746 R Other primary progressive tuberculosis 
A10z.00 147747 R Primary tuberculous infection NOS 
A11..00 147748 R Pulmonary tuberculosis 
A11..11 147749 R Lung tuberculosis 
A110.00 147750 R Infiltrative lung tuberculosis 
A111.00 147751 R Nodular lung tuberculosis 
A112.00 147752 R Tuberculosis of lung with cavitation 
A113.00 147753 R Tuberculosis of bronchus 
A114.00 147754 R Tuberculous fibrosis of lung 
A115.00 147755 R Tuberculous bronchiectasis 
A116.00 147756 R Tuberculous pneumonia 
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A117.00 147757 R Tuberculous pneumothorax 
A11y.00 147758 R Other specified pulmonary tuberculosis 
A11z.00 147759 R Pulmonary tuberculosis NOS 
A12..00 147760 R Other respiratory tuberculosis 
A120.00 147761 R Tuberculous pleurisy 
A120000 147762 R Tuberculosis of pleura 
A120100 147763 R Tuberculous empyema 
A120200 147764 R Tuberculous hydrothorax 
A120z00 147765 R Tuberculous pleurisy NOS 
A121.00 147766 R Tuberculosis of intrathoracic lymph nodes 
A121000 147767 R Tuberculosis of hilar lymph nodes 
A121100 147768 R Tuberculosis of mediastinal lymph nodes 
A121200 147769 R Tuberculosis of tracheobronchial lymph nodes 
A121z00 147770 R Tuberculosis of intrathoracic lymph nodes NOS 
A122.00 147771 R Isolated tracheal or bronchial tuberculosis 
A122000 147772 R Isolated tracheal tuberculosis 
A122100 147773 R Isolated bronchial tuberculosis 
A122z00 147774 R Isolated tracheal or bronchial tuberculosis NOS 
A123.00 147775 R Tuberculous laryngitis 
A124.00 147776 R Resp TB bacteriologically and histologically confirmed 
A124000 147777 R TB lung confirm sputum microscopy with or without culture 
A124100 147778 R Tuberculosis of lung, confirmed by culture only 
A124200 147779 R Tuberculosis of lung, confirmed histologically 
A124300 147780 R Tuberculosis of lung, confirmed by unspecified means 
A124400 147781 R TB intrathoracic lymph nodes confirm bact histologically 
A124500 147782 R Tuberculosis of larynx, trachea & bronchus conf bact/hist'y 
A124600 147783 R Tuberculous pleurisy, conf bacteriologically/histologically 
A124700 147784 R Primary respiratory TB confirm bact and histologically 
A125.00 147785 R Respiratory TB not confirmed bact or histologically 
A125000 147786 R Tuberculosis of lung, bacteriologically & histolog'y neg 
A125100 147787 R Tuberculosis lung bact and histological examin not done 
A125200 147788 R Prim respiratory TB without mention of bact or hist confirm 
A125X00 147789 R Resp TB unspcf,w'out mention/bacterial or histol confrmtn 
A12y.00 147790 R Other specified respiratory tuberculosis 
A12y000 147791 R Tuberculosis of mediastinum 
A12y100 147792 R Tuberculosis of nasopharynx 
A12y200 147793 R Tuberculosis of nasal septum 
A12y300 147794 R Tuberculosis of nasal sinus 
A12yz00 147795 R Other specified respiratory tuberculosis NOS 
A13..00 147796 R Tuberculosis of meninges and central nervous system 
A130.00 147797 R Tuberculous meningitis 
A130000 147798 R Tuberculosis of cerebral meninges 
A130100 147799 R Tuberculosis of spinal meninges 
A130200 147800 R Tuberculous leptomeningitis 
A130300 147801 R Tuberculous meningoencephalitis 
A130z00 147802 R Tuberculous meningitis NOS 
A131.00 147803 R Tuberculoma of meninges 
A132.00 147804 R Tuberculoma of brain 
A133.00 147805 R Tuberculous abscess of brain 
A134.00 147806 R Tuberculoma of spinal cord 
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A135.00 147807 R Tuberculous abscess of spinal cord 
A136.00 147808 R Tuberculous encephalitis or myelitis 
A136000 147809 R Tuberculous encephalitis 
A136100 147810 R Tuberculous myelitis 
A136z00 147811 R Tuberculous encephalitis or myelitis NOS 
A13y.00 147812 R Other specified tuberculosis of central nervous system 
A13z.00 147813 R Tuberculosis of central nervous system NOS 
A14..00 147814 R Tuberculosis of intestines, peritoneum and mesenteric glands 
A140.00 147815 R Tuberculous peritonitis 
A14y.00 147820 R Other gastrointestinal tract tuberculosis 
A14y000 147821 R Tuberculosis of anus 
A14y100 147822 R Tuberculosis of large intestine 
A14y200 147823 R Tuberculosis of small intestine 
A14y300 147824 R Tuberculosis of mesenteric lymph glands 
A14y400 147825 R Tuberculosis of rectum 
A14y500 147826 R Tuberculosis of retroperitoneal lymph nodes 
A14yz00 147827 R Other gastrointestinal tract tuberculosis NOS 
A14z.00 147828 R Tuberculosis of gastrointestinal tract NOS 
A15..00 147829 R Tuberculosis of bones and joints 
A15..11 147830 R Tuberculous osteomylelytis 
A15..12 147831 R Tuberculous arthritis 
A15..13 147832 R Tuberculous synovitis 
A150.00 147833 R Tuberculosis of vertebral column - Pott's 
A151.00 147834 R Tuberculosis of hip 
A152.00 147835 R Tuberculosis of knee 
A153.00 147836 R Tuberculosis limb bones - Tuberculous dactylitis 
A154.00 147837 R Tuberculous mastoiditis 
A15x.00 147838 R Tuberculosis of other specified bones 
A15y.00 147839 R Tuberculosis of other specified joint 
A15z.00 147840 R Tuberculosis of bones or joints NOS 
A16..00 147841 R Tuberculosis of genitourinary system 
A160.00 147842 R Tuberculosis of kidney 
A160.11 147843 R Renal tuberculosis 
A160000 147844 R Tuberculous nephropathy 
A160100 147845 R Tuberculous pyelitis 
A160200 147846 R Tuberculous pyelonephritis 
A160z00 147847 R Tuberculosis of kidney NOS 
A161.00 147848 R Tuberculosis of bladder 
A162.00 147849 R Tuberculosis of ureter 
A163.00 147850 R Tuberculosis of other urinary organs 
A164.00 147851 R Tuberculosis of epididymis 
A165.00 147852 R Tuberculosis of other male genital organs 
A165000 147853 R Tuberculosis of prostate 
A165100 147854 R Tuberculosis seminal vesicle 
A165200 147855 R Tuberculosis of testis 
A165z00 147856 R Tuberculosis of other male genital organs NOS 
A166.00 147857 R Tuberculous oophoritis or salpingitis 
A166000 147858 R Tuberculous oophoritis 
A166100 147859 R Tuberculous salpingitis 
A166111 147860 R Fallopian tube tuberculosis 
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A166z00 147861 R Tuberculous oophoritis or salpingitis NOS 
A167.00 147862 R Tuberculosis of other female genital organs 
A167000 147863 R Tuberculous cervicitis 
A167100 147864 R Tuberculous endometritis 
A167z00 147865 R Tuberculosis of other female genital organs NOS 
A16z.00 147866 R Genitourinary tuberculosis NOS 
A17..00 147867 R Tuberculosis of other organs 
A170.00 147868 R Tuberculosis of skin and subcutaneous tissue 
A170100 147871 R Tuberculosis - lupus vulgaris 
A170z00 147879 R Tuberculosis of skin and subcutaneous tissue NOS 
A171.00 147880 R Tuberculosis with erythema nodosum hypersensitivity reaction 
A171100 147882 R Tuberculous erythema nodosum 
A171z00 147883 R Erythema nodosum with tuberculosis NOS 
A172.00 147884 R Tuberculosis of peripheral lymph nodes 
A172000 147885 R Tuberculous - cervical lymphadenitis 
A172011 147886 R Scrofula - tuberculous cervical lymph nodes 
A172100 147887 R Scrofulous tuberculous abscess 
A172200 147888 R Tuberculous adenitis 
A172z00 147889 R Tuberculosis of peripheral lymph nodes NOS 
A173.00 147890 R Tuberculosis of eye 
A173000 147891 R Tuberculous chorioretinitis 
A173100 147892 R Tuberculous episcleritis 
A173200 147893 R Tuberculous interstitial keratitis 
A173300 147894 R Tuberculous chronic iridocyclitis 
A173400 147895 R Tuberculous keratoconjunctivitis 
A173z00 147896 R Tuberculosis of eye NOS 
A174.00 147897 R Tuberculosis of ear 
A175.00 147898 R Tuberculosis of thyroid gland 
A176.00 147899 R Tuberculosis of adrenal glands - Addison's disease 
A177.00 147900 R Tuberculosis spleen 
A178.00 147901 R Tuberculosis oesophagus 
A17y.00 147902 R Tuberculosis of other specified organs 
A17y000 147903 R Tuberculosis endocardium 
A17y100 147904 R Tuberculosis myocardium 
A17y200 147905 R Tuberculosis pericardium 
A17y300 147906 R Tuberculosis of stomach 
A17y400 147907 R Tuberculosis of liver 
A17yz00 147908 R Tuberculosis of other specified organs NOS 
A17z.00 147909 R Tuberculosis of other organs NOS 
A18..00 147910 R Miliary tuberculosis 
A180.00 147911 R Acute miliary tuberculosis 
A180000 147912 R Acute miliary tuberculosis of a single specified site 
A180100 147913 R Acute miliary tuberculosis of multiple sites 
A18y.00 147914 R Other specified miliary tuberculosis 
A18z.00 147915 R Miliary tuberculosis NOS 
A1y..00 147916 R Other specified tuberculosis 
A1z..00 147917 R Tuberculosis NOS 
Ayu1.00 149556 R [X]Tuberculosis 
Ayu1000 149557 R [X]Other resp tubercul,confirmd bacteriologicly+histologicly 
Ayu1100 149558 R [X]Resp tuberculos unspcfd,confirmd bacteriolog+histologicly 
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Ayu1200 149559 R [X]Oth resp tubercul, w'out m/bacteriol or histol confirmatn 
Ayu1400 149561 R [X]Other tuberculosis of nervous system 
Ayu1500 149562 R [X]Tuberculosis of nervous system, unspecified 
Ayu1600 149563 R [X]Tuberculosis of other specified organs 
Ayu1700 149564 R [X]Acute miliary tuberculosis, unspecified 
Ayu1800 149565 R [X]Other miliary tuberculosis 
Ayu1900 149566 R [X]Miliary tuberculosis, unspecified 
AyuJ000 149819 R [X]Sequelae of central nervous system tuberculosis 
AyuJ100 149820 R [X]Sequelae of genitourinary tuberculosis 
AyuJ200 149821 R [X]Sequelae of tuberculosis of bones and joints 
AyuJ300 149822 R [X]Sequelae of tuberculosis of other organs 
AyuJ400 149823 R [X]Sequelae of respiratory and unspecified tuberculosis 
F004.00 157993 R Meningitis - tuberculous 
F033300 158093 R Encephalitis due to tuberculosis 
F033311 158094 R Tuberculous encephalitis 
F040600 158155 R Tuberculous intracranial abscess 
F041300 158161 R Tuberculous intraspinal abscess 
F4A5500 159718 R Keratitis due to tuberculosis 
G500300 161326 R Acute pericarditis - tuberculous 
G520600 161374 R Acute myocarditis - tuberculous 
H450.00 162924 R Pneumoconiosis associated with tuberculosis 
J550200 164628 R Peritonitis - tuberculous 
Jyu9300 165197 R [X]Tuberculous disorders of intestine and mesentery 
K154800 165894 R Cystitis in tuberculosis 
K214300 166196 R Prostatitis in tuberculosis 
K43..00 167129 R Female tuberculous pelvic inflammatory disease 
K803 168481 O EXCISION TUBERCULOUS LESION JOINT 
L173.00 170891 R Maternal tuberculosis in pregnancy/childbirth/puerperium 
L173000 170892 R Maternal tuberculosis,unspec whether in pregnancy/puerperium 
L173100 170893 R Maternal tuberculosis during pregnancy - baby delivered 
L173200 170894 R Maternal tuberculosis in puerperium - baby delivered 
L173300 170895 R Maternal tuberculosis in pregnancy - baby not yet delivered 
L173400 170896 R Maternal tuberculosis in puerperium - baby previously deliv. 
L173z00 170897 R Maternal tuberculosis in pregnancy/childbirth/puerperium NOS 
N018.00 174422 R Tuberculous arthritis 
N22yD00 176138 R Tuberculous infection of tendon sheath 
N304.00 176470 R Tuberculosis of spine (Pott's) 
N304.11 176471 R Tuberculosis of spine 
N304000 176472 R Tuberculosis of cervical spine 
N304100 176473 R Tuberculosis of thoracic spine 
N304200 176474 R Tuberculosis of lumbar spine 
N304300 176475 R Tuberculosis of sacrum/coccyx 
N305.00 176476 R Tuberculosis of limb bones 
N305000 176477 R Tuberculosis of unspecified limb bone 
N305100 176478 R Tuberculosis of the upper arm bone 
N305200 176479 R Tuberculosis of the forearm bone 
N305300 176480 R Tuberculosis of the pelvic and thigh bones 
N305400 176481 R Tuberculosis of the lower leg bone 
N305500 176482 R Tuberculosis of other limb bones 
N305600 176483 R Tuberculosis of multiple limb bones 
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medcode pcpsmedcode flag description 
N305z00 176484 R Tuberculosis of limb bones NOS 
N306.00 176485 R Tuberculosis of other bones 
N306000 176486 R Tuberculosis of bone, site unspecified 
N306100 176487 R Tuberculosis of the bones of the shoulder region 
N306200 176488 R Tuberculosis of the bones of the hand 
N306300 176489 R Tuberculosis of the bones of the ankle and foot 
N306400 176490 R Tuberculosis of the bones of other sites 
N306500 176491 R Tuberculosis of the bones of multiple sites 
N306z00 176492 R Tuberculosis of bone NOS 
Q402400 180831 R Congenital tuberculosis 
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Appendix 3  
 
Drugs Used to Treat TB – BNF Code Group 05.01.09.00 
Drug Code Drug name 
96773997 ETHAMBUTOL 
96773998 ETHAMBUTOL 
93406992 PYRAZINAMIDE 
95366998 PYRAZINAMIDE 
95314997 RIFAMPICIN+ ISONIAZID 
95314998 RIFAMPICIN+ ISONIAZID 
98684997 RIFAMPICIN+ ISONIAZID 
98694998 RIFAMPICIN+ ISONIAZID 
99178998 RIFAMPICIN+ ISONIAZID 
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Appendix 4  
 
Top 40 GPRD Non-GP Consultations during 6 Months 
Pre-TB 
GPRD consultation diagnosis OXMIS or 
Read Code 
Frequency 
Did not attend - no reason R 2050 
Blood sample -> Lab NOS R 1916 
Reviewed at hospital R 1727 
Blood test O 1587 
Injection given R 1363 
Reviewed at hospital O 1235 
Influenza vaccination R 1190 
Incoming mail NOS R 1183 
DNA (did not arrive) O 1041 
X-ray chest O 886 
Full blood count O 844 
Discharged from hospital R 835 
Certificates - administration R 713 
Influenza vaccine given O 709 
Consultant letter from: R 599 
Seen in general medical clinic R 581 
Letter received O 567 
Letter sent to consultant R 516 
Urine test O 502 
Vaccination prophylactic O 496 
Full blood count - FBC R 481 
Failed encounter R 458 
Immunisations R 453 
Seen in chest clinic R 451 
MSU O 438 
U & E'S (urea & electrolytes) O 432 
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GPRD consultation diagnosis OXMIS or 
Read Code 
Frequency 
Injection given O 413 
Test liver function O 407 
Prescription given no examination of patient R 372 
Failure to attend appointment O 355 
Standard chest X-ray R 340 
Seen in hospital out-pat. R 313 
Seen in medical clinic O 312 
Letter sent to outside agency R 311 
Patient reviewed at hospital R 295 
Seen in hospital casualty R 292 
Blood glucose result R 282 
URINE CULTURE O 275 
Seen in ENT clinic R 259 
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Appendix 5  
 
Visits per Patient by TB Type over the 6 Month Period 
Pre-Diagnosis 
Visits 
ALL TB Extra-pulmonary TB Pulmonary TB 
No. % No. % No. % 
0 visits pre-TB  291 9.6 44 9.1 62 8.2 
1 visit pre-TB 356 11.7 60 12.4 77 10.1 
2 visits pre-TB 383 12.6 62 12.8 84 11.1 
3 visits pre-TB 354 11.7 58 12.0 103 13.6 
>3 visits pre-TB 1648 54.4 259 53.7 433 57.0 
>=6 visits pre-TB 1121 37.0 136 28.2 248 32.7 
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Appendix 6  
 
IRRs and Confidence Intervals for Different TB-Types 
by Symptoms and Respiratory Diseases 
 
Consultation 
types 
ALL TB Extra-Pulmonary TB Pulmonary TB 
IRR 
(95% CI) 
p 
value 
IRR 
(95% CI) 
p 
value 
IRR 
(95% CI) 
p value
Cough 2.51 
(2.15-2.93) 
<0.001
 
1.26 
(0.79-2.01) 
0.327 
 
2.87 
(2.21-3.72) 
<0.001 
 
Fever 4.71 
(2.99-7.42) 
<0.001
 
5.25 
(1.44-19.18) 
0.012 
 
8.67 
(2.58-29.07) 
<0.001 
 
Sweating 13 
(3.86-43.80) 
<0.001
 
- - - - 
Lymphadenopathy 7.15 
(4.16-12.29) 
<0.001
 
8.11 
(2.38-27.69) 
0.001 
 
1.67 
(0.40-6.98) 
0.485 
 
Haemoptysis - - - - - - 
Weight loss 
 
8.93 
(5.19-15.38) 
<0.001 2.5 
(0.48-12.90) 
0.274 16.25 
(5.80-45.56) 
<0.001 
 
All respiratory 
diseases 
2.28 
(2.07-2.50) 
<0.001
 
1.33 
(0.99-1.79) 
0.06 
 
2.38 
(2.03-2.78) 
<0.001 
 
Respiratory inf. 
(incl. cough) 
2.73 
(2.47-3.01) 
<0.001
 
1.35 
(0.98-1.84) 
0.062 
 
2.92 
(2.46-3.47) 
<0.001 
 
LRTI only 
 
2.20 
(1.95-2.49) 
<0.001
 
1.2 
(0.82-1.76) 
0.353 
 
3.04 
(2.42-3.81) 
<0.001 
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Appendix 7  
 
GP Consultations 12-18 Months Pre and 12-18 Months 
Post-TB 
 
Pulmonary (n=477) 
GP consultations 
per individual 
18-12 
months 
pre-diag 
12-18 
months 
post-diag 
IRR Stats using 
GEE Model 
95% CI 
p value 
Consultations for coughs 64 69 1.08 (0.73 – 1.60 ) 0.71 
Consults for resp disease  257 278 1.08 (0.85 – 1.38) 0.52 
Consults for resp infections  190 201 1.06 (0.82 – 1.37) 0.67 
Consultations for LRTI  102 104 1.02 (0.71 – 1.47) 0.92 
Consultations for influenza 7 5 0.71 (0.25 – 2.04) 0.53 
Comment – no statistically significant results  
 
Extra-Pulmonary TB (n=340) 
GP consultations 
per individual 
 
18-12 
months 
pre-diag 
12-18 
months 
post-diag 
IRR Stats using 
GEE Model 
95% CI 
p value 
Consultations for coughs 27 33 1.22 (0.72 – 2.06 ) 0.45 
Consults for resp disease  102 113 1.11 (0.75 – 1.63) 0.60 
Consults for resp infections  81 85 1.05 (0.72 – 1.53) 0.80 
Consultations for LRTI 46 35 0.76 (0.45 – 1.28) 0.30 
Consultations for influenza 2 7 3.5 (0.60 – 20.39) 0.16 
Comment – no statistically significant results 
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APPENDIX 8 
 
Power Calculation for Case Control Study  
 
 
Assuming that 50% of TB cases consult at least 3 times in the 6 months prior to a 
diagnosis of TB and that only 12.5% of controls consult at least 3 times in the same 
time period; in order to have 90% power to observe a significant difference (p<0.05) 
between cases and controls and if 5 controls per case are selected I would need at least 
2,749 cases and 13,745 controls to detect an Odds Ratio of 1.15.  
This size of study should also have ample power to explore the relatively subtle 
differences in consultation behaviour and cope with sub-group analysis. 
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